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Abstract
The burden and behaviour of influenza in Southeast Asia is poorly charac-
terised, leading to uncertainty about the importance of influenza as a local
health problem and the role of Southeast Asia in the global epidemiology of
influenza. Prospective community-based studies have provided fundamental
insights into the epidemiology of influenza in temperate regions; therefore a
household-based cohort study was established with the aim of determining the
intensity and characteristics of influenza transmission in a semi-rural tropical
setting. The primary results of the cohort study are presented, along with the
results of a survey of social contact patterns in the cohort and a mathemati-
cal model of the spread of pandemic influenza A/H1N1/2009 in Vietnam that
utilises data from the cohort.
Highly pathogenic avian influenza A/H5N1 remains endemic in poultry in parts
of Southeast Asia and continues to infect humans. Marked familial clustering of
human H5N1 cases has led to speculation that susceptibility to H5N1 infection
may have a host genetic component. The epidemiological data that led to
the hypothesis of genetic susceptibility to H5N1 is summarised, whilst the
evidence for a role of host genetics in susceptibility to influenza in general
is systematically reviewed. A genome-wide case-control genetic association
study was conducted in Vietnam and Thailand to test the hypothesis of genetic
susceptibility to H5N1 infection, and the results are presented.
This work provides new data and understanding of the patterns and deter-
minants of inter-pandemic, pandemic, and avian influenza epidemiology. The
cohort study has added to the body of knowledge that is accruing on the
burden and epidemiology of influenza in the tropics by providing community
level data that were previously absent. The genetics study has provided the
first direct evidence of genetic loci associated with susceptibility to H5N1 and
opens new avenues of research to test these findings and their relevance to the
pathogenesis of H5N1 and other types of influenza.
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Preface
This thesis is divided into two major sections. The first deals with the results
of a prospective community cohort that was established to provide data on
the epidemiology of inter-pandemic influenza in Vietnam. The cohort was
running when pandemic influenza A/H1N1/2009 emerged and therefore also
provides data on the epidemiology of pandemic influenza in Vietnam. The
second section deals with work to test the hypothesis that host genetic factors
play an important role in susceptibility to highly pathogenic influenza A/H5N1.
Since the epidemiology of H5N1 is quite different from inter-pandemic and
pandemic influenza, each section begins with a separate description of the
scientific background to the work and the research questions.
In accordance with the LSHTM Research Degrees Regulations, much of the
thesis is presented as a series of published or accepted research manuscripts.
The research papers are supplemented by additional material to explain my
contribution, to provide additional methodological details, and to describe how
the thesis represents a coherent body of new scientific material. The presen-
tation of the work as a series of stand-alone manuscripts inevitably results
in some repetition of background information. Differing editorial conventions
between journals may result in inconsistencies in terminology and formatting.
I conceived of all the presented research, drafted all the research protocols
and data collection instruments, submitted all protocols for ethical approval,
implemented the studies, and supervised all the field work and data collection.
I either analysed data personally or was closely involved in any statistical or
mathematical analysis that was led by other individuals. The laboratory work
was conducted by others but I was involved in the planning and design of
all laboratory analyses and the interpretation of results. Where colleagues
have contributed to laboratory or statistical aspects of the work this is clearly
acknowledged.
Research by foreign academic individuals and institutes within Vietnam must
be conducted in partnership with a local ‘competent authority’, which for
health research is an institute under the jurisdiction of the Ministry of Health.
The work presented in this thesis was conducted under the umbrella of a
project agreement between the National Institute of Hygiene and Epidemi-
ology (NIHE) and the Oxford University Clinical Research Unit in Hanoi. The
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research was approved by the Institutional Review Boards of NIHE, the Viet-
nam Ministry of Health, and the Oxford University Tropical Research Ethics
Committee. The host genetics work in Thailand was conducted in partnership
with the Ministry of Public Health.
The term ’inter-pandemic influenza’ is used to distinguish influenza subtypes
that normally circulate in humans from avian influenza viruses and from the
pandemic influenza A/H1N1 strain that emerged in 2009. The term ’seasonal
influenza’ is not used since seasonality is less marked in the tropics and pan-
demic influenza A/H1N1/2009 also exhibits seasonality. For brevity the term
‘H5N1’ is used to refer to highly pathogenic avian influenza A/H5N1 unless
otherwise stated.
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Chapter 1
General introduction
1.1 Influenza viruses
Influenza viruses are enveloped RNA viruses of the family Orthomyxoviridae with a
segmented negative-sense, single-stranded genome. They can be categorised serologically
and genetically into three types (A,B, and C). Influenza B and C are predominantly
human pathogens whilst type A naturally infects a wide range of birds and mammals.
Influenza A is the most important type since it regularly causes large epidemics and, when
a new subtype emerges to which the population are immunologically na¨ıve, can cause a
global outbreak (pandemic). Type A is categorised into subtypes based on the antigenic
characteristics of two surface glycoproteins, hemagglutinin (HA) and neuraminidase (NA).
There are currently 16 identified HA (H 1-16) and 9 NA (NA 1-9) antigenic variants,
giving a total of 144 possible HA-NA combinations. Only 3 HA subtypes (H1, H3, and
H2) and 2 NA subtypes (N1 and N2) are known to have caused sustained transmission
in human populations. The majority of HA and NA combinations have been identified in
aquatic birds, which are the primary natural reservoir of influenza A viruses, and which
are thought to be the source of progenitor viruses or gene segments of pandemic influenza
A strains (Alexander, 2007). Zoonotic, non-human-adapted, influenza A viruses, such as
highly pathogenic avian influenza (HPAI) A/H5N1, occasionally infect humans.
Host range restriction of influenza A viruses is multi-factorial but one key determinant
is HA receptor binding specificity (Kuiken et al., 2006). Influenza viruses infect cells
through the binding of HA to the terminal sialic acid molecules of glycoproteins and
glycolipids expressed on host cell membranes, and the subsequent fusion of viral and
cell membranes (Gamblin and Skehel, 2010; Wiley and Skehel, 1987). HA is synthesised
as a precursor protein HA0 that must be cleaved by host proteases into HA1 and HA2
for membrane fusion to occur. Whilst the HA of human influenza viruses preferentially
bind sialic acid with an α2-6 linkage to galactose residues, which are abundant in the
upper respiratory tract of humans, avian viruses bind more readily with an α2-3 linkage,
which are found in the intestinal tract of birds and the lower respiratory tract of humans
(Kuchipudi et al., 2009; Shinya et al., 2006). Swine viruses are able to bind sialic acid in
both types of linkage (Gamblin and Skehel, 2010; Glaser et al., 2007; Matrosovich et al.,
2006; Skehel and Wiley, 2000). The receptor binding and infection process is however
almost certainly more complex and nuanced than a simple dichotomy between human-α2-
6-upper airway and avian-α2-3-lower airway, and the specific identify of the cell-surface
13
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molecules to which HA binds is not yet known (Matrosovich et al., 2006; Nicholls et al.,
2008; Peiris et al., 2009; Shelton et al., 2011; Viswanathan et al., 2010).
Influenza viruses have a high potential for genetic and antigenic diversity. This is the
result of two intrinsic characteristics. First, influenza viruses have no system of ‘proof-
reading’ during replication of viral RNA by the viral polymerase, leading to high rates of
uncorrected transcription errors. This potential for diversity is actualised most strongly
in the HA as a result of immune-mediated selection pressures. The binding site of the HA
protein is the main target for neutralising antibodies and this region is therefore under
intense immune-mediated selection pressure, resulting in the acquisition and retention
of amino acid substitutions which favour escape from immunity. The result is regular
epidemics caused by antigenically distinct (drifted) strains, which are well visualised using
the technique of antigenic cartography (Smith et al., 2004). The second characteristic is the
segmented nature of the influenza genome, which allows for reassortment of gene segments
when cells are concurrently infected with more than one influenza strain. Reassortment
can result in the generation of novel strains to which there is little population immunity,
causing a pandemic.
1.2 Influenza disease in humans
Influenza is one of the commonest infections of humans, with a recent meta-analysis
estimating there were 20 million cases of influenza-associated acute lower respiratory tract
infection and 1 million severe cases in children younger than 5 years in 2008 (Nair et al.,
2011). In the US between 1976 and 2007, influenza-attributable mortality was estimated
at between 1.4 to 16.7 deaths per 100,000 persons, with around 90% occurring in people
≥ 65 years of age (CDC, 2010). Similar results have been found elsewhere (Cohen et al.,
2010; Nielsen et al., 2011; Nunes et al., 2011; Yang et al., 2011). Estimating the health
burden of influenza is however difficult since influenza may not be recognised as the im-
mediate cause of death even though it precipitated the illness event, and influenza burden
is highly heterogenous, with an epidemic profile that may go relatively unnoticed or cause
a pandemic with tens of millions of deaths.
The clinical syndrome of influenza is classically associated with upper respiratory tract
symptoms accompanied by fever, headache and myalgia; although mild and subclinical
infection is common. Children generally have the highest clinical attack rate since they
are immunologically na¨ıve. Although antibodies directed against the binding site of the
HA are the primary mechanism for neutralising immunity, a wide range of other host
responses influence the probability of infection and the severity of illness e.g. antibodies
to NA, antibodies to conserved regions of the HA protein, innate immune responses, cell-
mediated immunity, and HA glycosylation. There is particular interest in the potential
of inducing immunity to a range of subtypes (heterosubtypic immunity) through cell-
14
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mediated or humoral immunity directed against conserved epitopes, such as the fusion-
peptide of the HA2 molecule (Corti et al., 2011; McMichael et al., 1983).
Severe disease is most frequently seen in the very young, the elderly, and people with
chronic medical conditions, and, as with several other infections, pregnancy is also a risk
factor for severe influenza-associated disease (Jamieson et al., 2006). Whilst such host
factors are important in determining disease severity, viral factors are equally important.
The determinants of the high virulence of the 1918 H1N1 and H5N1 viruses is not com-
pletely understood but is clearly polygenic, with polymorphisms in the HA, NS1, and the
polymerase complex genes all playing a role (Basler and Aguilar, 2008; Fukuyama and
Kawaoka, 2011). However, one key determinant of virulence is tissue tropism, which is
co-determined by receptor binding affinity and the specificity of host proteases involved in
post-translational cleavage of HA0. The α2-3 linked sialidases found in the intestinal tract
of birds, to which avian influenza viruses have a high binding affinity, are also found more
commonly in the terminal bronchioles and alveoli of humans (Shinya et al., 2006; van Riel
et al., 2006). Whilst human-type receptor affinity seems to be associated with attenuation
of virulence and efficient human-to-human transmission (van Riel et al., 2010; Watanabe
et al., 2011), avian-type receptor affinity is seen in H5N1 and has been identified in some
viruses causing severe 1918 H1N1 and 2009 H1N1 disease (Chutinimitkul et al., 2010;
Sheng et al., 2011; Watanabe et al., 2011). Human-adapted viruses and low-pathogenic
avian viruses posses a single arginine at the site of cleavage of HA0 into HA1 and HA2.
The presence of multiple basic amino acids1 at this site is a feature of highly pathogenic
avian influenza viruses and permits the cleavage of HA0 by intracellular enzymes present
in wide range of tissues, resulting in extensive virus replication and systemic infection
(Perdue et al., 1997). This feature is however not alone sufficient to cause severe disease
in humans since a highly pathogenic H7N7 virus with multiple basic amino acids at the
cleavage site caused generally mild illness in humans in the Netherlands in 2003 (Fouchier
et al., 2004).
1.3 Influenza epidemiology in humans
Influenza epidemiology is characterised by annual winter epidemics at higher latitudes,
with periodic influenza A pandemics that may escape seasonal patterns (Shaman et al.,
2011; Tamerius et al., 2011). The attack rate varies from 10-40% per season depending
on the immunological attributes of the population, the antigenic novelty of the virus,
and the transmission intensity (which may vary with climate and contact behaviours).
Transmission is through infectious respiratory secretions but the relative contribution of
large respiratory droplets versus small airborne particles remains unresolved, and perhaps
differs with climate (Brankston et al., 2007; Lowen and Palese, 2009; Tellier, 2009). The
1Histidine, Lysine, and Arginine
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explosive nature of influenza epidemics in temperate areas is largely due to the short serial
interval1 rather than its intrinsic infectiousness (Boelle et al., 2011; Cowling et al., 2009;
Truscott et al., 2012).
Annual influenza epidemics and periodic pandemics are a testament to the adaptive
competence of influenza, yet whilst the molecular processes underlying influenza evolution
are fairly well described, the population and environmental dynamics driving global in-
fluenza evolution are less well understood. A central question remains “when and where
does most antigenic drift occur?”(Nelson et al., 2007). The answer is important since it
may offer opportunities to either predict evolution or use strategic surveillance to detect
emerging new strains. Antigenic drift has not been observed within one locality and sea-
son (Lavenu et al., 2006), and several authors have proposed a source-sink model, where
East and Southeast Asia acts as a regional source of drifted viruses that seed annual sea-
sonal epidemics in temperate regions (Rambaut et al., 2008; Russell et al., 2008). This
source-sink model has however recently been challenged by Bahl et al. (2011) and the role
of the tropics in general and of Southeast Asia in particular in the global epidemiology of
influenza remains unclear.
In temperate regions the annual pattern of influenza epidemics, with alternation of
dominant subtypes/antigenic variants, has been attributed to a combination of homosub-
typic immunity lasting 3-8 years, short lived heterotypic immunity, and a seasonal forcing
component (Ferguson et al., 2003; Truscott et al., 2012). The seasonal forcing component
has been variously postulated to be contact behaviours, absolute humidity, and Vitamin
D concentrations (Cannell et al., 2008; Shaman et al., 2011). Attempts have not been
made to model the parameters that determine patterns of influenza in the tropics, since
patterns have not yet been well delineated.
Avian and swine influenza viruses occasionally infect humans, causing disease of vari-
able severity, and although limited person-to-person transmission of both H5N1 and H7N7
has occurred it has not been sustained. Recent publicised but unpublished work in ferret
models show that H5N1 can readily adapt to become transmissible by the aerosol route
whilst retaining virulence, so there is no reason to believe that highly pathogenic animal
influenza viruses are unable to successfully adapt to humans. Indeed, the pandemic viruses
of 1918, 1957, 1968, and 2009 all possessed novel gene segments thought to be of animal
origin (Guan et al., 2010).
1.4 Influenza in East and Southeast Asia
East and Southeast Asia has been of interest to the influenza community for some time
as a possible epicentre for the generation of novel influenza viruses (Shortridge and Stuart-
Harris, 1982). However, three relatively recent events reignited international interest in
1The time interval between successive cases in the chain of transmission
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influenza in tropical areas of East and Southeast Asia: Severe Acute Respiratory Syndrome
highlighted the potential for new zoonotic pathogens to emerge and spread rapidly from
Asia to affect the rest of the world; the epizootic of H5N1 that began in 2003 resulted in
unprecedented numbers of human H5N1 cases with concerns of person to person spread of
a highly virulent pathogen; and genetic and antigenic analyses of the HA suggested that
influenza H3N2 virus strains causing seasonal outbreaks in temperate areas may originate
from a transmission network within East and Southeast Asia (Rambaut et al., 2008; Russell
et al., 2008). These events have led to a perception that the control of avian and human
influenza in East and Southeast Asia is a ‘global public health good’ (Lee et al., 2007).
Vietnam is viewed as an important stakeholder in improved global understanding of
avian and human influenza since it possesses a large backyard and commercial poultry
industry in which H5N1 is endemic and has a large human population living in close prox-
imity to one another and to poultry and pigs. It is also one of only three countries to have
reported more than 100 human H5N1 cases and is closely linked to Southern China, where
avian influenza viruses circulate widely in wild and domestic birds. The surveillance and
control of inter-pandemic influenza in Vietnam, although of less direct international inter-
est, is viewed as a mechanism for establishing the infrastructure, expertise, and systems
for control of more globally threatening influenza viruses.
1.5 Influenza in Vietnam
Prior to 2004 influenza was a low priority for the Ministry of Health (MoH) and
research community in Vietnam, with national surveillance limited to routine monthly
reporting of influenza-like illness (ILI) cases by administrative area, and one small study
of virologically confirmed influenza in Hanoi (Nguyen et al., 2007). Influenza vaccination
was not available in the public or private sector. This changed with the emergence in 2003
of H5N1 and its transmission to humans. Although it was known prior to 2003 that H5N1
was present in poultry in Vietnam, this fact and its significance had escaped local health
and veterinary authorities (Jadhao et al., 2009; Nguyen et al., 2005).
The re-emergence of H5N1 in Asia in 2003 was first detected in Vietnam following the
investigation of a cluster of unexplained deaths from respiratory illness in children and this
resulted in enormous international pressure on Vietnam to investigate and control H5N1
in poultry and prevent human infections (Tran et al., 2004). As a result, Vietnam has
seen considerable investment in influenza surveillance, with the establishment in 2005 of
a World Health Organisation (WHO) designated National Influenza Centre (NIC) at the
National Institute of Hygiene and Epidemiology (NIHE) and the development of a national
influenza surveillance program in 2005 (Nguyen et al., 2009). Vietnam has also invested
in influenza vaccine development, with the generation of H5N1 vaccine seed strains and
the development of influenza vaccine pilot lot production capabilities at three sites under
17
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a cooperative agreement with United States Department of Health and Human Services
(Hoa et al., 2011).
1.6 Vietnam
Vietnam has a land area that is about 30% greater than that of the United Kingdom
and is an elongated country with a length of 1,650 km that straddles different climate
zones. It lies within the Tropic of Cancer, and whilst the climate is constantly hot in
the southern region, with temperatures rarely dropping below 20◦C, the northern region
has four distinct seasons, with winter temperatures occasionally falling as low as 10◦C in
Hanoi. It has a long land border, with China to the north and Laos and Cambodia to
the east. It is the third most populous country in Southeast Asia after Indonesia and the
Philippines, with an estimated population of 85.7 million (GSO, 2010). The population
density is 259 persons/km2, slightly higher than that of the UK. 30% of the population
live in urban areas and the population is concentrated in the agriculturally productive
and industrial zones of the Red River Delta in the north and the Mekong River Delta in
the south. The age distribution of the population is: 25% aged under 15 years, 68% aged
15-64 years, and 7% aged 65 years or more (GSO, 2010).
Vietnam has experienced sustained economic growth in the last two decades (average
annual growth 7.1%) and recently transitioned from a low income to a lower-middle income
country. The per capita gross national income in 2010 was estimated to be around 1,000
US$, and around 60% of the population have unskilled occupations or work in agriculture,
fisheries, and forestry. Around 13% of the population live on less than 1.25 US$ per day
(2008 Asian Development Bank estimate). Vietnam has good health and development
indicators relative to its gross domestic product.
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Chapter 2
Background to household
cohort study
2.1 Longitudinal community studies
Influenza infection is often mild and cases self-presenting to health service providers
are not representative of the true incidence and distribution of infection. Community-
based studies are therefore necessary to fully understand the epidemiology of influenza
and since influenza epidemiology varies by season, these studies need to be longitudinal
(Monto, 1994). Such studies are important since the impact of public heath measures such
as immunisation, social distancing, and chemoprophylaxis, on the incidence of influenza
are dependent on the dynamics of influenza transmission (Ferguson et al., 2006). With the
direct and indirect benefits of influenza control measures targeted at specific population
subgroups being contingent on the burden of infection and disease in that group, and the
contribution of that group to onward transmission of infection.
Seminal community-based studies of influenza transmission were conducted in the
United Kingdom and the United States from the 1920’s to the early 1980’s, and are
the source of much of our current understanding of the epidemiology of influenza. These
studies have been summarised by Fox (1974) and Monto (1994), and have consistently
demonstrated that influenza is a common cause of respiratory illness in the studied com-
munities. The Cleveland Family Study reported seroconversion rates1 of 15-25% during
epidemic seasons (Jordan et al., 1958); the New York Virus Watch study reported sero-
conversion rates of 12% for influenza A and 3% for influenza B (Hall et al., 1971); the
Seattle Virus Watch study reported seasonal infection rates of up to 31% (Fox et al., 1982,
1972); the Tecumseh study reported influenza seroconversion rates of 16.7% for influenza
A and 7.6% for B (Monto and Kioumehr, 1975); and the Houston Family study found
H3N2 infection rates of 33%, H1N1 of 15%, and B infection rates of 20-24% (Frank et al.,
1983, 1985). These studies have also provided data on the relative pathogenicity of in-
fluenza types and subtypes, with a tendency for H3N2 to cause more severe disease and
more infections in adults compared to H1N1 and B (Fox et al., 1982; Hope-Simpson, 1984;
Monto et al., 1985; Monto and Sullivan, 1993). However, the data also demonstrate that
“there is no such thing as a typical year” (Monto, 2008).
1The denominator for rates varies between studies and are summarised in the table on page 58
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These community studies have also demonstrated that there are high rates of serolog-
ical evidence of infection without corresponding disease (Hall et al., 1973; Jordan et al.,
1958; Monto, 1994); that, depending on the season and subtype, pre-school or school-age
children have the highest rates of infection, (Fox et al., 1982; Glezen and Couch, 1978;
Hall et al., 1973; Hope-Simpson, 1984; Jordan et al., 1958; Lidwell and Sommerville, 1951;
Monto and Kioumehr, 1975; Monto et al., 1985); that mothers have higher attack rates
than fathers (Badger et al., 1953b; Hall et al., 1971; Jordan et al., 1958; Monto and Sul-
livan, 1993); and that school-age children play an important role in introducing infection
into families (Badger et al., 1953a; Fox et al., 1982; Lidwell and Sommerville, 1951; Monto
and Kioumehr, 1975; Philip et al., 1961). More recent studies have enrolled households
of index influenza cases presenting to health care facilities, confirming the importance of
children in transmitting infection within households, and refining estimates of the house-
hold secondary attack rate and serial interval (Boelle et al., 2011; Cauchemez et al., 2004;
Cowling et al., 2010; Viboud et al., 2004). The findings from these observational studies
have been used to guide influenza control interventions in both field studies (Hurwitz et al.,
2000; Monto et al., 1970; Reichert et al., 2001) and computer simulations (Ferguson et al.,
2006; Glass and Barnes, 2007), and provide the rationale for the use of school closure
and childhood immunisation to reduce the overall incidence of influenza in the community
(Cauchemez et al., 2009; Reichert et al., 2001).
2.2 Social contact patterns
Rates of contact between individuals of different ages are thought to be a key de-
terminant of influenza transmission patterns and are a core component of mathematical
models to predict epidemic dynamics and the impact of control measures (Wallinga et al.,
1999, 2006). Such models are increasingly being used to guide decisions about the appli-
cation of control measures (Keeling and Danon, 2009). Social contact patterns relevant
to the spread of respiratory-transmitted infections such as influenza are dependent on
many factors, such as household size, family structures, child care arrangements, working
patterns, commuting patterns, and schooling. Since these factors are likely to vary with
socio-economic, cultural, and climatic conditions, it is possible that social contact patterns
may also vary. As with the community studies of influenza transmission, empirical studies
of social contact patterns relevant to influenza transmission have been conducted almost
exclusively in Europe and the US (Edmunds et al., 1997; Glass and Glass, 2008; Mossong
et al., 2008).
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2.3 Inter-pandemic influenza in East and Southeast Asia
Whilst it has long been suggested that China may be an epicentre for influenza evo-
lution (Shortridge and Stuart-Harris, 1982), influenza associated morbidity and mortality
had been assumed to be unimportant in the tropics and subtropics. This assumption be-
gan to be challenged by studies in the late 1990’s and early 2000’s. Simmerman and Uyeki
(2008) have summarised the English language literature on the burden of influenza in
East and Southeast Asia from 1980 to 2006, and although the data are somewhat limited,
it appears that the burden of influenza in high income countries of East and Southeast
Asia (Hong Kong, Singapore, Thailand, and Japan) is similar to Europe and North Amer-
ica; with 11-26% of outpatients with ILI having laboratory confirmed influenza infection,
and influenza being identified in 6-14% of pneumonia admissions (Simmerman and Uyeki,
2008). Studies published since the review by Simmerman and Uyeki add to the evidence
that influenza causes a substantial burden of disease in Southeast Asia (Brooks et al., 2010;
Clague et al., 2006; Hanshaoworakul et al., 2009; Lee and Fidler, 2007; Lee et al., 2009;
Leo et al., 2009; Nair et al., 2011; Simmerman et al., 2009; Viboud et al., 2006; Yang et al.,
2011). In fact, influenza associated hospitalisation rates in young children may be higher
than in temperate developed countries (Chiu et al., 2002; Nair et al., 2011; Simmerman
et al., 2009; Wong et al., 2006). Nevertheless, large gaps remain in our understanding
of the burden of influenza amongst the enormous population of poor people in East and
Southeast Asia (e.g. China, Indonesia, and the Philippines).
The periodicity of inter-pandemic influenza in Southeast Asia is also gradually be-
ing elucidated, with data showing that although epidemics may be less pronounced, less
synchronous between countries, and less predictable in tropical and subtropical regions
compared to temperate regions, seasonal influenza epidemics clearly do occur, usually as-
sociated with the rainy season (Moura, 2010; Nelson et al., 2007; Russell et al., 2008; Shek
and Lee, 2003; Tamerius et al., 2011; Viboud et al., 2006), with some areas experiencing
more than one transmission period per year (Chew et al., 1998; Lee et al., 2009; Simmer-
man et al., 2009; Wong et al., 2006; Yang et al., 2011). The less distinct epidemic patterns
probably contribute to the earlier misperception that influenza is not a significant health
issue in the tropics and subtropics. Parts of the tropics and subtropics experience extended
viral circulation compared to temperate areas, but it has not been shown that there is
continuous year-round circulation of any single influenza subtype in any one country (Bahl
et al., 2011; Russell et al., 2008).
Despite the value of the longitudinal community studies mentioned above, very few
comparable studies have been undertaken in Southeast Asia. Since population densities,
family structures, behaviours, material conditions, health and climate are different in
Southeast Asia compared to the USA or the UK, the epidemiology of influenza transmis-
sion may also differ in important ways. Only one household-based study of influenza in
Asia has been published (Riley et al., 2011). This study analysed paired serology from
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770 individuals aged 3 - 103 years in Hong Kong to make estimates of the 2009 pandemic
H1N1 infection rate and to identify risk factors for infection. The study found age-specific
infection rates similar to those reported elsewhere, and identified an increased risk of in-
fection in adults who shared their household with a child (Riley et al., 2011). The 2009
pandemic H1N1 is not however characteristic of inter-pandemic influenza, and Hong Kong
is not characteristic of Southeast Asia.
2.4 Inter-pandemic influenza in Vietnam
Influenza vaccine development is being encouraged and pursued in Vietnam (Hoa et al.,
2011; Perdue and Bright, 2011), yet little is known about the epidemiology of influenza
in Vietnam other than the periodicity of strains detected through sentinel surveillance (Li
et al., 2008; Nguyen et al., 2009, 2007). Vital statistics data are too unreliable and frag-
mentary to make estimates of excess mortality from influenza-associated illness (Rao et al.,
2010) and although ILI is one of 24 legally notifiable disease syndromes in Vietnam, there
is no laboratory confirmation of aetiology and the data are not available disaggregated
by age. If inter-pandemic and pre-pandemic influenza vaccination is to be considered in
Vietnam it is possible that a school age programme may be an efficient strategy since
childhood vaccination may have a community wide protective effect (Hurwitz et al., 2000;
Monto et al., 1970; Reichert et al., 2001) and Vietnam has no systems established for iden-
tifying and vaccinating high-risk adults. However data from Vietnam to guide the design
and implementation of immunisation and other influenza control policies are lacking.
2.5 Objectives of household cohort study
A household-based cohort was established with the aim of estimating the incidence
of ILI and laboratory confirmed influenza infection in the community; describing age and
gender specific clinical and sub-clinical attack rates; identifying risk factors for influenza
infection; and describing contact patterns within the cohort in order to provide local
parameters to guide influenza control programmes and to improve understanding of the
dynamics of influenza transmission in tropical Southeast Asia.
2.6 Candidate’s role
I conceived the study, acquired funding (Principal Applicant Wellcome Trust grant
WT081613/Z/06/Z), wrote the protocol and case record forms, and prepared all the pa-
perwork for ethical approval in the UK and Vietnam. I was the Principal Investigator of the
study and directly supervised all aspects of study implementation in Vietnam, including
field staff appointment and training, the preparation of Standard Operating Procedures,
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data management, and finances. Laboratory assays were conducted by trained laboratory
personnel under the supervision of our Unit immunologist Dr Annette Fox.
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Chapter 3
Contribution of research
papers(cohort study)
This chapter briefly introduces the research papers compiled in this thesis that arose
from the cohort study and describes how they form an original contribution. Three papers
are included, of which I am the first author on two and senior author on one. I am the
corresponding author on all three papers.
3.1 Outline of research papers
3.1.1 Research paper 1
Research paper 1 is currently in press as Horby et al. (2012) and describes the main
results of the cohort study, focusing on the estimated incidence of influenza infection and
illness by season, subtype and age. The paper also presents an analysis of risk factors for
influenza infection. This paper is only the second published longitudinal, household-based
study of influenza infection and disease from a tropical country; the other being the paper
by Riley et al. (2011) that looked only at pandemic H1N1. Research paper 1 is therefore
the first publication to assesses the incidence and risk factors for both inter-pandemic and
pandemic influenza in a community in the tropics.
3.1.2 Research paper 2
Research paper 2 was published as Horby et al. (2011) and describes the results of the
social contact and mobility survey that was conducted in the cohort in order to provide
data for estimating influenza transmission probabilities by age and gender. This paper
represents the first published data from either a developing country or a tropical country
on social contact patterns relevant to the transmission of influenza. As such the work
represents an important contribution to the literature on social contact patterns and in-
fectious disease transmission. It is also the first publication to examine contact patterns
in a household structured design.
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3.1.3 Research paper 3
Research paper 3 was published as Boni et al. (2009) and describes the results of a
mathematical modelling exercise to predict the burden and spread of pandemic H1N1 in
Vietnam that was parametised using the social contact and mobility data presented in
research paper 2, and other data assembled by the authors. This paper demonstrates
the practical application of the data collected through the cohort study to predict the
epidemiology of influenza in Vietnam, and is the first published mathematical model of
influenza epidemiology in Vietnam.
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Research paper 1
Title: The epidemiology of inter-pandemic and pandemic influenza in Vietnam, 2007-
2010: the Ha Nam household cohort study.
Author(s): Peter Horby, Le Quynh Mai, Annette Fox, Pham Quang Thai, Nguyen Thi
Thu Yen, Le Thi Thanh, Nguyen Le Khanh Hang, Tran Nhu Duong, Dang Dinh Thoang,
Jeremy Farrar, Marcel Wolbers, Nguyen Tran Hien.
Journal/Publisher: American Journal of Epidemiology
Type of publication: Original contribution
Stage of publication: In press
Academic peer-reviewed: Yes
Copyright: Open access publication charges have been paid.
Candidate’s role: All the data presented in this paper were collected through the com-
munity cohort study of which I was the principal investigator. I prepared the dataset
and wrote the first draft of the analysis plan, which was then further developed in dis-
cussion with a biostatistican Marcel Wolbers. Marcel Wolbers wrote and implemented
the R-code for the statistical analysis. I reviewed and commented on all the statistical
analysis outputs. I wrote the first and all subsequent drafts of the manuscript, submitted
the manuscript for publication, and responded to all reviewers comments.
Candidate’s signature:
Supervisor or senior author’s signature to confirm Candidates role:
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!ABSTRACT 
Prospective community-based studies have provided fundamental insights into the 
epidemiology of influenza in temperate regions but few comparable studies have been 
undertaken in the tropics. The authors conducted prospective influenza surveillance and 
intermittent seroprevalence surveys in a household-based cohort in Vietnam between 
December 2007 and April 2010, providing 1,793 person-seasons of influenza surveillance. 
Age and gender standardized estimates of the risk of acquiring any influenza infection per 
season in persons aged ≥5 years were 21.1% (95% confidence interval: 17.4, 24.7) in season 
1, 26.4% (95% confidence interval: 22.6, 30.2) in season 2, and 17.0% (95% confidence 
interval: 13.6, 20.4) in season 3. Some individuals experienced multiple episodes of infection 
in the same season with different influenza types/subtypes (n=27), or re-infection with the 
same subtype in different seasons (n=22). The highest risk of influenza infection was in the 
age group 5-9 years, where the risk of influenza infection per season was 41.8%. Although the 
highest infection risk was in school-aged children, there were important heterogeneities in the 
age of infection by sub-type and season that may influence the impact of school closure and 
childhood vaccination on influenza transmission in tropical areas such as Vietnam.  
 
Key words: Influenza, human; epidemiology; disease transmission, infectious; tropical 
climate; prevention and control.
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!INTRODUCTION 
Until relatively recently influenza had been conceptualized as a developed country 
problem, with little consideration given to the frequency and burden of influenza in low-
income and tropical countries. This all changed with the widespread reemergence of highly 
pathogenic avian influenza A/H5N1 in 2004, and further intensified with analyses suggesting 
that Southeast Asia may be the region where H3N2 influenza viruses undergo evolution 
before subsequent spread to the Northern and Southern hemispheres (1,2). As a result, 
influenza surveillance and control in Southeast Asia has come to be perceived as a global 
public health good, with substantial investment in influenza surveillance, anti-viral 
stockpiling, vaccine development, and epidemic preparedness (3,4).  
Despite this interest in influenza in Southeast Asia, very little data are available on 
influenza transmission at the community level. In order to plan responses to both seasonal and 
pandemic influenza and the optimal application of interventions such as vaccination, antiviral 
prophylaxis, or school closure, it is first necessary to have a detailed understanding of how 
influenza is transmitted within the community (5). A key source of information on the 
transmission behavior of influenza has been community-based studies with follow up over 
several years. These studies have provided important insights into the epidemiology of 
respiratory infections and crucial information for the design of public health interventions. 
They have demonstrated that pre-school and school age children have the highest rate of 
respiratory illnesses (6–9); that mothers have higher attack rates than fathers (6,10); that 
children play an important role in introducing infection into families (9,11–13); and that there 
are high rates of serological evidence of infection without corresponding disease (5,14,15). 
However, those studies largely took place between the 1940’s and early 1980’s in the U.S., 
and very few comparable community or household-based studies have been undertaken in the 
tropics. Population densities, family structures, behaviors, mobility, material conditions, 
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!health and climate are different in Southeast Asia compared to the U.S., so the epidemiology 
of influenza may also differ in important ways. Studies of influenza in Southeast Asia have 
largely assessed the incidence of clinical illness at health-care facilities, or analysis of 
surveillance and health care utilization data (16–20). Such studies are important in quantifying 
the clinical burden of influenza but cannot provide a full understanding of the epidemiology 
and transmission of influenza. Recent studies of pandemic influenza A/H1N1 have mostly 
relied on single cross-sectional serology to infer infection rates, but this is a less robust 
method of identifying recent infection than the detection of increases in antibody titers in 
paired sera (21). The authors therefore established a household-based cohort with the 
objective of quantifying the burden of influenza infection in a semi-rural community of 
northern Vietnam and to gain insights into the epidemiology of influenza in the tropics.  
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!MATERIALS AND METHODS 
Study design and setting 
A full description of the materials and methods are provided in the Web Appendix and 
only a brief description is provided here. In 2007 a prospective, household-based community 
cohort was established in Thanh Ha Commune, Thanh Liem District, Ha Nam Province, 
Vietnam. The primary sampling unit of study was the household and all households in the 
Commune were eligible for inclusion in the study. Households were randomly selected from a 
list of all households using a random number table. If a randomly selected household declined 
to participate, the next nearest household was approached until a household was successfully 
recruited. All permanent residents in the household were eligible for inclusion and were 
requested to participate.  
Blood sampling 
Participants aged 5 years and older (at time of sampling) were asked to provide blood 
at recruitment and at three further time points. Recruitment blood samples were drawn 
between 1st-7th December 2007 (bleed 1). Subsequent bleeds took place between 9th-15th 
December 2008 (bleed 2), 2nd-4th June 2009 (bleed 3), and on the 3rd April 2010 (bleed 4). 
The bleeding time points were not decided a priori but were chosen when national influenza 
surveillance data indicated that influenza circulation was minimal.  The four sets of samples 
provided three sets of paired sera.  
Influenza-like illness surveillance 
 Trained hamlet Health Workers undertook weekly active surveillance of each 
participating household for episodes of influenza-like illness (ILI) and for changes in 
household composition. ILI was defined as ‘as an illness with oral temperature of 38°C or 
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!more and either a cough or a sore throat’. Any participant reporting an ILI was asked to 
provide a nose swab and a throat swab, and complete a 10-day symptom diary. 
Definition of exposure and outcome variables 
For the purpose of analysis, an influenza ‘season’ was defined as the period between 
consecutive bleeds, and an influenza ‘transmission period’ was defined as the period when 
influenza was known to be circulating on the basis of RT-PCR confirmed clinical cases. 
‘Influenza infection’ was defined as either the detection of influenza RNA in a swab 
sample by reverse transcription polymerase chain reaction (RT-PCR) or a four fold or greater 
rise in HI antibody titre in paired sera, with the second titre at least 1:40. If paired sera were 
not available, a single high titre of at least 1:160 for seasonal influenza, or a titre of ≥ 1:80 in 
someone aged under 40 years for pandemic influenza H1N1, was also considered to indicate 
recent ‘influenza infection’. 
‘Influenza illness’ was defined as the detection of influenza-specific RNA in a swab 
by RT-PCR and the reporting of an ILI, or serological evidence of recent influenza infection 
(see above) plus an ILI episode occurring during a known period of transmission of the 
relevant influenza subtype. For linking serological evidence of recent influenza A infection to 
specific ILI episodes, influenza ‘transmission periods’ were defined based on periods of 
detection of RT-PCR confirmed influenza. 
  
Laboratory methods   
Detection of influenza viruses was performed on all nasal- and throat-swab specimens 
using RT-PCR. Influenza hemagglutination inhibition (HI) assays were performed using 
standard methods. Samples that were negative by HI assay in the lowest dilution (1:10) were 
assigned a titre of 1:5 for the purposes of computing seroconversion.  
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!Statistical methods 
Absolute observed risks of ILI (for subjects under ILI surveillance) and of influenza 
infection (for subjects under influenza infection surveillance) were calculated per season. 
Participants were considered under ILI surveillance for a particular season if they were under 
weekly ILI surveillance throughout the influenza transmission period and were considered 
under influenza infection surveillance if they additionally contributed a post-season blood 
sample.  
Survey analysis methodology was used to derive risk estimates and associated 95% 
confidence intervals standardized to the age and gender structure of the Vietnamese rural 
population based on the 2009 Population and Housing Census. This provides valid inference 
accounting for effects of the survey design, which was based on cluster sampling by 
household, and biases in the provision of blood samples. As children under 5 years of age 
were not asked to give blood samples, standardization for influenza risks was to the census 
population aged ≥5 years. Standardization was implemented by raking, i.e. post-stratification 
on the target age and gender distribution in turn until convergence (22). 
Seven potential risk factors for influenza infection were pre-defined. To assess these 
factors, data were pooled over all three seasons and the overall risk of an influenza infection 
was modeled with a logistic mixed effects model depending on the season, a random 
household effect (to account for potential clustering within households), a random subject 
effect (to account for potential within-subject correlation between seasons) and the respective 
risk factors.  
All analyses were performed with the statistical software R 2.10.1 (R Foundation for 
Statistical Computing, Vienna, Austria) and the companion R packages survey 3.22-3 (for 
survey sampling) and lme4 0.999375-35 (for mixed models) (23).  
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!RESULTS 
940 individuals in 270 households were recruited from a study base of 2127 
enumerated households. The household refusal rate was approximately 10% but a record was 
not kept of the number of refusals or reasons for refusal. The baseline characteristics of the 
940 individuals and 270 households are shown in table 1. None of the participants had ever 
received influenza vaccination. The age distribution of the cohort was significantly different 
from that of both Ha Nam province and the national rural population (chi-square tests; both 
P<0.001). This was largely due to an over-representation of 10-19 year olds and an under-
representation of 20-34 year olds in the cohort (Web Figure 1). The household size 
distribution of the cohort matched well with that of the Red River Delta rural population (chi-
square goodness of fit test: P=0.86). 
The cohort was studied for three consecutive influenza seasons from December 2007 
through April 2010. Data on age was absent from 11 of the original cohort of 940 so these 
were excluded from all further analysis, and three children were born into participating 
households during the study, to give a total cohort size of 932 people (Figure 1). Some 
participants were absent from the study site during periods of influenza transmission and were 
therefore excluded from analysis for the relevant season. Figure 1 shows the number of 
participants included in each season’s analysis; a total of 1,793 person-seasons of influenza 
surveillance were available. The completeness of bleeds varied by age and gender, the highest 
provision of blood being females in bleed one (85%), and the lowest being males in bleed two 
(55%) (Web Figure 2).   
The temporal relationship between periods of ILI and RT-PCR confirmed influenza 
activity and the bleeding time points are shown in Figure 2.  Three clear peaks of influenza A 
activity were detected: summer 2008 (influenza transmission period 1: 01/07/2008-
30/09/2008), spring 2009 (influenza transmission period 2: 01/04/2009-05/06/2009), and 
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!autumn 2009 (influenza transmission period 3: 01/09/2009-31/12/2009).  Clear peaks in 
influenza B activity were not seen. Co-circulation of influenza B, H1N1, and H3N2 was 
detected in summer 2008 and in spring 2009.  
Table 2 shows the number of reported ILI episodes detected in participants under ILI 
surveillance, the age and gender standardized ILI risk per season, and the number of influenza 
RT-PCR positive swabs in participants reporting an ILI.  The standardized risk of ILI per 
season ranged from 14.1% in season 1 to 4.9% in season 3, and the maximum risk of RT-PCR 
confirmed influenza illness occurred amongst 5-19 year olds in season 3, where 5% of this 
age-group were affected. The influenza A virus strains detected in the cohort during the three 
seasons were: Season 1 - A/H1N1/Brisbane/59/2007-like, A/H3N2/Brisbane/10/2007-like; 
Season 2 - A/H1N1/Brisbane/59/2007-like, A/H3N2/Perth/16/2009-like; Season 3 - 
A/H1N1/California/7/2009-like. There was co-circulation of both influenza B Yamagata 
lineage and Victoria lineage in seasons 1 and 2, but with a predominance of Yamagata lineage 
in season 1 and Victoria lineage in season 2. In seasons 1 and 2 the overall rate of successful 
detection of influenza viruses from respiratory swabs was 18.4%, with the detection rate being 
greatest in children aged 0-4 years (50%) and declining with age, to 8.9% in those aged 40 
years and over.  
Unadjusted and standardized estimates of influenza infection and influenza illness 
rates per season are shown in Table 3. This analysis is restricted to those participants who 
were under ILI surveillance and also provided at least an end-of-season blood sample (figure 
1). Standardized estimates of the risk of acquiring any influenza infection per season in 
persons aged >=5 years were 21.1% in season 1, 26.4% in season 2, and 17% in season 3. 
H3N2 infection was more common in season 2 compared to season 1 following a change in 
the circulating virus strain from A/H3N2/Brisbane/10/2007-like to A/H3N2/Perth/16/2009-
like.  
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!427 participants could be assessed for influenza infection over all three seasons, of 
which 242 (56.7%) showed evidence of at least one acute influenza infection over the whole 
study period. After adjustment for the household-based sampling design and standardization 
to the age and gender structure of the Vietnam rural population, the estimated risk of any 
influenza infection in people aged >=5 years over the entire three season period was 55.4% 
(95% CI 49.6-61.2%). In all seasons the estimated influenza illness risks were substantially 
lower than infection risks. The percentage of identified influenza infections in which an 
influenza illness was also detected was: H1N1 14% (13/95); H3N2 11% (11/97); B 15% 
(21/137); H1N1/2009 16% (17/109).  
Multiple episodes of influenza infection by different influenza types/subtypes in the 
same season (multiple infections) were identified in 27 individuals; 23 had evidence of 
infection by two types/subtypes, and 4 had evidence of infection by all 3 types/subtypes (see 
footnotes Table 3). Re-infection with the same influenza type/subtype in season 2 as in season 
1 was detected in 8 participants (H3N2=1 older adult [≥40 years]; seasonal H1N1=2 children 
aged 5-14 years; B=4 children aged 10-14 and 1 older adult). In addition, 14 participants who 
had been infected with seasonal H1N1 in season 1 (1 child aged 5-9 and 3 adults) or season 2 
(6 children aged 5-14 and 4 adults) were also infected with pandemic H1N1 in season 3.  
Influenza infection risk varied by age most clearly for season 3 when pandemic 
influenza H1N1 first circulated in the cohort and infected a large proportion of children and 
young adults (Figure 3). Age patterns in infection risk were less marked for inter-pandemic 
strains. The highest infection risk for H3N2 (seasons 1 and 2) and H1N1 (season 1 only) was 
in children aged 5-9 years. In season 2 the highest risk of H1N1 infection was in people aged 
10-19 years. To assess the significance of the apparent age-dependent peaks of H3N2 
infections in season 2 we applied the same methodology as we did for table 4 (without a 
random effect for patient because there is only one patient record per season). In season 2, 
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!significantly higher H3N2 risks compared to the age group 20-40 years were observed in ages 
<10 years (OR 3.47; 95% CI 1.37, 8.79; P-value=0.009) and 10-20 years (OR 2.3; 95% CI 
1.02, 5.17; P-value=0.043). The second peak for ages >=40 years is borderline significant 
with OR 2.12 (95% CI 0.99, 4.54; P-value=0.052). Web Figure 3 shows the proportion of 
participants with influenza infection per season by age group and type/subtype compared to 
previously publish household-based cohort studies. 
Risk factors for influenza infection were explored in univariate and multivariate 
analysis (Table 4). Age was significantly associated with the risk of influenza infection in 
both univariate and multivariate analysis. This association was also observed for inter-
pandemic H1N1, H3N2, and pandemic H1N1 when analyzed separately, but not for influenza 
B (see footnote Table 4). The highest risk of influenza infection was in the age group 5-9 
years, where the observed absolute risk of influenza infection per season was 41.8%. The 
lowest infection risk was in the 20-39 year age group. There was no observed gender effect 
(Table 4, Web Figure 4) and no other covariates were significantly associated with influenza 
infection risk in either univariate or multivariate analysis. 
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DISCUSSION 
This study is one of the first to prospectively quantify the incidence of influenza infection in 
the same individuals over multiple seasons in a tropical setting. It demonstrates that influenza 
infection is common, with an estimated risk of influenza infection in a single season of 
between 17% and 26%, and around 57% of people experiencing at least one acute influenza 
infection over a three-year period. These estimates are minimum estimates since we used the 
HI assay, which is less sensitive than the microneutralization assay, and conservative 
definitions of laboratory evidence of influenza infection (24). Although varying study designs, 
laboratory methods, data availability, and differing periods of influenza emergence and re-
emergence confound direct comparison with earlier family studies in temperate settings, the 
levels of infection we identified are similar, as shown in Web Figure 3 (9,10,14,15,25–29). 
Although the rates we observed are generally in the lower range of those reported from other 
household studies, most of these previous studies recruited only households with infants or 
young children and did not standardize the results to the general population structure. For 
example, 5-14 year olds constituted 47% of the Cleveland family study during the H2N2 
pandemic (14).  Also, we were not able to obtain blood samples from children aged less than 
five years old, who are expected to have high rates of infection. The 17% infection rate for 
pandemic influenza H1N1 in our study is similar to contemporary seroepidemiology reports 
from other areas (30–34).  
As found in other longitudinal studies, multiple infections in the same season with 
different influenza types/subtypes, and re-infection with the same subtype in consecutive 
seasons do occur and, although more common in children, can occur at any age (8,15,35–38).  
Between 11% and 16% of influenza infections resulted in an illness that was detected 
by weekly active ILI surveillance. Our figures of the proportion of infections that cause 
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!clinically detected illness are lower than estimates obtained by Monto et al, where at least 15-
25 per cent of H3N2 infections and 19-34 per cent of type B infections resulted in clinical 
disease (39). Whilst this may be a real effect, perhaps influenced by the slightly greater 
proportion of participants aged >=40 years in our study compared to the Tecumseh study, it 
may also represent a reporting bias, with a greater propensity for participants to report 
illnesses in Tecumseh in the 1970’s than in our study site. 
The data reveal clear variations in the risk of influenza by age and subtype. As 
observed elsewhere, the 2009 H1N1 pandemic resulted in very high infection rates in young 
children that dropped sharply with age. The high rates of H1N1/2009 in 5-29 year olds, which 
exceed those seen for any other subtype and season, may be explained by the immunological 
naivety of this age group to this antigenic HA variant. The low pandemic H1N1 infection 
rates in older adults indicate that long-lived and cross-protective immunity against H1N1 may 
be induced either by repeated infection or by infection with an antigenically related virus 
(40,41). Similar long-lived protection was observed when H1N1 re-emerged in 1977 after an 
absence of 20 years (26,39).  
H3N2 infections in season 2 (when a drifted variant circulated) peaked in school-aged 
children, with a second peak in older adults. A recent cross-sectional sero-prevalence study 
from Canada also found a second peak in H3N2 titers in people aged over 60 years (42), and 
there is ample evidence that adults experience higher rates of H3N2 infection and reinfection 
compared to other influenza types/subtypes (28,43–47). These serological measures of risk 
also translate into clinical illness, with H3N2 more commonly causing clinical illness in adults 
in the community and in institutional care compared to other influenza viruses (48–52). We 
observed a fairly constant risk of influenza B infection across the whole age range. This 
contrasts to some earlier studies in temperate countries where influenza B risk peaked in pre-
school or school-age children (15,26,27,29). Whilst this pattern may be due to the absence of 
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!an influenza B epidemic during the study period, the influenza B infection rates were 
moderately high and the age distribution may therefore be the consequence of prolonged 
circulation of influenza B viruses without the opportunity for a build-up of a large cohort of 
susceptible children. 
One possible explanation for the more even age-distribution of the risk of inter-
pandemic influenza infection in our study compared to some historic studies in temperate 
climates is that there is less intense seasonal and school-based forcing in the tropics, resulting 
in less intense school based transmission and greater community based transmission. Multiple 
epidemics per year and more prolonged virus circulation may also limit the size of the pool of 
susceptible children. In this respect it is relevant that, in contrast to community studies 
conducted in temperate settings, we did not identify an increased risk of influenza infection in 
women compared to men, nor an association between caring for children or the presence of a 
school aged child in the house and the risk of influenza in adults. This may have important 
implications for the impact of school closure and childhood vaccination on the transmission of 
inter-pandemic influenza in tropical areas such as Vietnam.  Whilst school-closure was 
reported to be effective in reducing transmission of H1N1/2009 in Hong Kong, our study 
shows that the age distribution of H1N1/2009 infection was not characteristic of inter-
pandemic influenza in the tropics (53).  
Longitudinal studies such as we have presented here, which follow individuals of all 
ages over multiple seasons with serial serology, provide not only the most robust estimates of 
true influenza infection incidence, they also provide information that is critical for 
understanding influenza epidemiology in the tropics and for planning effective influenza 
control strategies.  
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!Table 1 Characteristics of Participants and Households at Recruitment, Ha Nam, 
Vietnam, 2007-2010. 
Category Subcategory x/n (%) 
Age in years 0 to <5 83/929 (8.9%) 
 5 to <10 70/929 (7.5%) 
 10 to <20 209/929 (22.5%) 
 20 to <40 246/929 (26.5%) 
 40 to <60 241/929 (25.9%) 
 ≥60 80/929 (8.6%) 
Female gender - yes  508/932 (54.5%) 
Chronic diseases - yes  5/869 (0.6%)a 
Adults (age ≥18; N=592):   
Caring for children at home or at work Never 284/569 (49.9%) 
 Sometimes 100/569 (17.6%) 
 Most days 185/569 (32.5%) 
Smoking – yes  107/560 (19.1%) 
Cigarettes smoked per day <= 5  49/103 (47.6%) 
 6-10 45/103 (43.7%) 
 11-20 9/103 (8.7%) 
Households (N=270):   
Household size 1 person 28/270 (10.4%) 
 2 people 41/270 (15.2%) 
 3 people 65/270 (24.1%) 
 4 people 74/270 (27.4%) 
 5 people 42/270 (15.6%) 
 >5 people 20/270 (7.4%) 
Home crowding (>2 people/room) – yes  46/237 (19.4%) 
School age children (age 5 to <18) in household  - yes  156/264 (59.1%) 
a 2 chronic lung diseases, 2 chronic heart diseases, and one chronic liver disease. 
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  Table 2 ILI Episodes and Influenza Virus Detections by Season and Age Group, Ha Nam, Vietnam, 2007-2010. 
  Age group at the beginning of the season (years) 
Season Variable 0 to <5 5 to <20 20 to <40 ≥40 All ages 
1 Number of participants included 84 273 240 319 916 
 Number reporting an ILI episode – x (%) 4 (4.8) 42 (15.4) 31 (12.9) 57 (17.9) 134 (14.6) 
 Standardized ILI risk/season a - % (95% CI) 5.3 (0.3,10.2) 15.5 (10.5, 20.4) 11.7 (7.9, 15.4) 17.8 (13.5, 22.1) 14.1 (11.3, 16.8) 
 Influenza A H1N1 PCR virus detections – x (%) 1 (1.2) 6 (2.2) 2 (0.8) 1 (0.3) 10 (1.1) 
 Influenza A H3N2 PCR virus detections – x (%) 0 (0.0) 1 (0.4) 1 (0.4) 1 (0.3) 3 (0.3) 
 Influenza B virus PCR detections – x (%)  1 (1.2) 4 (1.5) 1 (0.4) 3 (0.9) 9 (1.0) 
2 Number of participants included 59 284 226 326 895 
 Number reporting an ILI episode – x (%) 0 (0.0) 16 (5.6) 13 (5.8) 22 (6.7) 51 (5.7) 
 Standardized ILI risk/season a - % (95% CI) 0.0 5.7 (2.9, 8.5) 4.6 (2.1, 7.1) 6.9 (3.8, 9.9) 5.2 (3.5, 6.9) 
 Influenza A H1N1 PCR virus detections – x (%) 0 (0.0) 4 (1.4) 0 (0.0) 0 (0.0) 4 (0.4) 
 Influenza A H3N2 PCR virus detections – x (%) 0 (0.0) 3 (1.1) 2 (0.9) 2 (0.6) 7 (0.8) 
 Influenza B virus PCR detections – x (%) 0 (0.0) 1 (0.4) 0 (0.0) 0 (0.0) 1 (0.1) 
3 Number of participants included  54 279 225 329 887 
 Number reporting an ILI episode – x (%)b 3 (5.6) 21 (7.5) 11 (4.9 10 (3.0) 45 (5.1) 
 Standardized ILI risk/season a - % (95% CI) 5.8 (0.0, 
12.2) 
7.5 (4.3, 10.6) 4.4 (1.4, 7.4) 2.7 (1.0, 4.3) 4.9 (3.1, 6.6) 
 Pandemic influenza A virus detections – x (%) 0 (0.0) 14 (5.0) 7 (3.1) 3 (0.9) 24 (2.7) 
a  Standardized to age and gender distribution of Vietnamese national rural population (2009 Population and Housing Census).  
b 5 subjects reported 2 ILI episodes during the season.
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  Table 3 Unadjusted and Standardized Risks of Influenza Infection and Influenza Illness by Season, Persons Aged ≥ 5 Years, Ha Nam, 
Vietnam, 2007-2010. 
Season Influenza 
type/subtype 
Sero-
conversions 
Single 
high titres 
Positive 
RT-PCR a 
Observed  
influenza 
infections 
Standardized b 
influenza infection 
risk 
Observed  
influenza 
illnesses 
Standardized b 
influenza illness 
risk 
     x/n (%) % (95% CI) x/n (%) % (95% CI) 
1  (n=555; 7 with 
single titres) 
Any c 116 0 17 (4) 120/555 (21.6%) 21.1 (17.4, 24.7) 28/555 (5.0%) 4.5 (2.8, 6.3) 
 H1N1 36 0 8 (4) 40/555 (7.2%) 7.4 (5.0, 9.8) 8/555 (1.4%) 1.3 (0.3, 2.3) 
 H3N2 13 0 3 (0) 13/555 (2.3%) 2.3 (0.8, 3.8) 3/555 (0.5%) 0.6 (0.0, 1.3) 
 B 69 0 6 (1) 70/555 (12.6%) 12.0 (8.8, 15.2) 17/555 (3.1%) 2.6 (1.3, 4.0) 
2  (n=640; 139 
with single titres) 
Any d 152 23 12 (3) 178/640 (27.8%) 26.4 (22.6, 30.2) 17/640 (2.7%) 2.4 (1.2, 3.7) 
 H1N1 46 7 4 (2) 55/640 (8.6%) 8.3 (6.1, 10.5) 5/640 (0.8%) 0.8 (0.1, 1.6) 
 H3N2 71 12 7 (1) 84/640 (13.1%) 11.8 (9.0, 14.6) 8/640 (1.2%) 1.0 (0.2, 1.9) 
 B 59 7 1 (1) 67/640 (10.5%) 10.2 (7.7, 12.7) 4/640 (0.6%) 0.6 (0.0, 1.1) 
3  (n=598; 58 with 
single titres) 
H1N1 98 6 18 (5) 109/598 (18.2%) 17.0 (13.6, 20.4) 17/598 (2.8%) 2.6 (1.3, 3.9) 
a Numbers in brackets refer to PCR-positive samples without documented seroconversion or single high titre. 
b Standardized to age and gender distribution of Vietnamese national rural population aged >=5 years (2009 Population and Housing Census). 
c One subject had both influenza A H1N1 and influenza A H3N2 conversion; one subject had both influenza A H1N1 and influenza B conversion; 
one subject was H1N1 PCR+ (but no seroconversion) and had influenza B seroconversion. 
d 4 subjects were infected by all 3 influenza subtypes, 5 by H1N1 and H3N2, 7 by H1N1 and B, 8 by H3N2 and B.
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  Table 4 Risk Factors for Influenza Infection, Aggregated Over Influenza Subtypes and Seasons, Ha Nam, Vietnam, 2007-2010. 
  Aggregated a observed 
absolute influenza 
infection risk per 
season 
Univariate association Multivariate association b 
Covariate Category x/n (%) OR (95% CI) P-value OR (95% CI) P-value 
Age (years) 5 to <10 79/189 (41.8%) 3.65 (2.50, 5.34) <0.001c 4.15 (2.41, 7.13) <0.001 
 10 to <20 120/408 (29.4%) 2.11 (1.52, 2.91)  2.34 (1.44, 3.79)  
 20 to <40 88/513 (17.2%) - (baseline)  -  
 ≥40 120/683 (17.6%) 1.06 (0.77, 1.45)  1.10 (0.77, 1.58)  
Genderd Male 164/745 (22.0%) -  -  
 Female 243/1048 (23.2%) 1.07 (0.85, 1.35) 0.55 1.06 (0.81, 1.38) 0.66 
Household size 1-2 31/185 (16.8%) 0.64 (0.39, 1.04) 0.25 0.76 (0.43, 1.33) 0.81 
 3 83/350 (23.7%) -  -  
 4 138/590 (23.7%) 1.00 (0.71, 1.42)  0.98 (0.69, 1.40)  
 ≥ 5 155/668 (23.2%) 0.98 (0.70, 1.39)  0.98 (0.61, 1.56)  
Home crowding (>2 people/room) No 250/1132 (22.1%) -  -  
 Yes 119/507 (23.5%) 1.10 (0.84, 1.44) 0.50 0.90 (0.60, 1.35) 0.62 
Caring for children at work or home 
(for adults, age≥18) 
No 84/549 (15.3%) -  - 0.18 
 Sometimes 36/201 (17.9%) 1.23 (0.77, 1.95)  1.40 (0.89, 2.21)  
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   Most days 88/435 (20.2%) 1.40 (0.98, 2.01) 0.18 1.37 (0.93, 2.00)  
School age children (age 5 to <18) in 
household (for adults, age≥18) 
No 83/462 (18.0%) -  -  
 Yes 131/767 (17.1%) 0.94 (0.67, 1.32) 0.72 0.87 (0.61, 1.26) 0.47 
Smoking (for adults, age≥18) No 172/970 (17.7%) -  -  
 Yes 32/200 (16.0%) 0.87 (0.56, 1.34) 0.53 0.89 (0.54, 1.45) 0.63 
OR=Odds ratio, P-value corresponds to a Wald-type test for the significance of the whole factor. 
a Aggregated over all seasons and influenza subtypes (but only pandemic flu assessed in season 3), x=# of influenza infection in subgroup, n=# 
of person-seasons observed. 
b Adjusted for all other covariates in the model. Covariates that are reported in adults only for the univariate associations (e.g. caring for children 
at work) were included as indicator variables with value 0 for children.   
c Also significant for H1N1 alone (p<0.001), H3N2 alone (p=0.02), pandemic H1N1 alone (p<0.001), but not influenza B (p=0.33). 
d Univariate analysis of gender for adults only is also non-significant. 
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Web Figure 2. Frequency of bleeding amongst cohort participants under ILI surveillance,
by age and gender. Ha Nam, Vietnam, 2007-2010.
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Web	  Table	  1.	  Source data for Web Figure 3.	   	   Proportion	  infected	  by	  age	  group*	   	  
Reference	   Study	  site	   Year(s)	  
Type	  /	  
subtype	  
Definition	  of	  infection	   Outcome	  measure	  
Pre-­‐
school	  
School
-­‐age	   Adult	   All	   Notes	  
(4)	   Cleveland	  
Fall	  1947	  -­‐	  
Spring	  1948	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	  	   	   	   	   15.2	   	  
(4)	   Cleveland	   Spring	  1948	  -­‐	  
Fall	  1948	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   17.2	   	  
(4)	   Cleveland	   Fall	  1948	  -­‐	  
Spring	  1949	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   16.4	   	  
(4)	   Cleveland	   Spring	  1949	  -­‐	  
Fall	  1949	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   15.4	   	  
(4)	   Cleveland	   Fall	  1949	  -­‐	  
Spring	  1950	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   14.9	   	  
(4)	   Cleveland	   Spring	  1950	  -­‐	  
Fall	  1950	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   6.4	   	  
(4)	   Cleveland	   Fall	  1950	  -­‐	  
Spring	  1951	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   23.8	   	  
(4)	   Cleveland	   Spring	  1951	  -­‐	  
Fall	  1951	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   6.4	   	  
(4)	   Cleveland	   Fall	  1951	  -­‐	  
Spring	  1952	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   10	   	  
(4)	   Cleveland	   Spring	  1952	  -­‐	  
Fall	  1952	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   5.7	   	  
(4)	   Cleveland	   Fall	  1952	  -­‐	  
Spring	  1953	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   26.6	   	  
(4)	   Cleveland	   Spring	  1953	  -­‐	  
Fall	  1953	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   6.4	   	  
(4)	   Cleveland	   Fall	  1947	  -­‐	  
Spring	  1948	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   3.2	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(4)	   Cleveland	   Spring	  1948	  -­‐	  
Fall	  1948	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   9.8	   	  
(4)	   Cleveland	   Fall	  1948	  -­‐	  
Spring	  1949	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   7.4	   	  
(4)	   Cleveland	   Spring	  1949	  -­‐	  
Fall	  1949	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   9.1	   	  
(4)	   Cleveland	   Fall	  1949	  -­‐	  
Spring	  1950	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   17.2	   	  
(4)	   Cleveland	   Spring	  1950	  -­‐	  
Fall	  1950	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   10.9	   	  
(4)	   Cleveland	   Fall	  1950	  -­‐	  
Spring	  1951	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   5.6	   	  
(4)	   Cleveland	   Spring	  1951	  -­‐	  
Fall	  1951	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   11.4	   	  
(4)	   Cleveland	   Fall	  1951	  -­‐	  
Spring	  1952	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   26.8	   	  
(4)	   Cleveland	   Spring	  1952	  -­‐	  
Fall	  1952	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   4.8	   	  
(4)	   Cleveland	   Fall	  1952	  -­‐	  
Spring	  1953	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   4.9	   	  
(4)	   Cleveland	   Spring	  1953	  -­‐	  
Fall	  1953	  
B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  	  
%	  of	  persons	  with	  two	  samples	  
taken	  at	  approximately	  six	  month	  
intervals.	   	   	   	   1.4	   	  
(5)	   Cleveland	   1956-­‐1957	   H2N2	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  by	  CF	  or	  HI	  test,	  or	  both.	  	  
%	  of	  persons	  with	  2	  serum	  
samples	  at	  approximately	  six	  
month	  intervals,	  except	  for	  infants	  
followed	  from	  birth	  whose	  first	  
serum	  specimen	  at	  12	  to	  18	  
months	  of	  age	  was	  taken	  to	  reflect	  
their	  infection	  experience	  since	  
birth.	   50	   71.6	   24.2	   54.7	   Pandemic	  year	  
(6)	   New	  York	   1961-­‐1965	   H2N2	  
Seroconversion	  to	  positive	  or	  
a	  4-­‐fold	  or	  greater	  rise	  in	  CF	  
antibody	  titer	  
%	  of	  persons	  with	  2	  serum	  
samples	  at	  approximately	  six	  
month	  intervals	  (except	  infants)	  	   10	   14.9	   12	   12	   	  
59
(6)	   New	  
Orleans	  
1956-­‐1959	   H2N2	  
Seroconversion	  to	  positive	  or	  
a	  4-­‐fold	  or	  greater	  rise	  in	  CF	  
antibody	  titer	  
%	  of	  persons	  with	  2	  serum	  
samples	  at	  approximately	  six	  
month	  intervals	  (except	  infants)	   43.1	   49	   21	   33	   Pandemic	  year	  
(6)	   New	  York	   1961-­‐1965	   B	  
Seroconversion	  to	  positive	  or	  
a	  4-­‐fold	  or	  greater	  rise	  in	  CF	  
antibody	  titer	  
%	  of	  persons	  with	  2	  serum	  
samples	  at	  approximately	  six	  
month	  intervals	  (except	  infants)	  	   0	   9.6	   3	   3	   	  
(6)	   New	  
Orleans	  
1956-­‐1959	   B	  
Seroconversion	  to	  positive	  or	  
a	  4-­‐fold	  or	  greater	  rise	  in	  CF	  
antibody	  titer	  
%	  of	  persons	  with	  2	  serum	  
samples	  at	  approximately	  six	  
month	  intervals	  (except	  infants)	   5.3	   	   	   4	   	  
(7)	   Seattle	   1965-­‐1969	  	   A	  
Seroconversion	  to	  positive	  or	  
a	  4-­‐fold	  or	  greater	  rise	  in	  CF	  
antibody	  titer	  
Per	  100-­‐person	  years	  
25.5	   18	   14.1	   18.6	  
0-­‐<6	  years	  and	  6-­‐
19	  years	  
(7)	   Seattle	   1965-­‐1969	  	   B	  
Seroconversion	  to	  positive	  or	  
a	  4-­‐fold	  or	  greater	  rise	  in	  CF	  
antibody	  titer	  
Per	  100-­‐person	  years	  
27.2	   15	   16.8	   19.9	  
0-­‐<6	  years	  and	  6-­‐
19	  years	  
(8)	   Seattle	   1975-­‐1976	   H3N2	  
Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
23.4	   25	   10.9	   18.4	   	  
(8)	   Seattle	   1976-­‐1977	   H3N2	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
2.6	   5.2	   6.9	   5.8	   	  
(8)	   Seattle	   1977-­‐1978	   H3N2	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
26.2	   33.2	   12.7	   23.7	   	  
(8)	   Seattle	   1978-­‐1979	   H3N2	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
0	   0.4	   0.5	   0.4	   	  
(8)	   Seattle	   1975-­‐1976	   B	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
8.5	   28.6	   6.3	   16.6	   	  
(8)	   Seattle	   1976-­‐1977	   B	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
3.9	   1.6	   1.2	   1.6	   	  
(8)	   Seattle	   1977-­‐1978	   B	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
1.6	   4.3	   2.2	   3.2	   	  
(8)	   Seattle	   1978-­‐1979	   B	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
0	   2.3	   2.7	   2.4	   	  
(8)	   Seattle	   1977-­‐1978	   H1N1	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
8.2	   6.5	   2.2	   4.8	   	  
(8)	   Seattle	   1978-­‐1979	   H1N1	   Virus	  isolation	  or	  4-­‐fold	  or	  
greater	  rise	  in	  CF	  or	  HI	  titer	  	  
%	  per	  season	  
42.3	   54	   1.8	   30.6	   Pandemic	  year	  
(9)	   Tecumseh	   1966-­‐1971	   A	  
A	  4-­‐fold	  or	  greater	  rises	  in	  HI	  
titer	  or	  1:16	  titre	  in	  person	  
with	  previously	  undetectable	  
titre.	  
%	  per	  surveillance	  year	  
17.7	   18.5	   15	   16.7	   	  
(9)	   Tecumseh	   1966-­‐1971	   B	  
A	  4-­‐fold	  or	  greater	  rises	  in	  HI	  
titer	  or	  1:16	  titre	  in	  person	  
with	  previously	  undetectable	  
titre.	  
%	  per	  surveillance	  year	  
3.3	   12.6	   4.9	   7.6	   	  
(10)	   Tecumseh	   1977-­‐1978	   H3N2	   A	  4-­‐fold	  or	  greater	  rise	  in	  HI	   %	  per	  outbreak	  period	   42.9	   32.8	   12.9	   19.1	   Outbreak	  year	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titer	  or	  virus	  isolation	  
(10)	   Tecumseh	   1980-­‐1981	   H3N2	   A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  or	  virus	  isolation	  
%	  per	  outbreak	  period	  
23.8	   14.8	   14.5	   16	   Outbreak	  year	  
(10)	   Tecumseh	   1977-­‐1978	   H1N1	   A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  or	  virus	  isolation	  
%	  per	  outbreak	  period	  
6.9	   31.8	   4.6	   12.3	   Outbreak	  year	  
(10)	   Tecumseh	   1978-­‐1979	   H1N1	   A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  or	  virus	  isolation	  
%	  per	  outbreak	  period	  
28.6	   44.5	   4.1	   18.4	   Pandemic	  year	  
(10)	   Tecumseh	   1980-­‐1981	   H1N1	   A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  or	  virus	  isolation	  
%	  per	  outbreak	  period	  
10.8	   15.3	   1.3	   6.1	   Outbreak	  year	  
(10)	   Tecumseh	   1976-­‐1977	   B	   A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  or	  virus	  isolation	  
%	  per	  outbreak	  period	  
3.8	   27.1	   3.5	   9.9	   Outbreak	  year	  
(10)	   Tecumseh	   1979-­‐1980	   B	   A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  or	  virus	  isolation	  
%	  per	  outbreak	  period	  
8.6	   27.1	   9.6	   14.4	   Outbreak	  year	  
(11)	   Houston	   1976	   H3N2	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  
titer	  or	  virus	  isolation	  
%	  per	  between	  January	  1975-­‐April	  
1976.	   36.2	   33.3	   17.9	   27.7	   Outbreak	  year	  
(12)	   Houston	   1976-­‐1977	   B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  or	  
microneutralization	  titer,	  or	  
virus	  isolation.	  
%	  per	  epidemiologic	  year	  
22.8	   45.4	   17.8	   24.3	   Outbreak	  year	  
(12)	   Houston	   1979-­‐1980	   B	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  or	  
microneutralization	  titer,	  or	  
virus	  isolation.	  
%	  per	  epidemiologic	  year	  
21.4	   32.7	   15.2	   20.4	   Outbreak	  year	  
(13)	   Houston	  
1977-­‐1979	  &	  
1980-­‐1981	  
H1N1	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  or	  
microneutralization	  titer,	  or	  
virus	  isolation.	  
Per	  100-­‐person	  years	  
18.9	   30.9	   7.2	   15.3	  
Outbreak	  years	  /	  
0-­‐<6	  years	  and	  6-­‐
17	  years	  
(13)	   Houston	  
1977-­‐1979	  &	  
1980-­‐1981	  
H3N2	  
A	  4-­‐fold	  or	  greater	  rise	  in	  HI	  or	  
microneutralization	  titer,	  or	  
virus	  isolation.	  
Per	  100-­‐person	  years	  
39.9	   34.1	   26.2	   32.7	  
Outbreak	  years	  /	  
0-­‐<6	  years	  and	  6-­‐
17	  years	  
Horby	   Ha	  Nam	   2007-­‐2008	   H1N1	   See	  main	  paper	  
Unadjusted	  %	  per	  season.	  See	  
main	  paper	   	   10	   5.9	   7.2	   	  
Horby	   Ha	  Nam	   2007-­‐2008	   H3N2	   See	  main	  paper	  
Unadjusted	  %	  per	  season.	  See	  
main	  paper	   	   3.9	   1.6	   2.3	   	  
Horby	   Ha	  Nam	   2007-­‐2008	   B	   See	  main	  paper	  
Unadjusted	  %	  per	  season.	  See	  
main	  paper	   	   12.8	   12.6	   12.6	   	  
Horby	   Ha	  Nam	   2008-­‐2009	   H1N1	   See	  main	  paper	  
Unadjusted	  %	  per	  season.	  See	  
main	  paper	   	   17.2	   4.5	   8.6	   	  
Horby	   Ha	  Nam	   2008-­‐2009	   H3N2	   See	  main	  paper	  
Unadjusted	  %	  per	  season.	  See	  
main	  paper	   	   16.7	   11.3	   13.1	   	  
Horby	   Ha	  Nam	   2008-­‐2009	   B	   See	  main	  paper	  
Unadjusted	  %	  per	  season.	  See	  
main	  paper	   	   11.5	   10.1	   10.5	   	  
Horby	   Ha	  Nam	   2009-­‐2010	  
H1N1/20
09	  
See	  main	  paper	  
Unadjusted	  %	  per	  season.	  See	  
main	  paper	   	   33	   9.6	   18.2	   Pandemic	  year	  
* Unless otherwise stated pre-school = 0-4 years; school-age = 5-19 years; adult ≥ 20 years 
HI = Hemagglutination Inhibition assay. CF = Complement Fixation assay	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Full materials and methods 
In 2007 a prospective, household-based community cohort was established in 
Thanh Ha Commune, Thanh Liem District, Ha Nam Province, Vietnam. Vietnam is a 
lower middle-income country that has achieved rapid economic growth since the 
economic reforms of the late 1980’s. It has a population of 85.8 million (2009 
census), making it the third most populous country in Southeast Asia and 13th in the 
world. Vietnam has a high population density (259 persons/km2), with 70% of the 
population living in rural areas, and good health indicators for its level of 
development. Ha Nam Province is situated in the Northern Red River Delta of 
Vietnam, the most densely populated area of Vietnam (930 persons/km2), about 60km 
south of the capital city Hanoi. At a latitude of 20.502034 decimal degrees and 
longitude 105.928642, Thanh Liem District has a tropical climate with an average 
monthly median temperature of 24.2°C, minimum monthly median 14.2°C, and a 
maximum monthly median of 33°C (2007-2008). The Province was selected on the 
basis of the availability of trained staff, the travelling distance from Hanoi, the prior 
circulation of influenza A/H5N1, and the quality of relationships with the 
implementing institute, the National Institute of Hygiene and Epidemiology (NIHE). 
Members of the Provincial  Preventive Medicine Centre selected the study site 
following discussions with various sites about the willingness of the community to 
participate in the research. Thanh Ha Commune is a semi rural community with a 
population of 7,663 (2007), making a living mostly through mixed agriculture and 
small-scale production (e.g. embroidery). The Commune has a Health Centre and is 
divided administratively into seven hamlets, each with one or more hamlet health 
workers. A community consultation meeting was held to explain the purpose of the 
study to community members, elected representatives of the community, and 
representatives of community organizations.  
The primary sampling unit of study was the household and all households in 
the Commune were eligible for inclusion in the study. A list of all households in the 
Commune was compiled from the local Government population register and was the 
source document for the selection of households for inclusion in the study. 
Households were randomly selected from the household list using a random number 
table. If a randomly selected household declined to participate, the next nearest 
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household was approached until a household was successfully recruited. All 
permanent residents in the household were eligible for inclusion and were requested 
to participate. All potential participants were given information on the purpose of the 
study, the associated risks and benefits, and were required to provide written informed 
consent before inclusion in the study. Parents or legal guardians provided written 
consent for participants aged less than 18 years. 
Baseline variables 
Households were recruited and baseline information collected during 
November and December 2007. Trained hamlet health workers (HHW) conducted 
face-to-face interviews with all participants. Individual participants provided 
information on date of birth; gender; ethnicity; occupation; contact with children at 
work or home; the number of children in the school and class (for participants of 
school age only); the presence of chronic disease; frequency of travel outside of the 
Commune, District, Province, and Country; influenza vaccination history; and 
smoking behavior. The nominated ‘household head’ provided information on the 
number of people living in the house; the familial relationship between household 
members; the number of rooms in the house; and the ownership of household assets.  
Blood sampling 
Participants aged 5 years and older (at time of sampling) were asked to 
provide blood at recruitment and at three further time points. Recruitment blood 
samples were drawn between 1st-7th December 2007 (bleed 1). Subsequent bleeds 
took place between 9th-15th December 2008 (bleed 2), 2nd-4th June 2009 (bleed 3), and 
on the 3rd April 2010 (bleed 4). The bleeding time points were not decided a priori 
but were chosen when national influenza surveillance data indicated that influenza 
circulation was minimal.  The four sets of samples provided three sets of paired sera. 
Sodium heparin blood collection tubes were used for bleeds 1-3 in order that 
peripheral blood mononuclear cells (PBMCs) could be extracted for a sub-study on T-
cell responses in influenza; sodium heparin tubes provided plasma for determining 
haemagglutination inhibiting (HI) antibody titres. DNA was extracted from the cell 
pellet of the heparin blood samples for a sub-study of host genetic influences on 
influenza infection. Bleed 4 used clot-activator serum tubes, which provide serum for 
determining HI antibody titres. 
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Influenza-like illness surveillance 
 Trained HHWs undertook weekly active surveillance of each 
participating household for episodes of influenza-like illness (ILI) and for changes in 
household composition. Participants were also encouraged to actively report any 
episode of ILI as soon as possible directly to the HHW. ILI was defined as ‘as an 
illness with oral temperature of 38°C or more and either a cough or a sore throat’. All 
participating households were provided with an alcohol-in-glass clinical thermometer 
and informed of the definition of an ILI used in the study. Any participant reporting 
an ILI was asked to attend the Commune Health Centre where a trained member of 
the health centre staff would take a nose swab and a throat swab for storage in viral 
transport media at 2-4 °C pending transfer to the laboratory for testing. Synthetic 
tipped swabs with plastic shafts were used and placed in 3 ml of transport media 
(DMEM with 2% v/v BSA, 0.3% v/v NaHCO3 and antibiotics). Participants whom 
reported an ILI were asked to complete a 10-day symptom diary. 
Definition of exposure and outcome variables 
For the purpose of analysis, an influenza ‘season’ was defined as the period 
between consecutive bleeds, and an influenza ‘transmission period’ was defined as 
the period when influenza was known to be circulating on the basis of RT-PCR 
confirmed clinical cases. 
‘Influenza infection’ was defined as either the detection of influenza RNA in a 
swab sample by reverse transcription polymerase chain reaction (RT-PCR) or a four 
fold or greater rise in HI antibody titre in paired sera, with the second titre at least 
1:40. If paired sera were not available, a single high titre of at least 1:160 for seasonal 
influenza, or a titre of ≥ 1:80 in someone aged under 40 years for pandemic influenza 
H1N1, was also considered to indicate recent ‘influenza infection’. 
‘Influenza illness’ was defined as the detection of influenza-specific RNA in a 
swab by RT-PCR and the reporting of an ILI, or serological evidence of recent 
influenza infection (see above) plus an ILI episode occurring during a known period 
of transmission of the relevant influenza subtype. For linking serological evidence of 
recent influenza A infection to specific ILI episodes, the following influenza A 
‘transmission periods’ were defined: 01/07/2008-30/09/2008 (influenza transmission 
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period 1), 01/04/2009-05/06/2009 (influenza transmission period 2); and 01/09/2009-
31/12/2009 (influenza transmission period 3). Influenza B circulated throughout 2008 
and a ‘transmission period’ could not be defined, therefore serological evidence of 
recent influenza B infection was putatively linked to any ILI episode that was not 
attributable to influenza A infection.  
 
Laboratory methods  - reverse transcription polymerase chain reaction (RT-
PCR) assay  
Detection of influenza viruses in nasal- and throat-swab specimens was 
performed using either conventional or real-time RT-PCR. The real-time assay was 
performed according to the U.S. CDC/WHO protocols (CDC reference no. I-007-05, 
Accessed November 30, 2009, at 
http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_Swine
H1Assay-2009_20090430.pdf.). Conventional RT-PCR assays for H1N1/2009 were 
performed according to WHO Protocols using primers M30F2/08 and M264R3/08 for 
influenza A matrix and NIID-swH1 Conv-F1 and NIID-swH1 Conv-R1 for 
H1N1/2009 (WHO information for laboratory diagnosis of pandemic H1N1/2009 
virus in humans – revised. 23 November 2009 
(http://www3.ha.org.hk/idctc/document/swineflu/WHO_Diagnostic_Recommendatio
nsH1N1_20090521.pdf). Conventional RT-PCR for seasonal influenza strains was 
preformed using one-step reactions with primers for influenza A matrix (as above); 
H3N2 (forward AAGCATTCCYAATGACAAACC, reverse 
ATTGCRCCRAATATGCCTCTAGT); H1N1 (forward 
AGGCAAATGGAAATCTAATAGCGC, reverse 
CCATTGGTGCATTTGAGGTGATG); and influenza B (forward 
TCCTCAACTCACTCTTCGAGCG, reverse CGGTGCTCT TGACCAAATTGG). 
Laboratory methods  - hemagglutination inhibition (HI) assay 
Influenza hemagglutination inhibition (HI) assays were performed according 
to standard protocols. Virus stocks used as antigens were cultured from swabs from 
select study participants with positive RT-PCR assays for each subtype in each 
season, except for season 3 where the WHO reference strain 
A/H1N1/California/7/2009-like was used. They were either propagated in the 
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allantoic cavities of 10-day-old embryonated hen’s eggs or in MDCK cells. Virus 
concentrations were determined by haemagglutination (HA) assay titration with 
appropriate erythrocytes at 0.5% (v/v) and used at titres of 1:8. Each virus was 
initially tested in HA with erythrocytes from chickens, guinea pigs and turkeys, and 
erythrocytes from chicken were selected for 2008 H1N1 (2008), and from turkey for 
H3N2 and H1N1/2009. Participant and reference serum or plasma was treated with 
receptor destroying enzyme (Denka Seiken, Japan), heat inactivated then adsorbed 
against packed appropriate erythrocytes. HI assays were performed in U-bottom 96-
well microtitre plates with 0.5% v/v appropriate erythrocytes. Cell controls and 
positive controls containing WHO reference sera for each strain were included with 
each batch of sera tested and two sera controls were included for each participant. 
Paired sera were tested together in the same assay run.  
Serum/plasma samples were tested at an initial dilution of 1:10 and then at 
two-fold serial dilutions to a maximum dilution of 1:1280. Results were accepted if 
sera and cell controls provided the correct non-agglutinated pattern and if positive 
controls were within two-fold of anticipated/historical titres. Samples that were 
negative by HI assay in the lowest dilution (1:10) were assigned a titre of 1:5 for the 
purposes of computing seroconversion.  
Study size 
The Tecumseh study of respiratory illness in the community estimated 
influenza virus associated illness occurred at a rate of around 220 per 1000 population 
per year with an additional 50 to 100 asymptomatic but serologically confirmed 
infections (Monto & Sullivan, 1993). Assuming an incidence rate of influenza 
infection of around 20% per influenza season and ignoring potential household 
clustering of influenza illness, a total of 1000 recruited subjects would lead to a two-
sided 95% confidence interval for the incidence with a precision (width) of 5%.  
Handling of quantitative variables in the analysis 
The age of participants at the start of each influenza season was calculated 
from their date of birth. For analysis and presentation of data on ILI episodes and RT-
PCR confirmed influenza infection, age was grouped into four categories to ensure 
sufficient outcome events in each category: 0-<5 years, 5-<20 years, 20-<40 years, 
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≥40 years. The same categories (except for <5 years olds which were not asked to 
provide blood) were used for the analysis of data on risk factors for influenza 
infection. For graphical presentation of serological outcomes, we used a finer age 
resolution with the following categories: 0-<5, 5-<10, 10-<20, 20-<30, 30-<40, 40-
<50, 50-<60, 60-<70, ≥70. Home crowding was defined as being present if there were 
more than 2 people per room. 
 
Statistical methods 
Absolute observed risks of ILI (for subjects under ILI surveillance) and of 
influenza infection (overall and for influenza subtypes, for subjects under influenza 
infection surveillance) were calculated per season. Participants were considered under 
ILI surveillance for a particular season if they were under weekly ILI surveillance 
throughout the influenza transmission period and they were considered under 
influenza infection surveillance if they additionally contributed a post-season blood 
sample. Absolute risks per season were preferred to rates (events per person time) as 
the incidence of influenza varies strongly over time. For example, while the time from 
bleed 1 to bleed 2 (season 1) was one year and the time from bleed 2 to bleed 3 
(season 2) only 6 months, both seasons contained a full transmission period of both 
influenza H1N1 and H3N2. 
Survey analysis methodology was used to derive risk estimates and associated 
95% confidence intervals in the full population and in age subgroups. This provides 
valid inference accounting for effects of the survey design, which was based on 
cluster sampling by household. The inclusion of subjects for assessment of influenza 
infection required blood samples and the willingness to provide blood differed by age 
and gender. To correct for this sampling bias, and to provide results that can be 
generalized to the broader population, the influenza risk estimates were standardized 
to the age and gender structure of the Vietnamese rural population based on the 2009 
Population and Housing Census. As children under 5 years of age were not asked to 
give blood samples, standardization for influenza risks was to the census population 
aged ≥5 years. Standardization was implemented by raking, i.e. post-stratification on 
the target age and gender distribution in turn until convergence (Lumley, 2010). 
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Seven potential risk factors for influenza infection were pre-defined. To assess 
these factors, data were pooled over all three seasons and the overall risk of an 
influenza infection was modeled with a logistic mixed effects model depending on the 
season, a random household effect (to account for potential clustering within 
households), a random subject effect (to account for potential within-subject 
correlation between seasons) and the respective risk factors. The analysis was 
repeated for each influenza subtype separately. 
All analyses were performed with the statistical software R 2.10.1 (R 
Foundation for Statistical Computing, Vienna, Austria) and the companion R 
packages survey 3.22-3 (for survey sampling) and lme4 0.999375-35 (for mixed 
models) (“R Development Core Team: R: A Language and Environ,” n.d.). 
Missing data and loss to follow-up 
Participants were excluded from all analyses if data on age or sex were 
missing. Participants were excluded from analysis of a particular influenza season if 
they were absent from the study site for a period of one week or more during the 
influenza transmission period; this included absence due to death, permanent out-
migration, or temporary absence. 
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Background: The spread of infectious diseases from person to person is determined by the frequency and nature of
contacts between infected and susceptible members of the population. Although there is a long history of using
mathematical models to understand these transmission dynamics, there are still remarkably little empirical data on contact
behaviors with which to parameterize these models. Even starker is the almost complete absence of data from developing
countries. We sought to address this knowledge gap by conducting a household based social contact diary in rural Vietnam.
Methods and Findings: A diary based survey of social contact patterns was conducted in a household-structured
community cohort in North Vietnam in 2007. We used generalized estimating equations to model the number of contacts
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distribution towards the Vietnamese population. We recorded 6675 contacts from 865 participants in 264 different
households and found that mixing patterns were assortative by age but were more homogenous than observed in a recent
European study. We also observed that physical contacts were more concentrated in the home setting in Vietnam than in
Europe but the overall level of physical contact was lower. A model of individual versus household vaccination strategies
revealed no difference between strategies in the impact on R0.
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Introduction
Mathematical models of infectious disease transmission have
become indispensible tools for understanding epidemic processes
and for providing policy makers with an evidence base for
decisions when empirical data is limited. The success of
mathematical models in informing critical decisions to protect
human and animal health has been demonstrated for many
diseases including pandemic influenza, SARS, foot and mouth
disease, and new variant CJD [1]. Infections directly transmitted
from person to person by the respiratory route have been of special
interest for modeling because of their ability to spread quickly and
affect large numbers of people.
The validity of mathematical models, and therefore the
effectiveness of policies based on these models, is dependent on
the robustness of the parameters entered in to the model [1,2]. A
key parameter in infectious disease models is the probability of
contact between an infectious source and a susceptible individual.
For infections transmitted from person to person various
assumptions are required to simplify the range of human relations
into tractable mathematical models. Earlier assumptions of
homogenous mixing, where everyone in the population has an
equal probability of contact, have been replaced by more realistic
frameworks where the probability of contact varies between
groups, most often defined by age. The extent to which individuals
preferentially mix with people of the same age (assortativeness) is a
key heterogeneity that is now routinely included in models and
attempts have also been made to further represent the underlying
structure of contact patterns by partitioning the population into
household and workplace compartments [3,4,5].
Understanding and incorporating the key elements of popula-
tion contact structures into models is important since it improves
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the predictive accuracy of the model and also permits investigation
of the effect of interventions targeted at specific settings, such as
schools, workplaces or homes [5,6]. Indeed, family size and
composition have been associated with both social contact
frequency and the risk of infection with influenza and other
respiratory pathogens [7,8,9].
Seroepidemiological studies have been used to infer contact
patterns relevant to the transmission of infections and a number of
surveys have been conducted to directly measure social contacts
[10,11,12,13,14]. The self reported social contact data derived
from such surveys have been shown to better predict the observed
patterns of respiratory infections than other representations of
contact probabilities, such as homogenous or proportionate
mixing [12,14,15,16]. The frequency and nature of social contacts
are however determined by demographic factors, the living and
working environment, socio-cultural norms and individual lifestyle
choices; all of which vary by place and time. A study of eight
European countries found that contact patterns were very similar
but little is known about differences in social contact behaviors
across more diverse socio-cultural environments [13].
The vast majority of social contact surveys have been conducted
in developed western countries yet the majority of the world’s
population live in less developed countries where family structures,
socio-cultural norms, population mobility and the home and work
environment may differ in important ways from Europe.
Developing countries are also more often sites for the emergence
of infectious diseases and in an increasingly connected world,
localized outbreaks can rapidly ‘go global’ with devastating health
and economic impacts. There is therefore a need to determine
social contact patterns in developing country settings, so that the
benefits of mathematical modeling can be extended to these higher
risk and more vulnerable populations [17].
To address this knowledge gap we have used a social contact
diary approach to estimate the frequency and nature of social
contacts in a semi-rural community of Vietnam. Since the
household is a fundamental unit for the transmission of many
infections and household characteristics clearly influence trans-
mission risks, we employed a household-based survey design.
Methods
Study area and population
Vietnam has a population of 85.8 million people, making it the
3rd most populous country in Southeast Asia (after Indonesia and
the Philippines) and the 13th most populous nation in the world.
70% of the population lives in rural areas. The Red River Delta in
the north and the Mekong River Delta in the South together
comprise 43% of the population and the Red River Delta is the
most densely populated area, with 930 people per km2 [18]. Data
on the national distribution of household sizes and the population
age structure was obtained from the Vietnam General Statistics
Office (GSO; http://www.gso.gov.vn).
Survey population
In 2007 a household-based cohort was established in a semi-
rural community in the Red River Delta of North Vietnam.
Households were randomly selected from a list of all households in
the commune (the third administrative level) using a random
number table. If a selected household declined to participate the
nearest neighbor was approached for participation.
Survey methods
A paper-based questionnaire was developed based on an earlier
European study but adapted to the local context [13]. With the
assistance of a trained interviewer, subjects recorded the details of
each contact made on the day preceding the interview. In order to
improve recall, subjects were informed of the day on which they
would be interviewed in advance. The same definition of a contact
was used as the European study, which was: either skin-to-skin
contact (a physical contact), or a two-way conversation with three
or more words in the physical presence of another person but no
skin-to-skin contact (a nonphysical contact). One entry was made
for each person contacted during the diary day, which was defined
as starting at 5 a.m. on the morning of the day assigned and
ending at 5 a.m. the next morning. If an individual was contacted
multiple times during the day, the individual was recorded only
once but the total time spent with that person during the day was
entered. Information was recorded on the age and gender of each
contact, the location and duration of the contact, whether skin-to-
skin contact had occurred, and how often the interviewee normally
had contact with the individual. The diary is available in the
Supporting Information (text S1).
Every member of each participating household was requested to
complete the contact diary. Participants completed the question-
naire with the assistance of trained village health workers during
face-to-face interviews. For children aged 10 years or less, the
diary was completed with the assistance of the child’s parent or
guardian. Data were double entered into an Access database.
Data analysis
We used generalized estimating equations (GEE) to model the
number of contacts participants in age-category I make with
persons in age-category J while taking into account the correlation
introduced by sampling households. GEEs use working correlation
matrices to take the correlation into account and provide unbiased
estimates even if the working correlation matrix is misspecified,
albeit at the potential loss of efficiency. We used an independence
working correlation matrix to take into account clustering within
households and as a result of using the GEE approach the
correlation between the number of contacts from the same
participant over different age-categories is also taken into account.
Sampling weights are calculated using Vietnamese census data to
balance the contribution over the different days of the week and to
balance the household size and age distribution towards the
Vietnamese population. Matrices of the relative intensity of
contact between age groups were estimated using weighted GEE
and were made reciprocal (i.e. the relative frequency of 0–5 years
old subjects having contact with 0–5 year olds is the same) by
averaging across the two cells. Reciprocal, balanced matrices are
needed for next generation matrices in mathematical models of
disease transmission. The use of a weighted GEE approach allows
population level inferences to be made from the sample dataset.
In order to model the effect of individual or household targeted
immunization strategies we mimicked the immunization process of
individuals or households by setting their corresponding contacts
to 0 for all age-categories. The basic reproduction number R0 can
be calculated as the dominant eigenvalue of the next generation
operator [19] which can be calculated as the dominant eigenvalue
of the matrix NDb where N is a vector of age-group specific
population sizes, D is the mean infectious period and b is the per
capita transmission rate. Under the social contact hypothesis,
Wallinga et al. 2006 assumed b= qC where q is a proportionality
factor and C is the per capita contact matrix. The relative
reduction in R0 when immunizing from p= 0% up to 30% of the
population can then be calculated as the ratio of dominant
eigenvalues of NCp and NC, respectively [20]. Here Cp is the
matrix of per capita contact rates between the different age-groups
as estimated using the GEE when immunizing a proportion p of
Contact Patterns Vietnam
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Figure 1. Household sizes (A) and number of reported contacts per person per day (B).
doi:10.1371/journal.pone.0016965.g001
Table 1. Number of recorded contacts per participant per day by characteristics, and relative number of contacts from weighted
GEE analysis.
Category Covariate Number of participants
Mean (SD) of Number of Reported
Contacts
Relative Number of Contacts
(95% Confidence interval)
Age of participant 0–4 74 5.47 (2.17) 1.00
5–9 66 6.74 (3.84) 1.23(1.10–1.37)
10–14 95 7.91 (5.65) 1.09(0.96–1.25)
15–19 94 7.67 (3.47) 1.30(1.08–1.56)
20–29 110 7.02 (2.68) 1.17(0.93–1.46)
30–39 120 8.02 (3.21) 1.33(1.13–1.58)
40–49 157 8.65 (4.44) 1.29(1.07–1.55)
50–59 76 8.71 (3.51) 1.44(1.19–1.75)
60+ 73 8.21 (3.18) 1.31(1.02–1.68)
Sex of participant Female 471 7.74 (3.78) 1.00
Male 389 7.67 (3.97) 1.01(0.94–1.08)
Missing Value 5 9.00 (3.08) 1.77(1.54–2.02)
Household Size 1 32 8.59 (3.40) 1.00
2 96 7.89 (3.48) 0.94(0.79–1.12)
3 219 8.01 (4.35) 1.06(0.88–1.26)
4 236 7.30 (4.35) 1.02(0.84–1.24)
5 185 7.72 (3.24) 1.16(0.94–1.44)
6+ 97 7.60 (2.86) 1.03(0.84–1.26)
Day of the week Monday 8 7.75 (2.66) 1.00
Tuesday 148 8.92(4.50) 1.17(0.92–1.49)
Wednesday 302 7.83 (3.24) 0.96(0.79–1.15)
Thursday 181 7.20 (4.21) 0.93(0.76–1.14)
Friday 134 7.15 (4.04) 0.97(0.81–1.17)
Saturday 30 6.82 (2.90) 0.93(0.79–1.08)
Sunday 26 7.19 (2.62) 1.05(0.92–1.18)
Missing Value 6 12.00 (6.36) 1.52(0.90–2.55)
Dispersion parameter alpha = 0.79 (0.33,1.24); alpha = 0 would correspond to no overdispersion.
NA indicating missing values.
doi:10.1371/journal.pone.0016965.t001
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the population by either randomly selecting individuals or
households and putting their contacts to 0 for all age-categories.
C is the matrix of per capita contact rates without immunization.
Statistical analysis was conducted in R 2.9.0 (The R Foundation
for Statistical Computing).
Results
Participant characteristics, number of contacts and
associated covariates
We recorded 6675 contacts from 865 participants in 264
different households. The mean age of respondents was 32 years
(range 0–90) and 55% were female. The mode household size was
3 persons and the mean number of different people contacted per
respondent per day was 7.7 (sd 3.9) indicating the need to use a
count model that allows for overdispersion (i.e. the exhibited
variability exceeds what is expected using a Poisson model, where
the variability equals the mean. Note that the WGEE approach in
addition to the mean parameter uses a dispersion parameter to
allow for overdispersion) (figure 1). In a weighted GEE analysis we
observed no association between the total number of recorded
contacts and household size or gender. The number of reported
contacts was found to be smaller for infants aged 0–4 years as
compared to older participants, among which no difference was
observed (table 1). This demonstrates, at an aggregate level, rather
homogenous frequencies of social contacts across ages, genders
and days of the week.
Nature, duration, location and frequency of contacts
In the weighted GEE analysis just over 81% of all contacts lasted
more than four hours whilst contacts of shorter duration
(,5 minutes; 5–15 minutes; 15 minutes to 1 hour; 1–4 hours)
contributed between 4–5% of contacts each. Most reported contacts
(93%) were with people that the respondent reported meeting daily
or almost daily, with only one reported contact with an individual
that the respondent had never met before. The most common
reported location where contact occurred was the home (85%),
followed by school (5%) and work place (4%) (figure 2).
Figure 2. Contacts by location, duration and frequency. The
figures are based on a WGEE with weights based on household size,
days of the week and age.
doi:10.1371/journal.pone.0016965.g002
Figure 3. The location, duration and frequency of contacts. The proportion of contacts that were physical or non-physical by duration (panel
A), location (panel B) and frequency of contact (panel C). The duration of contact by frequency of contact (panel D). The figures are based on a WGEE
with weights based on household size and days of the week.
doi:10.1371/journal.pone.0016965.g003
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Forty four percent of all reported contacts involved physical
contact. Physical contact was most common in the home setting,
where 91% of all physical contacts occurred. Physical contact was
also more common when the duration of contact was long and
when the subject had contact with that person on an almost daily
basis (figure 3). 91% of physical contacts were with people with
whom the respondent spent more than four hours during the day
and 93% of physical contacts were with people who the
respondent usually contacted daily or almost daily. In total, 85%
of all physical contacts were in the home for more than four hours
with people the respondent meet daily or almost daily.
Age related social mixing patterns
The weighted GEE-model was used to estimate the intensity of
contacts between age groups for all participants (figure 4). The
matrix shows that contact intensity for all contacts tends to be
highest in the diagonal, demonstrating an assortative mixing pattern
where the greatest contact is between individuals of a similar age
group. However, a wide area of moderate intensity contact is also
apparent for adults aged 26 to 65 years, indicating rather
homogenous mixing amongst working age adults. Two secondary
areas of moderate intensity contact are also apparent between the
20–65 year age group and children aged 0–5 years. This probably
represents contact between parent and their children and,
grandparents and their grand children. Physical contacts are most
intense amongst children aged 0–5, both within that age group and
with young adults, as shown in the right hand panel of figure 4.
Comparison of immunization strategies
Assuming that infection is transmitted through the recorded
contact behaviors and that there is full susceptibility to infection,
modeling of the potential impact of individual versus household
targeted immunization strategies revealed no difference in the
predicted effect for a given level of vaccine coverage (figure 5).
Discussion
The successful spread of an infectious disease that is transmitted
from person to person is dependent onmany factors, but key amongst
these are the susceptibility of the population, and the frequency and
assortativeness of contacts that effectively transmit infection.
Quantifying these parameters is critical for estimating the impact of
such infections, for designing and targeting preventive interventions,
and for modelling their impact [1]. Whilst much work has been
conducted on defining these parameters for sexually transmitted
infections, less has been done on contact behaviours relevant to the
transmission of respiratory infections; and what has been done has
been conducted exclusively in developed countries [10,11,12,13].
Here we report the first data from a developing country on social
contacts relevant to the spread of respiratory pathogens.
Using the same definition of a contact and comparable
methodology to a large European study, we have identified both
similarities and potentially important differences in our study site
in Vietnam [13]. Similarities with the European data include
significant over dispersion in the distribution of contacts and no
gender differences in reported contact frequency. As observed in
Europe, we too found a peak in contact frequency in school age
children, but in contrast to the European data, we also observed a
second peak in adults aged 40–60 years. Another similarity with
Figure 4. Contact intensity matrices for all contacts (A) and for physical contacts only (B). Yellow indicates high contact rates and blue
low contact rates, relative to the mean contact intensity.
doi:10.1371/journal.pone.0016965.g004
Figure 5. The predicted effect on R0 of immunizing individuals
or households. The figure shows the predicted effect on R0
immunizing a random selection of individuals (solid line) versus a
random selection of households (broken line).
doi:10.1371/journal.pone.0016965.g005
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the European study was that prolonged and frequent contacts, and
contacts occurring at home were much more likely to be physical
in nature. However, there were important differences in the total
number of contacts, and the duration and intimacy of contacts.
Overall we recorded a mean of 7.7 contacts per participant per
day versus 13.4 in the study by Mossong et al. The lower number of
daily contacts we recorded may be a feature of the particular
community studied or may reflect a recall bias introduced by the
retrospective nature of our study design compared to the
prospective design of the European study. Over 80% of contacts
that occurred on a daily basis in the Vietnam study were more
than four hours, compared to only around 45% in the study by
Mossong et al [13] Physical contact was more common in the
European study, with 75% of home contacts being physical
compared to around 45% in our study, and over 60% of daily
contacts being physical compared to around 40% in our study.
The importance of these differences to disease patterns depends on
the relative importance of duration of contact versus intimacy of
contact on the probability of successful transmission.
In general the contact patterns in our study were more
homogenous than that reported elsewhere. We saw smaller
differences between age groups in contact frequency and no
significant differences between household sizes. We saw similar
patterns of age dependent mixing to those reported by Mossong et al,
with pronounced assortative mixing seen as a high intensity diagonal,
signals of parent-child mixing, and a ‘plateau’ of mixing of adults with
one another. We also observed no significant differences in contact
frequency by day of the week, whereas significantly more contacts in
Europe were recorded on weekdays compared to weekends. This is
may be because weekends are not generally observed as a special rest
period in rural Vietnam to the extent they are in Europe. We also saw
fewer contacts in ‘leisure’ settings (1% vs 16%), which may reflect true
differences in the amount of time devoted to leisure, cultural
differences in the conceptual separation between work, family and
leisure activities, or limitations of the survey method in distinguishing
leisure from other activities. Surprisingly, only one contact was
reported with a person that the respondent had never met before.
Whilst the studied community is rural, it is within ten kilometres of a
small town, so cannot be considered remote.
Although we used weights to make inferences about contact
behaviours in the general population of Vietnam, the reliability of
such a generalization is limited by the fact that the study was
conducted in only one setting and at only one time point. It is
possible that contact behaviours may vary significantly between
rural and urban areas and by season. Future studies will be needed
to further define such heterogeneities.
The added value of our data compared to previous published
work is two-fold. We are the first group to report on contact
behaviours relevant to the spread of respiratory infections from a
developing country, and we are the first to report household
structured contact diaries of this nature. These novel features of our
data can provide valuable insights into the spread of directly
transmitted infections in a rural developing country setting and the
potential impact of individual versus household targeted control
strategies. Although we found no difference in the estimated impact
on R0 between individual- and household-targeted immunisation
strategies, the model assumed that all recorded contacts were
equally important in the transmission of infection, whereas it is likely
that the risk of successful transmission is heterogeneous and varies
with different intensity and duration of contacts.
The spread of directly transmitted infections is dependent on at
least four unknown parameters: the susceptibility of the popula-
tion; the frequency of contacts; the assortativeness of contacts; and
the type of contact that transmits infection. The susceptibility of
the population can in part be measured by serological and other
surveillance data, and this study has gone some way to answering
the second two unknowns. The fourth unknown, the types of
contact that transmit respiratory infections and their relative
importance, is however harder to answer. There has been a
vigorous debate over the relative importance of aerosols versus
large droplets in the transmission of influenza, and even
suggestions that the predominant route may vary between climatic
regions [21,22,23,24]. It is a critical question since models that
assume all social contacts provide an equal opportunity for
infection may result in incorrect conclusions [2,25]. As an adjunct
to physico-mechanical explorations of the transmission of
respiratory infections, a valuable supplementary approach is to
explore associations between the frequency, intensity and duration
of contacts and the measured risk of transmission. This has been
done to some extent by comparing seroepidemiological data with
contact patterns at an aggregated, population level, but might also
be done at an individual level [15]. Multi-country studies that
incorporate biomarkers of infection will help to further define
spatial and temporal heterogeneities in contact behaviours and the
relevance of particular contact profiles to infection risk.
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Abstract
Background: A novel variant of influenza A (H1N1) is causing a pandemic and, although the illness is
usually mild, there are concerns that its virulence could change through reassortment with other influenza
viruses. This is of greater concern in parts of Southeast Asia, where the population density is high, influenza
is less seasonal, human-animal contact is common and avian influenza is still endemic.
Methods: We developed an age- and spatially-structured mathematical model in order to estimate the
potential impact of pandemic H1N1 in Vietnam and the opportunities for reassortment with animal
influenza viruses. The model tracks human infection among domestic animal owners and non-owners and
also estimates the numbers of animals may be exposed to infected humans.
Results: In the absence of effective interventions, the model predicts that the introduction of pandemic
H1N1 will result in an epidemic that spreads to half of Vietnam's provinces within 57 days (interquartile
range (IQR): 45-86.5) and peaks 81 days after introduction (IQR: 62.5-121 days). For the current published
range of the 2009 H1N1 influenza's basic reproductive number (1.2-3.1), we estimate a median of 410,000
cases among swine owners (IQR: 220,000-670,000) with 460,000 exposed swine (IQR: 260,000-740,000),
350,000 cases among chicken owners (IQR: 170,000-630,000) with 3.7 million exposed chickens (IQR: 1.9
M-6.4 M), and 51,000 cases among duck owners (IQR: 24,000 - 96,000), with 1.2 million exposed ducks
(IQR: 0.6 M-2.1 M). The median number of overall human infections in Vietnam for this range of the basic
reproductive number is 6.4 million (IQR: 4.4 M-8.0 M).
Conclusion: It is likely that, in the absence of effective interventions, the introduction of a novel H1N1
into a densely populated country such as Vietnam will result in a widespread epidemic. A large epidemic
in a country with intense human-animal interaction and continued co-circulation of other seasonal and
avian viruses would provide substantial opportunities for H1N1 to acquire new genes.
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Background
In early 2009 a novel influenza A (H1N1) variant emerged
which spread globally causing the first influenza pan-
demic in over 40 years. The dynamics and impact of this
pandemic are difficult to predict, especially since the
world has changed significantly in 40 years - the global
population has almost doubled, more people live in cit-
ies, people travel more frequently and over longer dis-
tances. These facts will undoubtedly influence the global
pattern of this pandemic, just as geographical heteroge-
neities will result in different local patterns [1]. More than
60% of the world's population live in low-income and
lower-middle income countries, and yet, at the time of
writing only, about 10% of confirmed cases have occurred
in these areas [2,3]. In densely populated low-income
countries, where public health systems, health care serv-
ices and drug availability are all stretched, influenza
H1N1 is likely to be almost impossible to contain result-
ing in a greater number of cases occurring in more vulner-
able populations resulting in a less benign epidemic.
Even more worrying, almost 60% of the world's human
population and over 50% of the world's poultry popula-
tion live in Asia, where highly pathogenic avian influenza
(HPAI) maintains a foothold and seasonal influenza
transmission is complex [4]. Previous pandemics have
demonstrated the potential consequences of reassortment
between human and animal influenza viruses. It is possi-
ble, therefore, that the new H1N1 - itself a reassortant of
swine viruses that had previously reassorted with human
and avian influenza - may follow a similar pattern [5,6].
The new H1N1 variant has already shown that it can be
transmitted from humans to pigs, and we know that the
H5N1 subtype is capable of infecting humans and of suc-
cessfully reassorting with human seasonal influenza
viruses under in vitro and in vivo experimental conditions
[7,8]. As the population is increasing and standards of liv-
ing are improving there has been an increase in livestock
production and thus there is probably more contact
between animals and humans than before. These contacts
offer opportunities for reassortment, and, if a novel virus
with the transmissibility of H1N1 and even a fraction of
the virulence of H5N1 were to emerge, the consequences
would be devastating.
In order to explore the potential impact of influenza A
(H1N1) on a densely populated low-income country, we
developed a mathematical model showing how an influ-
enza A (H1N1) epidemic might progress in Vietnam. We
used this model to estimate the frequency of contact
between H1N1 infected humans and domestic animals in
an attempt to quantify the opportunities for reassortment
between H1N1 and animal influenza viruses.
Methods
Mathematical model
We developed an age-structured gravity model - where
migration rates among sub-populations are balanced such
that there are no changes in the sizes of the sub-popula-
tions - based on traditional susceptible exposed infectious
recovered (SEIR) equations with stochastic migration and
hospitalization processes [9]. The model has geographical
resolution to the province level in Vietnam (64 provinces
in 2007) and tracks infection and mixing in seven age
groups. The incubation period was set at 1.4 days and the
infectious stage was separated into four stages to mimic an
infectious period that is !-distributed with a coefficient of
variation equal to 0.5. Mixing and infection among hosts
(humans) in the model occurred at the province level and
depended on the contact rates among the seven age
groups, age-specific susceptibilities, province-specific age
distribution and population density. The basic reproduc-
tive number, denoted by R0, is calculated via a next gener-
ation matrix assuming at most one cross-province
migration event during a single infection [10]. The R0
value described in the text and figures is for Ho Chi Minh
City and assumes that there is no migration from the city
(see supplementary materials, additional file 1, for detail
on the different R0 values that can be computed for this
model). The results are presented for a single case intro-
duced in Ho Chi Minh City, as this is where the first case
was confirmed on 31 May 2009. Infection among animal
populations is not modelled. Model equations and details
of computing the basic reproduction ratio are presented
in the supplementary materials (Additional file 1).
Data sources
We used seven age groups: 0-5 years, 6-15, 16-25, 26-34,
35-49, 50-64 and 65+. Provincial level data on resident
population by age class, number of public and private
hospital beds, number of households, and number of
households raising pigs, chickens, and ducks were derived
from the General Statistics Office of Vietnam. The age-
class specific daily probability of migration between prov-
inces was derived from a 2007 community survey con-
ducted in northern Vietnam [unpublished data, P Horby].
This gave a mean estimate of 1.35% of the population
moving between the provinces each day. This was used as
the lower end of the modelled range, as it is known that
populations closer to urban areas will have much higher
rates of movement. The number of major and minor
roads crossing provincial borders was determined from
1:250,000 road maps and were used to obtain a relative
measure of interprovincial traffic. Internal migration by
air travel was estimated using publicly available flight data
from all airlines operating domestically in Vietnam. The
known daily travel by air and the unknown daily travel by
road were combined to form a scalable migration network
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between the provinces of Vietnam where between 1.35%
and 5.00% of the population moved between provinces
on a daily basis.
Transmission and natural history parameters
Age-dependent mixing was included in the model by cre-
ating a contact matrix for seven age groups, using data
from a survey of social contact patterns conducted in 2007
among 865 members of a community in one semi-rural
district of northern Vietnam. Since both epidemiological
and serological data are suggestive of age-dependent sus-
ceptibility to H1N1 infection, an age-dependent suscepti-
bility term was also included [11,12]. This was derived
using data on the age distribution of cases in the USA and
data on age-dependent contact frequency from a Euro-
pean study [13]. We assumed no effect of season on the
transmission of infection or on contact patterns, as influ-
enza seasonality in Vietnam is not well understood, even
in the northern and more temperate part of the country
(unpublished data, PQ Thai).
Since reliable data on the natural history of infection with
H1N1 were not available at the time of writing, we
applied parameters previously estimated for seasonal
influenza. We applied an incubation period with a mean
of 1.4 days [14]. The mean of the !-distributed infectious
period was varied between 3.8 days and 5.5 days [15]. The
age-class specific relative probability of hospitalization
was derived from data of the proportion of H1N1 cases
hospitalized in Mexico and the USA. The overall hospital-
ization rate was varied between 0.5% and 1.5% of all
cases, since reported rates of 5%-6% are likely to be biased
by over-ascertainment of severe cases compared to mild
cases. Hospitalization time was set at 5 days [16].
Sensitivity analysis
Sensitivity was tested by varying the basic reproduction
ratio (1.2 - 3.1), the duration of infection (3.8 - 5.5 days),
the individual probability of cross-province migration
(1.35% - 5.00% daily probability), the relative amount of
traffic on large roads compared to small roads (one to two
times), and the overall expected hospitalization in the
population (0.5% - 1.5%). One thousand parameter com-
binations were sampled using Latin hypercube sampling,
and sensitivity results are reported for these parameter
samples [17]. The key parameter for this sensitivity analy-
sis is R0, the basic reproductive number. For influenza this
is traditionally estimated between 1 and 3 [18-20] and the
ranges reported so far for novel H1N1 have been 1.2, 1.4
to 1.6, 2.0 to 2.6, and <2.2 to 3.1 [11,21,22]. For the upper
band of our tested range, we used the highest estimate (R0
= 3.1) as opposed to the highest of the upper band 95%
confidence interval (R0 = 3.5).
Full details of data sources, parameter estimation and
model specification are available in the supplementary
materials (Additional file 1).
Results
Epidemic curve and geographic spread
Introducing a single infected case in Ho Chi Minh City,
and simulating the epidemic for one year (over 1000 ran-
domly sampled parameter sets), resulted in a median 6.4
million infections (IQR: 4.4 million - 8.0 million). In the
absence of any intervention, the epidemic would reach
half of Vietnam's provinces in 57 days (IQR: 45-86.5), and
would peak after 81 days (IQR: 62.5-121). Seventy-seven
percent of all cases and 67% of all hospitalizations occur
in the 6-34 year age group. Table 1 shows the range of out-
puts for the model simulations.
The epidemic was dominated by the peaks in Hanoi and
Ho Chi Minh City (Figure 1), Vietnam's most densely
populated metropolitan areas. Both of these provinces are
at least twice as densely populated as any other province
in Vietnam. The interval between the 100-case point in
Ho Chi Minh City and 100-case point in Hanoi is esti-
mated to be about 29 days (IQR: 23-43), but might be
doubled or tripled if a sustained social distancing cam-
paign were able to reduce all contacts by 50%. After the
Hanoi wave passes, the epidemic is expected to tail off
slowly as the disease spreads to less densely populated
rural areas. Figure 2 shows the geographic progression of
the median epidemic in Vietnam; Figure 3 shows the
median epidemic peak times for all the provinces, indicat-
ing an approximate 1-month delay between peaks in the
southern provinces and peaks in the northern provinces.
The epidemic in Vietnam is predicted to cause 58,000 hos-
pitalizations (IQR: 39,000-75,000). The health care sys-
tem would be severely stretched but is unlikely to be
overwhelmed, except in the case of a high-R0 epidemic or
increased virulence. Vietnam currently has a stockpile of
approximately 1.1 million oseltamivir treatment courses
(10 75 mg tablets) and sufficient powder to formulate
another 900,000 treatment courses. This should be ade-
quate for treatment of severe cases but for not mild cases
or for prophylaxis of contacts during a widespread epi-
demic.
Contacts between infected humans and domestic animals
Because of the slow dispersion of the epidemic into rural
areas, the peak exposure of domestic pigs, ducks and
chickens to infected humans occurs during the later
phases of the epidemic. Figure 1A shows the estimated
number of exposures of domestic animals to infected
humans; the highest exposure will be among domestic
chickens and the exposure of all domestic animals will
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Table 1: Median, quartile and minimum - maximum values for selected outputs of one year of model simulation.
Model output Minimum Lower quartile Median Upper quartile Maximum
Time to reach 20-case point (days) 9.0 12.0 14.0 19.0 39.0
Time to reach 100-case point (days) 13.0 18.0 22.0 32.0 71.0
Time for 32 provinces to be affected (days) 34.0 45.0 57.0 86.5 314.0
Time for 48 provinces to be affected (days) 41.0 55.0 71.5 112.0 > 1 year
Epidemic peak point (days) 45.0 62.5 80.8 121.0 not reached
Final epidemic size (number of cases) 103,885 4,432,247 6,377,555 8,021,328 9,796,738
Cumulative number hospitalized 594 38,832 58,165 74,935 104.976
Average number of new cases per day over 2-week peak period 1916 88,453 174,804 245,209 326,260
Average number of new hospitalizations per day over 2-week peak 
period
9 779 1,564 2,238 3508
Cumulative number of cases in swine owners 1940 224,208 410,276 671,703 1,159,291
Cumulative number of cases in chicken owners 630 172,731 351,243 632,316 1,174,682
Cumulative number of cases in duck owners 160 23,732 51,131 95,790 182,520
Number of days Hanoi hospitals running at > 150% bed capacity 0 0 0 14 20
Number of days HCMC hospitals running at > 150% bed capacity 0 0 0 0 11
Time from 100-case point in HCMC to 100-case point in Hanoi 12 23 29 43 156
Number of rural cases 16,105 963,791 1,540,008 2,184,359 3,220,171
Number of urban cases 87,780 3,440,732 4,844,258 5,831,431 6,668,559
Number of exposed pigs 3,053 259,328 462,633 737,443 1,239,324
Number of exposed chickens 4,612 1,890,957 3,745,045 6,417,106 11,419,922
Number of exposed ducks 2,319 580,132 1,176,129 2,072,495 3,708,187
Number of infections by age group
0 to 5 years 7,611 366,741 543,858 685,656 832,651
6 to 15 years 35,370 1,211,114 1,617,223 2,031,725 2,609,789
16 to 25 years 30,075 1,312,009 1,837,835 2,212,661 2,599,191
26 to 34 years 22,277 998,079 1,450,723 1,784,407 2,096,515
35 to 49 years 6,067 363,076 627,659 870,774 1,134,289
50 to 64 years 1,920 130,147 232,582 329,305 435,306
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65 years and over 565 38,492 71,658 106,032 147,498
Hospitalizations by age group
0 to 5 years 71 4,493 6,766 8,624 12,144
6 to 15 years 113 5,453 7,467 9,481 13,831
16 to 25 years 119 8,128 11,393 14,091 18,991
26 to 34 years 198 13,580 19,932 24,989 33,959
35 to 49 years 81 5,540 9,424 13,345 19,910
50 to 64 years 10 1,284 2,279 3,310 5,262
65 years and over 2 393 721 1,079 1,792
Table 1: Median, quartile and minimum - maximum values for selected outputs of one year of model simulation. (Continued)
(A) The range of possible epidemics in VietnamFigure 1
(A) The range of possible epidemics in Vietnam. The graph summarizes 500 simulated epidemics and resets their peaks 
to day zero so they can be compared on the same time axis. The red line shows the median number of infected persons. The 
medium gray region shows the interquartile range. The light gray region shows the 95% confidence interval based on the 
parameter ranges chosen via Latin hypercube sampling. The confidence band width is primarily determined by R0. The three 
dotted lines show the median number of exposed animals during the epidemic. (B) Median number of new cases by day, 
with day zero corresponding to the epidemic peak. Stacked bar graph has dark gray bars for Ho Chi Minh City, medium 
gray bars for Hanoi and light gray bars for the remaining 62 provinces.
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peak roughly 1 month after the peak in Ho Chi Minh City
and shortly after the epidemic peak in Hanoi. Note that
the tail phase of the epidemic wanes slowly and that a sig-
nificant number of chickens, ducks and pigs remain
exposed for up to 2 months after the human epidemic has
peaked in Hanoi (Figure 4).
In total, the epidemic simulations estimate a median
410,000 cases among swine owners (IQR: 220,000 -
670,000) with 460,000 exposed swine (IQR: 260,000-
740,000), a median 350,000 cases among chicken owners
(IQR: 170,000-630,000) with 3.7 million exposed chick-
ens (IQR: 1.9 M-6.4 M), and a median 51,000 cases
among duck owners (IQR: 24,000 - 96,000), with 1.2 mil-
lion exposed ducks (IQR: 0.6 M-2.1 M).
Effect of public health interventions
By restricting contacts in the 6-15 age group, school clo-
sures were modelled but showed little effect on the pro-
gression of the epidemic. Even a comprehensive strategy
of restricting all contacts within this age group would only
delay the epidemic peak by a few days and result in no
fewer cases. Any realistic restriction of flights between Ho
Chi Minh City and Hanoi (< 2 weeks) had little or no
effect on geographic spread or the total number of cases.
Monitoring incoming international flights and multiple
introductions was not modelled.
Sensitivity analysis
Like all epidemic models, the highest sensitivity is to R0.
All severity indices of the epidemic - total number of cases,
peak incidence and total number of hospitalizations - rise
steadily with the R0 value, or, in general, with the trans-
missibility of the virus (top panels, Figure 5). The most
important feature of the model is that with increasing R0
the epidemic becomes more rural. An increase in the pre-
dicted transmissibility of novel H1N1 in Vietnam results
not only in more infections, but in a higher proportion of
infection among rural populations and among those rais-
ing pigs, ducks and chickens domestically (bottom panels,
Figure 5). The model is not very sensitive to the other
parameters tested: the duration of the infection, the
amount of migration between the provinces, the hospital-
ization rate or the relative amount of traffic on large roads
versus small roads.
Discussion
The first cases of H1N1 were detected in Vietnam on 31
May 2009 and by mid-July there were more than 100 con-
firmed cases with probable community transmission that
Geographic spread of swine-origin influenza A (H1N1) in VietnamFigure 2
Geographic spread of swine-origin influenza A (H1N1) in Vietnam. Case numbers in each province are medians from 
1000 model simulations. See additional file 2 for corresponding animation.
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was most likely the initial budding of the coming nation-
wide epidemic. We have used a mathematical model to
explore how the epidemic might progress in the absence
of interventions and have estimated the number of pigs,
ducks and chickens that might be exposed to infected
humans during the epidemic. Employing mathematical
modelling for such a forecasting exercise comes with
many caveats. Of these, the most important are that real
individuals are heterogeneous in behaviour and transmis-
sion, that human behaviour can change as a result of the
severity of the epidemic and that the spatial dimensions of
transmission have many nested levels that may or may
not alter the progression of the epidemic on a larger scale
[23,24]. We used a 'patch model' with coarse province-
level spatial resolution for simplicity of model develop-
ment and rapid computation; the model results should,
therefore, be viewed as rough estimates of the epidemic's
impact in Vietnam on a year-long time scale.
The most important caveat in our analysis is that the true
basic reproductive number is not known; we used a con-
servative estimate, between 1.2 and 3.1, based on early
measurements taken in Mexico, USA and Japan, and we
stress that the R0 for Vietnam may be higher than these
estimates. For an R0 value of 4.0, our model predicted a
total of 13.3 million cases among humans; for an R0 value
of 5.0, 16.6 million cases were predicted. Unfortunately,
the uncertainty in Vietnam's R0 will not be resolved until
we analyse the progression of cases from the first wave of
this pandemic.
Although the model predicts substantially more cases
than have so far been reported from other H1N1 affected
countries, the clinical illness is predominantly mild and,
therefore, reported H1N1 cases to date reflect only a small
proportion of the total number of cases. Our modelled
epidemic affects a median of 7.4% of the population
Timing of provincial epidemic peaks based on the distance from the nearest airport to the capital cityF gure 3
Timing of provincial epidemic peaks based on the distance from the nearest airport to the capital city. The 
model does not take sub-provincial population structure into account, and the epidemic's progression is determined primarily 
by south-to-north movement rather than distance to the airport network. Binh Thuan has an early peak because it lies in a 
densely populated part of southern Vietnam. The Lai Chau peak, as estimated by our model, probably occurs too early. Lai 
Chau is remote and sparsely populated, but its adjacency to the Dien Bien Phu airport causes the model to predict an early epi-
demic peak.
86
BMC Medicine 2009, 7:43 http://www.biomedcentral.com/1741-7015/7/43
Page 8 of 12
(page number not for citation purposes)
(IQR: 5.2-9.3%). This rate is below the figures for previous
pandemics and might be considered too low given the
high transmissibility of this virus in some settings and the
expectation that most of the population would have no
immunity [12]. Due to the low probability of hospitaliza-
tion, it is unlikely that the health sector as a whole will be
over-whelmed in the scenario outlined in this model.
However, there is considerable variation in reported hos-
pitalization rates for H1N1 and the estimate of 1% that we
have used is considerably lower than the maximum of 6%
[25]. As elsewhere, the number of intensive care beds is
limited in Vietnam and occupancy is routinely at maxi-
mum; therefore intensive care capacity is likely to be easily
overwhelmed. Also, although Vietnam has impressive
health indicators for its economic status - the population
may have vulnerabilities, such as under-nutrition in chil-
dren, which might result in a greater number of severe
cases than observed elsewhere.
Containment does appear to have been temporarily suc-
cessful in some countries (Mexico and Japan) but not in
others (Australia and the USA). The reasons for these dif-
ferences are undoubtedly complex, but successful case
detection, isolation and treatment, quarantine and chem-
oprophylaxis of contacts, and social distancing measures,
may all have an effect on the results. In our model, school
closures did not make a substantial difference to the epi-
demic progression, although substantial decreases in con-
tact frequency across all age groups would delay the time
course of the epidemic. School outbreaks have been a
major feature in the early stages of this pandemic, and it is
possible that our model underestimates the role of the
range of contacts and susceptibility of school-age children
on the epidemic dynamics. School closures did seem to be
effective in Kobe, Japan, during 11-24 May 2009, but this
may have reflected the low number of overall infections in
Japan at that time (between four and 345 confirmed
cases) [26]. In the UK, a plateau in consultation rates
appears to have coincided with the closure of schools for
the annual summer holidays [27]. Previous work suggests
that school closure can modify peak attack rates and may
result in a modest reduction of the final number of cases,
Geographic timeline of chicken exposure during an influenza epidemic in VietnamFigure 4
Geographic timeline of chicken exposure during an influenza epidemic in Vietnam. The numbers of chicken expo-
sures are medians from 1000 models simulations. Duck and pig exposures were highly correlated with chicken exposures, geo-
graphically and temporally. Note that because of rounding and fractional cases, some sparsely-populated provinces may have a 
median of 0.2 human cases (rounded down to zero) and 0.8 chicken exposures (rounded up to 1). See additional file 3 for cor-
responding animation.
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Result sensitivity relative to the R0-value as it would have been measured in Ho Chi Minh CityFig re 5
Result sensitivity relative to the R0-value as it would have been measured in Ho Chi Minh City. Light gray lines 
show the variation in a particular epidemiological indicator as a function of R0. The other coloured lines are moving averages 
over nearby R0-values. The top two panels show the size of the epidemic and the time taken for it to peak, which always have 
a predictable relationship to R0. The bottom two panels show how animal exposure increases and how the epidemic becomes 
more rural as R0 increases. Note that with higher R0, not only does the risk to domestic animal owners increase but the rela-
tive risk of an owner to a non-owner also increases (not shown).
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but empiric data is still required on the effectiveness of
school closure on reducing the number of transmissions
[28-31]. Climate and other seasonally variable factors
may also have acted to limit transmission in temperate
regions [32,33]. Seasonal factors are likely to have less
influence in tropical regions where the seasonality of
influenza transmission is much less marked [4].
In the absence of effective interventions, we predict a large
amount of contact between infected humans and animals
that might harbour other influenza viruses, including
HPAI. In fact, we believe our model probably underesti-
mates the amount of contact between infected human and
animals for three reasons. First, we divided the total
number of human cases by the number of people per
household in order to derive an estimate of the number of
households with an infectious case. We did this to avoid
over counting animals that were exposed to multiple
infected individuals in the same household, but this is a
very conservative correction. Second, domestic animal
production is concentrated close to urban centres, where
population densities are higher than average. Third, we
did not model contacts which occurring in live poultry
markets or commercial farms.
The danger of human-animal contact lies in the opportu-
nity for reassortment among different influenza subtypes.
It is well known that influenza reassorts in humans [34],
that pigs play an important role in reassortment of
human/avian/swine influenza viruses [35-37] and that
the history of avian influenza viruses includes multiple
reassortment events [38,39]. However, very little is known
about the potential of human influenza viruses to jump to
animals, since most studies to date have focused on ani-
mal influenza activity and the risk it poses to humans [40-
42]. Pandemic H1N1 has already been detected in swine
and, since poultry and swine populations in Asia may har-
bour many different subtypes of influenza (at least H4,
H5, H6, H7, H9, H11, H12), the generation of a new sub-
type through a reassortment event is a real possibility
[43,44] [personal communication, Ken Inui].
Although these opportunities for genetic reassortment are
not unique, the current influenza landscape contains wor-
rying features. Widespread epidemics of novel H1N1 are
likely in tropical countries where HPAI is endemic and
seasonal influenza transmission is complex and sus-
tained, without the seasonal bottlenecks that characterize
transmission in temperate regions [4,33]. The overall
diversity of influenza viruses in southeastern Asia ensures
that an epidemic of the novel H1N1 will create many
opportunities for co-infection with other subtypes circu-
lating in the region. Genetic and antigenic data suggest
that Asia is a key source of influenza viruses that cause sea-
sonal outbreaks in the northern and southern hemi-
spheres [45]. This region, therefore, possesses the
conditions necessary for the genesis and dissemination of
new influenza variants [33,45]. Finally, the introduction
of H1N1 into southeastern Asia creates an optimal evolu-
tionarily environment for the virus, where re-assortment
is neither too frequent nor too rare [46]. This means the
virus receives the benefits of limited reassortment (a
genetic novelty) but not the penalty of high levels of reas-
sortment (the breaking apart of beneficial gene combina-
tions).
Our model provides a rough picture of what might hap-
pen in Vietnam, but it includes many assumptions, uncer-
tainties and un-modelled heterogeneities which require
that the results be interpreted with caution. Although
changes in human demography and migration over the
past 40 years may make a pandemic more difficult to con-
trol, the same period has seen massive advances in tech-
nology and communication that allow us to monitor and
predict this pandemic as never before. Mathematical mod-
els are one tool, but a criticism of these models is that the
predictions are not subsequently tested against real out-
break data [47]. Our model development has coincided
with the arrival of H1N1 in Vietnam and we are planning
to track the progression of the outbreak in Vietnam in an
attempt at real-time model validation and diagnostics.
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Supplementary material 
Spatial structure 
The boundaries of the 64 Provinces of Vietnam in 2009 were obtained in GIS format from the Global 
Mapping Project [http://www.iscgm.org/cgi-bin/fswiki/wiki.cgi].  All disease dynamics and relevant 
population characteristics were aggregated at the province level. 
 
Age structure 
Seven age classes were used: 0-5 years, 6-15, 16-25, 26-34, 35-49, 50-64, 65+. These age classes were 
chosen since they correspond to the age classes used in a community survey of contact and travel 
frequency. 
 
Population 
The estimated resident population, rural and urban, in 2007 by Province was obtained from the Government 
Statistics Office of Vietnam (GSO). The 2007 population estimates are compiled from statistical returns to 
GSO from Provincial and District Statistical Offices. The estimated population by seven age classes was 
derived by applying the age structure from the 1999 population census (originally 18 age classes) to the 
2007 figures.  Province specific population density was estimated using 2007 population data and provincial 
land area calculated in GIS after excluding forested areas (as classified by 2005 vegetation map from 
Ministry of Agriculture and Rural Development).  
 
Age dependent mixing 
Age class specific contact frequency was derived from a survey of social contact patterns conducted in 2007 
in 865 members of a community in one semi-rural district of north Vietnam.  A contact was defined as: 
 
Either  
• a two-way conversation with three or more words in the physical presence of another person 
Or 
• physical skin-to-skin contact (for example a handshake, hug, kiss or contact sports). 
   
Participants recorded every contact made during one day, the age of the contact, and the duration and 
location of each contact. If a person was contacted more than once in a day, the contact was recorded only 
once but the total time spent with that contact over the entire day was recorded. A contact intensity matrix 
by seven age classes was constructed by adjusting the daily contact frequency data by the size of each age 
class. The matrix was corrected for reciprocity, i.e. where the contact frequency between age classes was 
not symmetrical the mean of the two values was used for both. The data were normalized so that the all age-
class specific rates were relative to the maximum rate of 1. 
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The contact rate matrix is: 
AGE CLASS 0 TO 5 6 TO 15 16 TO 25 26 TO 34 35 TO 49 50 TO 64 >=65  
0 TO 5 .5797 .1726 .2000 .4804 .1873 .1760 .0489 
6 TO 15 .1726 .8722 .1986 .2331 .2495 .1193 .1427 
16 TO 25 .2000 .1986 .6889 .2782 .3162 .3344 .1630 
26 TO 34 .4804 .2331 .2782 .6777 .3713 .4990 .3141 
35 TO 49 .1873 .2495 .3162 .3713 .4836 .4593 .3504 
50 TO 64 .1760 .1193 .3344 .4990 .4593 1.000 .5606 
>=65 .0489 .1427 .1630 .3141 .3504 .5606 .9916 
 
and it represents relative contact rates corrected for population size, meaning these are the relative contact 
rates one would observe if each of the age classes had the same number of individuals.  The true contact 
patterns are different for each province since the age distribution in each province is somewhat different.  
This pattern is similar to one calculated from census data from Portland, Oregon (USA), in that the main 
areas of contact intensity are (1) within age-groups and (2) peaking in children and older adults [1]. 
 
Note that these contact patterns differ from the European data presented in Mossong et al, the main 
difference being the high intensity of contacts in the 50+ age groups in Vietnam [2].  The next-generation 
matrix computed for these data is different for each province in Vietnam (since age structure varies by 
province), and it is generally different than the Dutch next-generation matrix presented in Wallinga et al [3].  
According to these next-generation matrices, infection patterns in Vietnam would primarily be driven by the 
6-15 age group, while infection in the Netherlands would be evenly driven by 6- to 39-year-olds. 
 
Internal migration by land 
Age class specific frequency of travel outside of the Province of residence was estimated from a 
questionnaire based survey of travel patterns conducted in 2007 in 865 members of a community in one 
semi-rural district of north Vietnam.  
 
A 64 x 64 adjacency matrix was compiled for all 64 Provinces in Vietnam that recorded which Provinces 
share a common border. For each pair of adjacent Provinces, the number of major and minor roads crossing 
the common border was determined from 1:250.000 road maps. Key national highways were classified as 
major roads and other national roads, provincial roads, and bridges were classified as minor roads. Major 
roads were given a value of 1 and minor road value was varied between 0.5 and 1.0 in our sensitivity 
analysis; this was deemed a reasonable range of variation as we did not have any other measure of the 
amount of traffic on large roads relative to small roads.  These values were entered into a 64 x 64 
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connectivity matrix. A special direct connection was created between Hanoi and Hai Phong (the major port 
in north Vietnam) in the model, since a large amount of road traffic travels between these two Provinces 
along one major road but the two Provinces share no adjacent border, so connectivity was thought to be 
under-estimated in the model.   
 
Province and age-class specific frequency of travel overland outside of the Province of residence was 
estimated by adjusting the frequency of travel survey data by the relative connectivity of each Province. 
 
Internal migration by waterways and railways was ignored in the model since GSO data on the volume of 
traffic by type of transport indicated that waterway and railway travel together contributed less than 10% of 
all passenger volume in 2007.   
 
Internal migration by air 
Internal migration by air travel was estimated using publicly available data on the frequency of flights and 
aircraft type between domestic airports in Vietnam. It was assumed that all flights were full since data on 
the number of passengers was not available.  These data are publicly available for Vietnam Airlines 
(http://www.vietnamair.com.vn/wps/portal/vn/site/flight_info/time_table), JetStar 
(http://www.jetstar.com/vn/vi/cheap-flights/standard.aspx), and Indochina Airlines 
(http://www.indochinaairlines.vn/FliSchedule.aspx).  
 
Disease natural history 
Data on the natural history of novel H1N1 were derived from published surveillance, epidemiological and 
clinical data and from a model describing the pandemic potential of H1N1 [4].  See table S1 for parameter 
values used: 
 
 
 
 
 
 
 
 
 
 
 
 
 
94
Supplementary	  online	  material	  to	  Boni	  et	  al	  (2009)	  BMC	  Medicine	  
	  
Table S1 
Parameter Source Value 
Incubation period [5] 
Mean 1.4  
(exponential distribution 
mimicked via standard linear 
term in differential equations ) 
Infectious period [6] 
Mean varied between 3.8 days 
and 5.5 days 
(gamma distribution mimicked 
by four infectious compartments 
in SEIR model) 
Basic reproduction 
ratio* 
1.4-1.6 (genetic analysis 1.2) [4] 
Less than 2.2-3.1 [7] 
Japan 2.3 (2.0-2.6) [8] 
School outbreak in the U.S. 2.69 (2.20-3.2) 
ProMED-mail Influenza A (H1N1) - 
worldwide (51): 20090529.1999 
Range 1.2 – 3.1 
* number of secondary cases created by a single infectious case introduced into a fully susceptible 
population 
 
The overall hospitalization rate was set at 1% and the distribution of these hospitalizations across the age-
classes was derived from data of the proportion of H1N1 cases hospitalized in Mexico and the U.S by age 
[9]. In the model the overall hospitalization rate was varied between 0.5% and 1.5% of all cases, since 
reported rates of 5-6% are likely to be biased by over-ascertainment of severe cases compared to mild 
cases. (Table S2).  
 
Table S2 
Age class Probability of a case being hospitalized 
Age 0-5 0.013 
Age 6-15 0.005 
Age 16-25 0.006 
Age 26-34 0.014 
Age 35-49 0.016 
Age 50-64 0.010 
Age 65+ 0.011 
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Age dependent susceptibility to infection 
Fraser et al found that the model that best fit the available data included both an age-dependent contact 
intensity parameter and age dependent susceptibility to infection [4]. Studies of age specific serological 
reactivity against the novel H1N1 virus are consistent with an age-dependent susceptibility to infection or 
disease [10]. Since age-dependent contact intensity is represented in our model by the contact matrix 
described on page 2 of this supplement, we sought to estimate the contribution of age-dependent 
susceptibility. To do this we used data on the age distribution of cases in the US and data on age dependent 
contact frequency from a European study [2, 9]. The relative frequency of contact by age class was factored 
out of the relative distribution of H1N1 cases by age in the US in order to derive an estimate of 
susceptibility by age class, independent of contact behaviour (Table S3).  
 
Table S3 
Age class Relative susceptibility to infection 
Age 0-5 0.77 
Age 6-15 1.00 
Age 16-25 0.82 
Age 26-34 0.59 
Age 35-49 0.19 
Age 50-64 0.17 
Age 65+ 0.10 
 
Seasonality 
We assumed no seasonal affect on transmissibility of H1N1 or on contact patterns since the seasonality of 
human influenza in Vietnam is not predictable. Although clear peaks in influenza activity are observed, 
several peaks are observed each year and the timing of these peaks is not predictable and can occur 
throughout the year.  
 
Health care capacity 
Data on the number of public and private hospital beds, and the number of doctors and nurses by province 
in 2007 was obtained from the GSO. Number of ventilators by Province in 2007 was obtained from the 
Ministry of Health, Health Statistics YearBook 2007. The number of immediately available doses of 
oseltamivir in Vietnam in May 2009 was obtained from the Ministry of Health (not used in model).  
 
Domestic pig, chicken and duck raising 
Data on the number of households raising pigs, chickens and ducks by province were obtained from the 
GSO 2006 Rural, Agricultural and Fishery census. The denominator for estimating the proportion of 
96
Supplementary	  online	  material	  to	  Boni	  et	  al	  (2009)	  BMC	  Medicine	  
	  
households raising pigs, chickens and ducks by province (the total number of households) was obtained 
from the 1999 Population and Housing census. The number of households in 1999 by province was inflated 
proportional to the increase in Province specific population observed between 1999 and 2007. Since two 
new Provinces were created in 2004 by splitting two single Provinces, the number of households in 1999 in 
each of the two new Provinces was estimated by dividing the number of households in each original 
Province in 1999 proportionately to the population in the new and old Provinces in 2007.    
 
Contact between infectious humans and domestic pigs, chickens and ducks 
To estimate the number of domestic pigs, chickens and ducks exposed to an H1N1 infected human we 
divided the total number of infected persons in each province by the average household size for each 
province to give a conservative estimate of the number of infected households. This is a conservative 
estimate since it assumes all human H1N1 cases are clustered by household.   The estimated number of 
infected households was then multiplied by the proportion of households raising pigs, chickens and ducks 
and the average number of pigs, chickens and ducks present in households that raise these animals. 
 
Interventions 
We explored the potential impact of school closure by introducing a relative reduction in contact frequency 
among children in the age class 6 and 15 years. We explored the potential impact of broader social 
distancing measures by reducing contact frequency across all age classes. 
 
Mathematical Model 
 
An SEIR-model (Susceptible-Exposed-Infectious-Recovered) with a four-stage infectious period was used 
to model the core infection dynamics in each province.  The model equations are 
 
where Λkl represents the force of infection on age class k in province l.  Λkl is defined by 
97
Supplementary	  online	  material	  to	  Boni	  et	  al	  (2009)	  BMC	  Medicine	  
	  
 
where A=7 is the total number of age classes and the τ-variables allow for stage-specific infectivities.  The 
variable Skl represents the number of susceptible individuals in age class k currently in province l.  Ekl  
represents exposed individuals and Ikl,s represents infected individuals in stage s (out of a total of four) of 
their infection.   
 
The parameters τk were all set to one since we could not find good information on shedding and infection 
duration at the time the model analysis was run.  The parameters βk represent age-specific susceptibility and 
can be found in Table S3.  Parameters dl represent province-specific population density and were computed 
as outlined on page 1 of this supplement.  Parameters zik are mixing rates between age class i and age class k 
(from contact rate matrix on page 2).  The parameter ν is the recovery rate (1/ν is the duration of infection), 
and 1/e is the length of exposure before a host becomes infectious. 
 
Migration and hospitalization were integrated stochastically into the above differential-equations model.  
Once a day, discrete individuals could move from one province to another according to the migration matrix 
outlined earlier; migration probabilities were balanced between provinces so the system behaved like a 
gravity model.  In addition, once a day, discrete individuals in stage 4 of their infection could be 
hospitalized based on their age-dependent probability of hospitalization and the availability of hospital beds 
in their province.  Hospitalization time was five days.  Numbers of hospitalized and migrated individuals 
were drawn from a Poisson distribution.   
 
The basic reproduction ratio R0 for the entire model can be calculated with standard next-generation matrix 
methods (Diekmann and Heesterbeek, 2000).  Assuming at most one cross-province migration event during 
a single infection, a 448 by 448 matrix can be built showing the expected number of infections generated by 
an individual in age class k and location l in individuals of age class k’ and in location l.  If m is the 
probability of migrating from location l to any other location l’ during the course of an infection of length 
1/ν, then  
 L  =  (1 – m) × (1/ν)  +  m × (1/2ν) 
is the duration of time spent infectious in location l.  Then,  
 PT × L × βk’ × dl × zkk’ × Nkl 
is the number of infections generated at location l in age class k’, by an infectious individual in location l of 
age class k.  Nkl is the number of individuals in age class k at location l, and PT is a proportionality constant 
that depends on the unknown probability of transmission given contact.  A similar calculation can be done 
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when the two locations are not equal, and a complete next-generation matrix can be filled in.  This assumes 
only one migration event during a course of infection, but this is a fair approximation since daily migration 
probabilities are small and infections are short.  Note that some other parts of this computation are 
necessarily approximate since part of the model occurs in continuous time with fractional individuals, while 
another part (migration, hospitalization) occurs at discrete time points and concerns whole individuals. 
The R0 value described in the figures and text is for a hypothetical Ho Chi Minh City with no cross-
province emigration, and model results are presented for a single case introduced in Ho Chi Minh City.  The 
value R0,ng calculated for the model via the next-generation matrix (as above) will usually be 5% to 15% 
lower than this R0,HCMC computed for Ho Chi Minh City with no migration.  R0,HCMC is presented in the paper 
since (1) we do not know the true rate of migration, (2) sick individuals may not migrate in reality, and (3) 
true migration probably takes place under a “residency model” (where individuals reside in one place, 
migrate, then return) rather than under a gravity model. 
It is known that transmissibility varies from person to person and contact rates vary from community to 
community; thus, choosing a single R0 value for an entire population can prove difficult.  As a reference 
point, we use the R0 value for a hypothetical Ho Chi Minh City with spatially uniform population density, 
spatially uniform interpersonal contact behavior, and no emigration.  The R0 values for the other provinces 
are smaller by some amount, depending on each province’s population density and age structure. 
 
Sensitivity analysis 
 
The varied parameters with ranges were:  1.2 < R0 < 3.1;  3.8 days < duration of infection < 5.5 days;  
1.35% < daily probability of migration < 5.00%;  0.5 < traffic on small road relative to large road < 1.0;  
0.5% < probability of hospitalization < 1.5%.  1000 parameter sets were drawn randomly from this range 
using Latin hypercube sampling and medians and quartile ranges are presented from these 1000 runs [11]. 
 
Daily probability of migration was derived from the Ha Nam survey – which gave a mean estimate of 
1.35% of people moving province each day; this was used as the lower end of the modeled range. 
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Chapter 7
Discussion(cohort study)
7.1 Contribution to knowledge of influenza epidemiology
The three presented papers all arose from the cohort study and provide new insights
into the epidemiology of influenza in Vietnam that have direct relevance to influenza con-
trol activities in Vietnam. The papers themselves describe these insights in detail but in
summary I have shown that influenza infection is as common in Vietnam as in temper-
ate regions, and that although school-age children have the highest infection rates, there
are differences in age specific attack rates, risk factors, and contact patterns compared to
temperate regions which may attenuate the impact of control measures targeted at school-
age children and schools. Specifically, there appears to be less marked concentration of
infection risk in school age children, and hypotheses for this pattern are put forward in
research paper 1. The data on influenza infection rates in the community when combined
with the contact survey data presented in research paper 2, provide a resource for develop-
ing evidence-based influenza control strategies in Vietnam. Papers 2 and 3 represent such
exercises, with paper 2 modelling the potential effect of different immunisation strategies,
whilst paper 3 models the spatial and temporal transmission of influenza and the predicted
impact of social distancing measures and internal flight restrictions. The work was con-
ducted in partnership with NIHE, which has a key role in developing Vietnam’s influenza
control policies. The Director of NIHE is the Vice-Chairman of the National Committee
for the Prevention and Control of Human, Avian, and Pandemic Influenza, and as such
the work has directly fed-into policy-making forums in Vietnam.
The results of this research also contribute to an improved understanding of the epi-
demiological processes driving global influenza patterns. Several authors have highlighted
the need for better data from Southeast Asia in order to test the source-sink hypothesis,
which postulates that East and Southeast Asia acts as a global source of new influenza virus
variants (Nelson et al., 2007; Rambaut et al., 2008; Russell et al., 2008). Bahl et al. (2011)
have recently reported lower levels of relative genetic diversity of H3 HA in Southeast Asia
compared to temperate regions, which would seem to run counter to the hypothesis that
Southeast Asia is a reservoir of new viruses, since a source habitat is expected to maintain
higher levels of genetic diversity as a consequence of a larger population size (Bedford
et al., 2011). Low levels of diversity in Southeast Asia despite the probable absence of
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strong seasonal genetic bottle-necks1 suggests either that influenza transmission is low or
that there is strong selection pressure (Bedford et al., 2011). Bahl et al. (2011) made an
assumption that the strength of natural selection does not vary between populations, lead-
ing to the conclusion that the observed patterns suggest “influenza transmission in Hong
Kong and Southeast Asia was not as extensive as that observed in temperate regions”.
However, we observed substantial rates of infection in the Ha Nam cohort, and an alterna-
tive model is that influenza transmission is as extensive in Southeast Asia as in temperate
regions but the pattern of transmission and resulting selection dynamics differ. The lack
of synchronisation of epidemics, the broader period of virus circulation, the less intense
seasonal forcing, and the occurrence of multiple epidemics per year could theoretically
result in widespread infection that results in a strong and constant immune-mediated se-
lection pressure that constrains genetic diversity to a relatively small number of ‘fit’ virus
lineages (Bedford et al., 2011). Work in Brazil based on influenza-associated mortality
patterns has identified a low reproduction number2 for influenza mortality (mean repro-
duction number 1.03, 95% confidence interval: 1.02, 1.04), which the authors hypothesise
may be the result of high levels of population immunity (Chowell et al., 2010). This would
be consistent with a model of widespread influenza circulation resulting in high levels of
partially protective immunity. The findings of Bahl et al. (2011) suggest that even if
southeast Asia is a reservoir of influenza viruses, temperate regions are not a ‘black-hole
sink’ from which new viruses never emerge, but are a ‘reciprocal sink’ that transfers viruses
back to the source (Sokurenko et al., 2006). As such it may be that influenza evolution
is occurring both in temperate and tropical regions but is qualitatively different due to
differences in the pattern of selection pressures. Further work is clearly needed to fully
understand the drivers and dynamics of global influenza evolution, including comparative
studies of immune-mediated selection pressures in temperate and tropical areas.
Some limitations of the work have been presented in the discussion section of the papers
but there are two key changes I would make if I were to conduct the cohort study again.
First, I would request permission to take capillary blood samples from children under
the age of five years in order to provide infection incidence estimates across the entire
age range. This would also provide data on the rate of loss of maternal antibodies and
acquisition of new antibodies in the first years of life (a measure of the force of infection)
and data on which to estimate the potential impact of immunisation of pregnant women on
preventing infection in infants (Ortiz et al., 2011). Second, I would stagger the serological
surveys throughout the year, rather than conduct periodic cross-sectional surveys, in order
to be better able to examine temporal patterns in infection risk and to look for evidence of
year-round influenza transmission. For the contact diary study, I would ask participants
to complete the diary prospectively rather than retrospectively in order to reduce recall
bias, and I would collect data on the exact age of contacts rather than the age range,
1A collapse in virus population size followed by the survival of a restricted number of lineages
2The average number of secondary cases generated by a primary case
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which restricted the analyses we were able to conduct. We have subsequently conducted
a new study of contact patterns in 1000 rural and 1000 urban residents in Vietnam using
prospective diary completion.
7.2 Further research directions
The research papers included in this thesis represent only part of the output of the co-
hort study. Ongoing analysis is examining the relationship of prior HI titres and influenza
infection experience on the risk of subsequent influenza infection and illness. Peripheral
blood mononuclear cells were collected in the first and second bleeds and have been used to
identify T-cell responses to peptides of influenza H5, H3, and H1 hemagglutinin, N1 and
N2 neuraminidase, and the internal proteins of H3N2 in an interferon-γ enzyme-linked
immunospot T assay in collaboration with the MRC Human Immunology Unit at the
University of Oxford. The data on T-cell responses to H5 HA peptides have already been
published (Powell et al., 2012) (Annex A) and work is ongoing to explore the relationship
of pre-existing T-cell responses to influenza peptides to the risk of developing influenza
illness. A large number of respiratory swab samples were negative for influenza, and test-
ing for other viral respiratory pathogens is planned. The influenza PCR positive samples
will also be used to study intra-host and intra-community pathogen genetic diversity.
Collaboration is ongoing with the MRC Centre for Outbreak Analysis and Modelling at
Imperial College to use advanced statistical techniques to partition the observed influenza
infection risk into the probability of acquiring infection in the home or in the community,
and to examine heterogeneity in infectiousness (super-spreaders) (Cauchemez et al., 2009).
Work is also ongoing to integrate the social contact data with the data on influenza
outcomes to assess the risk of influenza in different age groups after controlling for both
contact behaviours and prior infection history (Goeyvaerts et al., 2010). This will provide
the first individual level (as opposed to ecological1) test of the ‘social contact hypothesis’,
which argues that for pathogens spread by the respiratory route, the age distribution of
conversational contacts is directly proportional to the age distribution of infection risk
(Wallinga et al., 2006). We will also directly test the hypothesis that intimate physical
contact, rather than casual face-to-face contact, best explains the transmission patterns
of diseases such as influenza (Melegaro et al., 2011).
1An ‘ecological’ analysis looks at exposure-disease associations at the population level only, without
linking exposures to outcomes at the individual level
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Chapter 8
Background to host genetics
study
8.1 Host genetics and infectious diseases
It has long been recognised, going back at least 60 years to the malaria-sickle haemoglobin
gene hypothesis, that the co-evolutionary struggle with microbes has shaped the genetic
architecture of humans (Piel et al., 2010). Indeed, immune response genes are amongst the
most common human genes and, as exemplified by the human leukocyte antigen and KIR1
loci, are also the most variable because of their need to recognise the shifting diversity of
pathogen antigens (Blackwell et al., 2009; Middleton and Gonzelez, 2010).
Studies of adoptees have demonstrated a strong inherited component to the risk of
death from a range of infections (Sorensen et al., 1988) and the emergence of affordable
genome-wide sequencing of up to one million single nucleotide polymorphisms (SNPs) has
resulted in an explosion of hypothesis-free genetic association studies that have identified
hundreds of gene-disease associations, although many associations have not been repli-
cated (Ioannidis, 2007; Manolio et al., 2008). Where robust associations with common
polymorphisms (minor allele frequency >1%) have been identified, they usually have a
small effect size and individually explain relatively little of the heritability (Cirulli and
Goldstein, 2010). However, genetic polymorphisms have been identified that have an im-
portant health benefit, mostly in the area of pharmacogenomics (Hudson, 2011), and which
have provided important insights into disease pathogenesis, such as the role of CCR5 in
HIV (Manolio et al., 2008; Vannberg et al., 2011). Meanwhile the role of rare variants (mi-
nor allele frequency ≤1%) is less explored because current SNP arrays cover only common
polymorphisms, but this is likely to change with the advent of affordable exome2, rather
than SNP, sequencing (Cirulli and Goldstein, 2010).
8.2 Host genetics and influenza
Until recently there was almost no consideration of the role of host genetics in suscep-
tibility to influenza but the re-emergence and global spread of highly pathogenic H5N1
in 2004 sparked interest in the host determinants of severe influenza. H5N1 is one of the
1Killer-cell Immunoglobulin-like Receptor
2The part of the genome that is translated into proteins
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most lethal infections of humans, with mortality approaching 60% in clinically detected
cases, and the determinants of this high virulence are of enormous scientific and public
health interest given the demonstrated ability of avian derived influenza A virus gene seg-
ments to successfully cross the species barrier. The scientific literature and other sources
of information on genetic susceptibility to influenza in general and H5N1 in particular are
summarised in research papers four and five and will not be repeated here.
The hypothesis that host genetic factors play an important role in susceptibility to
H5N1 infection arose from my own experiences of investigating the outbreak of human
H5N1 cases in Vietnam. In December 2003 I was the medical officer in charge of commu-
nicable disease outbreaks at the WHO office in Vietnam. I was invited by the Director of
the National Paediatric Hospital to investigate a series of unexplained deaths in children
from a severe respiratory infection. The initial fear was that these cases may represent
a recurrence of SARS, which had affected Hanoi earlier the same year. The clinical and
epidemiological picture was not suggestive of SARS and I arranged for respiratory spec-
imens to be sent to Hong Kong for testing for human and avian influenza viruses. The
samples were positive for HPAI H5N1 and represented the first identified human cases in
the epizootic of HPAI H5N1 that began in 2003 (WHO, 2005).
This very first series of cases included two family clusters. One cluster comprised a
mother and daughter, who both died of fulminant H5N1 disease, and the virus cultured
from the daughter (A/Vietnam/1194/04) has subsequently been widely used as a proto-
typical human clade 1 HPAI H5N1 virus and from which a clade 1 candidate vaccine virus
has been developed. Also, this mother and daughter were residents of the Commune that
was selected for the cohort study described in Chapters 3-7, hence the exploration of H5N1
antibodies and T-cell responses in the cohort. The second cluster comprised two young
siblings who both died of a respiratory illness, one of whom was a confirmed H5N1 case.
Subsequently I encountered numerous family clusters of H5N1 infection; far in excess of
what I had observed with any other infectious disease. The highly unusual epidemiology
led me to hypothesise that there is strong familial susceptibility to H5N1 infection or
disease. The observations underlying this hypothesis are summarised in research paper 4.
8.3 Objective of host genetic study
Despite the considerable challenges of undertaking a study of host genetic susceptibility
to such a rare disease with such a high case fatality ratio, if susceptibility were conferred by
a rare, highly penetrant, single locus genotype that greatly increased the risk of infection
or disease, this may be detectable even with a small sample size. The literature on genetic
susceptibility to influenza is systematically reviewed in research paper 5, and whilst a
large number of candidate genes have been proposed, there are no genetic studies in
humans that implicate any of these putative loci. Therefore a decision was taken to
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undertake an hypothesis free genome-wide approach. The objective of the host genetic
study was to determine if any SNPs are associated with H5N1 disease using a genome-
wide association (GWA) study design. Besides its direct relevance for H5N1, the study
can also be conceptualised as an example of an extreme-trait sequencing design, where a
subset of individuals with an extreme phenotype (susceptibility to avian influenza) may
provide insights into genetic factors acting in the wider population but which are difficult
to detect as the phenotype (severe inter-pandemic influenza) is less distinct and causality
is more multifactorial (Cirulli and Goldstein, 2010).
8.4 Candidate’s role
I conceived the study, secured funding (Wellcome Trust UK grants 081613/Z/06/Z and
077078/Z/05/Z, and the South East Asia Infectious Disease Clinical Research Network),
wrote the protocol and case record forms, and prepared all the paperwork for ethical
approval in the U.K., Vietnam and Thailand. I was the Principal Investigator of the
study and supervised all aspects of study implementation in Vietnam and Thailand. DNA
extraction was conducted by laboratory personnel in Vietnam and Thailand, and was
shipped to the Genome Institute of Singapore for genotyping. Statistical analysis was
undertaken by Dr Chiea C. Khor of the Genome Institute of Singapore.
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Contribution of research
papers(genetics study)
In this chapter I will briefly introduce the research papers that are compiled in this
thesis on the host genetic aspects and describe how they demonstrate my contribution to
knowledge in the field. Three papers are included and I am the first and corresponding
author on all three.
9.1 Outline of research papers
9.1.1 Research paper 4
This manuscript was published as Horby et al. (2010) and summarises and interprets
the epidemiological data that led to the formulation of the hypothesis addressed in re-
search paper 6, that host genetic factors have a strong influence on susceptibility to H5N1
infection. Other authors had speculated on the possibility of important host genetic fac-
tors influencing susceptibility to H5N1 based on the unusual level of family clustering but
none had formally assembled the evidence. The manuscript also contains a re-analysis I
conducted of the expected level of clustering (using data from the cohort study on house-
hold sizes), which was first presented by Pitzer et al. (2007) as evidence that the observed
level of clustering was not suggestive of genetic susceptibility. The R-code I wrote for the
reanalysis presented in figure 2 of research paper 4 is reproduced in Appendix B.
9.1.2 Research paper 5
Research paper 5 is in press as Horby, Nhu, Dunstan, and Baillie (Horby et al.) and is
a systematic literature review conducted according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) statement (Moher et al., 2009), which
summarises the evidence on the role of host genetics in susceptibility to influenza. This
extends the work of research paper 4 by including all types of influenza affecting humans
and systematically searching and summarising the published literature.
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9.1.3 Research paper 6
Research paper 6 presents the results of the genome-wide case-control association study
conducted in Vietnam and Thailand. Although a brief paper, it represents a large amount
of work undertaken over several years to assemble DNA samples from H5N1 cases. This
paper is only the third published study of human genetics and influenza, the other studies
having looked at ≈ 50000 SNPs in severe H1N1/2009 associated pneumonia (Zuniga et al.,
2011) and eight polymorphisms in the tumor necrosis factor and mannose-binding lectin
genes in fatal influenza cases (Ferdinands et al., 2011). Research paper 6 presents the first
direct evidence of genetic loci associated with susceptibility to H5N1 infection.
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SUMMARY
The apparent family clustering of avian influenza A/H5N1 has led several groups to postulate the
existence of a host genetic influence on susceptibility to A/H5N1, yet the role of host factors on
the risk of A/H5N1 disease has received remarkably little attention compared to the efforts
focused on viral factors. We examined the epidemiological patterns of human A/H5N1 cases,
their possible explanations, and the plausibility of a host genetic effect on susceptibility to
A/H5N1 infection. The preponderance of familial clustering of cases and the relative lack of
non-familial clusters, the occurrence of related cases separated by time and place, and the paucity
of cases in some highly exposed groups such as poultry cullers, are consistent with a host genetic
effect. Animal models support the biological plausibility of genetic susceptibility to A/H5N1.
Although the evidence is circumstantial, host genetic factors are a parsimonious explanation
for the unusual epidemiology of human A/H5N1 cases and warrant further investigation.
Key words: Influenza A virus, genetic susceptibility, H5N1 subtype.
INTRODUCTION
Human cases of influenza A subtype H5N1 appear to
cluster in families, a pattern which has led several
authors to comment that host genetics may play an
important role in susceptibility to A/H5N1 infection
or disease [1–5]. This has potentially far-reaching
implications, since the identification and subsequent
characterization of genetic factors that have a strong
influence on susceptibility to A/H5N1 disease would
highlight key virus–host interactions necessary or
contributory to infection or disease. Elucidating these
key interactions has the potential to catalyse advances
in areas such as the prediction of viral pathogenicity
and the development of new or improved preventive
and therapeutic interventions, which may be of
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relevance not only to zoonotic influenza but also to
seasonal and pandemic influenza.
Since it re-emerged in 2003 A/H5N1 has received
enormous attention, including the allocation of sub-
stantial financial resources for vaccine development
and pandemic preparedness. Yet the reasons for
its scarcity in humans, its poor ability to transmit
between people, the clustering of cases and the
risk factors for infection remain elusive; as does our
ability to predict the likelihood that A/H5N1 may
become a pandemic virus. Most research has focused
on the viruses; through genotypic and phenotypic
analysis and animal experiments using modified
viruses, but the other half of the equation, the host,
has been relatively neglected. Since it is epidemi-
ological patterns that have stimulated consideration
of host genetic factors, an important first step is
to review whether the epidemiological patterns are
consistent with a host genetic influence. Currently
only two publications have explicitly examined the
potential role of host genetics and human A/H5N1
infection. Pitzer et al. have looked at whether the ob-
served clustering could be explained by chance alone
[6]. Trammell & Toth have reviewed possible bio-
logical mechanisms of host susceptibility to influenza,
usingmostly data frommurinemodels [7].We examine
the epidemiological patterns of human A/H5N1 cases,
their possible explanations, and review the evidence
for a role for host genetics in susceptibility to influ-
enza A/H5N1.
THE CASE IN FAVOUR OF A ROLE FOR
HOST GENETICS
Familial aggregation of cases
Between 1 January 1997 and 25 November 2009 a
total of 36 clusters of two or more laboratory-
confirmed cases of A/H5N1 have been reported, with
at least an additional 16 clusters of one confirmed case
plus at least one probable case [3, 4, 8–11] (Table 1).
These 52 clusters account for 22% (103/463) of all
laboratory-confirmed cases and only six of the 103
cases occurring in clusters did not have a genetic re-
lationship to another case in the cluster. Although
there is no data on the familial aggregation of other
zoonosis for comparison, this degree of family clus-
tering has surprised many people, especially since
A/H5N1 is considered to only rarely transmit
from person to person. Since familial aggregation is a
hallmark of genetically determined diseases, genetic
susceptibility to A/H5N1 infection is one hypothesis
Table 1. Number of confirmed H5N1 cases and clusters by country
Country
Total
laboratory-confirmed
cases*
No. of
clusters#
n/N (% ) of
confirmed cases
occurring in
clusters
Azerbaijan 8 2 6/8 (75)
Bangladesh 1 0 0/1 (0)
Cambodia 8 1 1/8 (12)
China, mainland 38 4 4/38 (10)
Djibouti 1 0 0/1 (0)
Egypt 88 4 9/88 (10)
China, Hong Kong 20 2 4/20 (20)
Indonesia 141 18 36/141 (25)
Iraq 3 1 2/3 (67)
Laos PDR 2 0 0/2 (0)
Myanmar 1 0 0/1 (0)
Nigeria 1 1 1/1 (100)
Pakistan 3 1 3/3 (100)
Thailand 25 3 5/25 (20)
Turkey 12 2 6/12 (50)
Vietnam 111 13 26/111 (23)
Total (all countries) 463 52 103/463 (22)
* As of 25 November 2009.
# A cluster is defined as at least two cases of clinically compatible illness with at
least one case with laboratory-confirmed H5N1.
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that might explain the familial aggregation. Un-
fortunately the apparent increased risk in relatives
of affected cases compared to background risk has
not been quantified and the large cluster in Karo,
Indonesia was a missed opportunity to estimate the
familial relative risk by comparing the risk in related
and unrelated contacts of infected individuals. How-
ever, what we do know is that this cluster involved
eight cases (seven laboratory-confirmed) in a single
extended family residing in four households [12]. Nine
family members slept in the same room as the primary
case while the case was symptomatic and three of
these nine (33%) developed A/H5N1 infection [13]. It
is perhaps surprising that there were no unrelated
cases despite multiple opportunities for infection of
non-related contacts, including unprotected health-
care workers, and onset dates that stretched over a
period of 3 weeks [14].
The relative absence of non-familial aggregation
of cases
If all members of a community affected by A/H5N1
outbreaks in poultry are at equal risk then it would be
more likely to observe pairs of cases of unrelated
community members than to see household clusters
[6]. Yet of the 103 confirmed cases occurring in 52
clusters, only six cases occurring in four clusters were
not genetically related to any other case in the cluster
[one husband and wife pair (Vietnam 2005); one
healthcare worker (Vietnam 2005) ; one neighbour
(Azerbaijan 2006) ; two children (Egypt 2009)] [11].
This pattern is important since it suggests either
large differences in risk between families within affec-
ted communities, or large biases in the detection and
reporting of family-based clusters compared to un-
related case clusters.
Related but unassociated cases
At least two incidents have occurred where genetically
related individuals developed confirmed or probable
A/H5N1 disease independently of one another.
In August 2004 a 25-year-old women from
Hau Giang Province, southern Vietnam died from
laboratory-confirmed A/H5N1. Both the 19-year-old
brother of this case and their 23-year-old cousin died
of severe pneumonia within a week of the confirmed
case ; specimens from these two cases were not tested
for A/H5N1. The brother lived with the confirmed
case but the cousin lived in a non-adjacent commune
and investigations revealed that there had been no
contact whatsoever between the cousin (and her im-
mediate family) and the siblings (and their immediate
family) in the week prior to the earliest onset of illness
and the deaths. Local authorities concluded that
there was no likelihood of a common point source
of infection or of any other means of transmission of
A/H5N1 between the cousin and the sibling cases.
Therefore, the disease in the cousin seems to have
occurred independently from the sibling cases.
In Thailand three related individuals suffered
A/H5N1 infection during two different waves of the
outbreak. The first case was a boy (C.P.) who died
during the first wave of outbreaks in late 2003–2004
[15]. The mother of case C.P. also died of a respiratory
illness at the same time as her son, but samples were
not available for testing for A/H5N1 [8]. The other
two cases, a father and son (B.O and R.R.), were in-
fected in the 2005 outbreak [16]. Their family pedigree
is shown in Figure 1. C.P. lived in the same province
but a different district to B.O. and R.R.
Given the scarcity of A/H5N1 disease, these in-
cidents of related but apparently unconnected cases
seem an improbable misfortune, unless relatives have
an increased risk of A/H5N1 infection compared to
the general population.
Exposure and risk are not well correlated
Although data from three case-control studies show
that contact with dead or dying poultry is a significant
risk factor for A/H5N1 infection, the proportion of
cases that can be attributed to this factor is not high
[17–19]. About 25% of all confirmed clinical cases of
H5N1 infection cannot recall any recent poultry ex-
posure before illness onset and in many other cases
B.O.
R.R.
C.P.
Fig. 1. Family pedigree showing three H5N1 affected
individuals, with infections separated by 2 years.
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the reported exposure to infected poultry is tenuous
[17, 20–22]. The largest case-control study published
so far found that only 28% of all cases could be at-
tributed to preparing or cooking sick poultry [17]. The
same study found no differences between affected
and unaffected households in other poultry-handling
practices, hygiene behaviour or in other putative
risk factors such as the use of poultry fertilizer. This
absence of obvious risky practices in many affected
individuals and families juxtaposes starkly with the
almost complete absence of clinical cases in groups
who are known to have engaged in theoretically very
high-risk behaviours, i.e. culling infectedpoultry flocks
without personal protective equipment.
From 2003 to 31 January 2010, 49 countries have
reported over 6660 outbreaks of highly pathogenic
avian influenza A/H5N1 in domestic poultry or wild-
life to the World Organization for Animal Health and
several hundred million poultry have died or been
culled. These figures are a minimum, since only a
proportion of all outbreaks are detected and reported.
The number of people exposed to A/H5N1 as a result
of reported and unreported outbreaks is not known
but we do know that exposure to poultry is very
common in many of the worst affected countries. One
population-based study of more than 45000 people
in an A/H5N1-affected community in Vietnam found
that 25.9% (11 755) lived in households where poultry
were sick or had died [23]. A community survey in
Cambodia of 155 poultry-raising households in an
A/H5N1-affected area identified poultry deaths in 102
households (66%), and 42 households (27%) were
considered likely to have experienced an outbreak
of A/H5N1 [19]. A larger survey in Cambodia esti-
mated that most of the rural population has frequent
contact with poultry and 52% regularly have a
potentially high-risk exposure [1]. Therefore it likely
that very large numbers of people, possibly millions,
have been exposed to A/H5N1 since 2003 yet only 471
human cases have been reported globally over the
same period. It can be safely assumed that these
numbers, like poultry outbreaks, are a minimum as
the clinical presentation is non-specific and few
sites possess the capabilities to diagnose A/H5N1.
Although a survey in two affected villages in
Cambodia found serological evidence of subclinical
A/H5N1 infection in seven (1%) out of 674 subjects
[24], evidence from active surveillance and serological
surveys of populations known to be exposed to
A/H5N1 generally indicates that large numbers of
cases are not being missed [19, 21, 25–33]. While the
sensitivity and reproducibility of serological assays
for A/H5N1 infection is variable, many serological
studies have used the gold standard of micro-
neutralization assay with Western blot confirmation
and therefore provide the best estimate currently
available of A/H5N1 infection prevalence [34, 35].
The apparent low incidence of infection following
exposure to sick poultry and the low risk in some
intensely exposed groups indicates a substantial
species barrier, but a barrier that seems to be much
weaker in a small number of individuals and families
[36].
Person-to-person transmission
Families live together in intimate contact and person-
to-person transmission has been convincingly put
forward as an explanation for two family clusters
[37, 38] and an additional five reports have stated
that it could not be ruled out in at least seven families
[3, 4, 39–41]. The evidence for person-to-person
transmission outside of the family is mixed. In
the investigation of the 1997 Hong Kong cases, sero-
positive healthcare workers were identified, but none
have been found in subsequent studies [28, 31, 42]
and, as previously mentioned, non-familial clusters
are rare. Person-to-person transmission of A/H5N1
clearly can occur but what is perhaps most interesting
is the presence of limited intra-familial person-to-
person transmission risk but its possible absence in
other settings. This could be explained by the special
intimacy of familial relationships but alternatively
it could be an indicator of a genetic influence on
risk; i.e. family members are at increased risk of
person-to-person transmission because of a shared
genetic susceptibility to infection from any source.
Biological plausibility
Certain animal species are more susceptible to H5N1
than other species and possible factors determining
the host-range restriction of avian influenza viruses
have been reviewed elsewhere [36, 43, 44]. However,
within-species differences also exist and in-bred mice
strains exhibit large differences in their susceptibility
to influenza infection [7, 45–47]. Indeed, differences in
susceptibility of mouse strains to influenza infection,
followed by mapping of the mouse disease loci and
identification of the region on the human chromo-
some has led to the identification of the human Mx
genes involved in response to viral infections [48–50].
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Trammell & Toth have reviewed possible biological
mechanisms of host susceptibility to influenza in the
mouse model and similar host genetic influences on
susceptibility to infection or disease might also exist
in humans [7]. In fact a recent study demonstrated
genetic susceptibility to A/H5N1 in mice and called
for studies of genetic susceptibility in humans [47].
However, to date no human genetic studies of sus-
ceptibility to influenza have been conducted, other
than two genealogical studies, one of which identified
a heritable predisposition to death from influenza
[51, 52].
Candidate host genes that may contribute to severe
influenza illness can be proposed a priori from known
virus–host interactions critical to infection, repli-
cation and pathogenesis [53]. Alternatively, gene-
expression profiling using microarrays may provide
insights into genes associated with severe disease
[54]. The role of cell surface sialic acid receptors in the
determination of host specificity of influenza viruses
is well documented and therefore the genes encoding
these receptors and their associated glycan modifi-
cations are potential candidates [55–58]. Cytokine
dysregulation has been shown to be a feature of
A/H5N1 infection in clinical and animal studies
[59–61] and various aspects of innate immunity
including collectin-like mannose-binding lectin, toll-
like receptors (TLR 3, 7, 8), cytokines, chemokines,
and interferon-inducible proteins such as MxA are
also plausible candidates [62–68]. Interestingly, sus-
ceptibility to other viral respiratory pathogens has
been traced to genes of the innate immune system
[69–73].
THE CASE AGAINST
Chance
Pitzer et al. [6] have argued that the observed
pattern of clustering of A/H5N1 cases can be ex-
plained by chance and does not provide evidence
for a genetic effect. However, the application of simi-
lar methods using real data on household structures
in Vietnam show that observing 22% of cases oc-
curring in household clusters is consistent with a
risk of infection following exposure of around 8%
(95% prediction interval 6–10%) (Fig. 2). If the true
risk of infection following exposure were 8%, the
current 500 cases would be the result of exposure of
only 6250 people globally over the past 5 years. This is
an implausibly low number. The number of people
exposed is certainly orders of magnitude higher, the
risk of infection following exposure substantially
lower than 8% and, therefore, the observation of
22% household clustering unlikely to be a probable
outcome unless other factors are in play. Even if the
risk of infection following exposure were 8%, and
22% of cases occurring in household clusters were
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Fig. 2. Proportion of cases occurring in household clusters by probability of infection for different household sizes. (a) All
data. (b) Enlargement of left-hand corner of panel (a). The broken black lines represent the modelled data for household sizes
ranging from nine persons (top) to one person (bottom). The solid red line is the median estimate of the modelled data
applying the observed range of household sizes in a Vietnamese cohort. Red dotted lines represent 95% prediction intervals
for 10 000 simulations. The solid green lines show the probability of infection compatible with the observed clustering of
about 0.22 for median estimate and 95% prediction intervals of model.
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simply a numerical result of this high risk, in any
single affected community we would expect to observe
around three sporadic cases for every case occurring
in a household cluster (75% vs. 25%). As described
above, we actually see few non-familial community
clusters. The model of Pitzer et al. also only con-
sidered exposure of entire nuclear families with
every family member at equal risk. This negates the
influence of single or couple households, and oc-
cupational exposures outside of the home and there-
fore over-emphasizes the probability of familial
clusters.
Bias
A key premise is that the observed clustering is a true
reflection of the real situation – not simply an appar-
ent pattern caused by biases. It is probable that mul-
tiple cases of severe pneumonia in healthy children or
adults clustered in time and space are more likely than
sporadic cases to be perceived as abnormal and
therefore reported to the authorities. It is also true
that following a first case which was severely ill or
fatal, a second case in a family will rapidly seek
medical attention; and indeed several of the reported
clusters consist of a first fatality which is clinically
suspicious of H5N1 and a second laboratory-
confirmed case. So the observed level of clustering
could be an artifact of differential ascertainment of
clustered vs. sporadic cases. While this bias is bound
to be operating to some extent, the question is whether
it fully explains the clustering. Moreover, it might be
expected that this ascertainment bias would apply
similarly to community clusters of genetically un-
related cases as to family clusters.
Confounding
Familial risk does not necessarily mean genetic risk;
families share their homes, food and behaviours
with one another and therefore shared ‘high-risk’
exposures must be a strong contender to explain
family clusters. Indeed, the paucity of community
clusters of genetically unrelated human H5N1 cases
has been suggested to be a reflection of risky beha-
viours which are unique to the affected families [6]. As
noted above, unusual or risky practices have been
identified but it has not been possible to attribute
many cases to these behaviours since the behaviours
are widespread in the community yet absent in many
cases. It is certainly possible that behavioural factors
partially or completely explain the epidemiological
patterns but these have yet to be identified.
The scarcity of human cases despite widespread
exposure clearly demonstrates a substantial barrier to
humans acquiring infection, and much work has fo-
cused on unravelling the genetic and functional
characteristics of the viruses which would explain
these barriers [74]. There are clear differences between
virus strains in their ability to infect and cause severe
disease in animal models but the viruses isolated from
human cases occurring in family clusters have not
been found to be substantially different from viruses
causing sporadic human cases or poultry outbreaks
[75]. The family clusters have occurred in 11 different
countries as a result of infections with five different
clades (0, 1, 2.1, 2.2, 2.3). So while virus factors are
certainly critical in limiting the transmission of influ-
enza A/H5N1 from animals to humans, current data
do not allow us to attribute family clustering to viral
factors.
CONCLUSION
The routinely available data on the epidemiology of
human cases of A/H5N1 show some unusual patterns
to which host genetic susceptibility offers a parsi-
monious explanation. Of course, this does not mean it
is true; but it is both epidemiologically and biologi-
cally plausible and worthy of serious investigation.
The importance of host genetics in infectious diseases
is increasingly being recognized and explored [76–78]
and the relationship is usually a complex interaction
between the pathogen, environmental influences and a
range of innate and adaptive host factors. This poses
difficulties for attempts to detect genetic influences on
susceptibility to H5N1, since very large sample sizes
are needed to detect complex or weak effects, yet the
total number of cases is very small. However, a host
genetics association study may potentially be in-
formative if high-risk genotypes are present. A more
powerful strategy would be a genome-wide linkage
study in affected families, which could interrogate the
whole genome without assuming any prior hypoth-
eses on plausible candidate genes. Given the import-
ance of understanding the key virus–host interactions
underlying severe human influenza, a search for such
genetic factors in A/H5N1 is worthwhile. However,
the scarcity and widespread distribution of human
case means that international collaboration is essen-
tial to conduct studies of genetic susceptibility to
A/H5N1 disease.
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Abstract 
 
Background 
The World Health Organization has identified studies of the role of host genetics on 
susceptibility to severe influenza as a priority. A systematic review was conducted to 
summarize the current state of evidence on the role of host genetics in susceptibility to 
influenza (PROSPERO registration number: CRD42011001380).  
 
Methods and findings 
PubMed, Web of Science, the Cochrane Library, and OpenSIGLE were searched 
using a pre-defined strategy for all entries up to the date of the search. Two reviewers 
independently screened the title and abstract of 1371 unique articles, and 72 full text 
publications were selected for inclusion. Mouse models clearly demonstrate that host 
genetics plays a critical role in susceptibility to a range of human and avian influenza 
viruses. The Mx genes encoding interferon inducible proteins are the best studied but 
their relevance to susceptibility in humans is unknown. Although the MxA gene 
should be considered a candidate gene for further study in humans, over 100 other 
candidate genes have been proposed. There are however no data associating any of 
these candidate genes to susceptibility in humans, with the only published study in 
humans being under-powered. One genealogy study presents moderate evidence of a 
heritable component to the risk of influenza-associated death, and whilst the marked 
familial aggregation of H5N1 cases is suggestive of host genetic factors, this remains 
unproven. 
 
Conclusion 
The fundamental question ‘Is susceptibility to severe influenza in humans heritable?’  
remains unanswered. Not because of a lack of genotyping or analytic tools, nor 
because of insufficient severe influenza cases, but because of the absence of a 
coordinated effort to define and assemble cohorts of cases. The recent pandemic and 
the ongoing epizootic of H5N1 both represent rapidly closing windows of opportunity 
to increase understanding of the pathogenesis of severe influenza through multi-
national host genetic studies. 
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Introduction 
 
The on-going family clustering of highly pathogenic avian influenza A/H5N1 cases, 
as demonstrated by the deaths in 2011 of a mother and son in Cambodia, and of two 
siblings and their mother in Indonesia, has led to much speculation that host genetics 
play a critical role in susceptibility to H5N1 influenza [1-5]. Although H5N1 is an 
unusually virulent influenza virus, patterns of disease in other influenza epidemics 
also suggest a possible role for host genetics in susceptibility to severe influenza: 
around one-quarter to one-half of patients with severe pandemic influenza A/H1N1/09  
were previously healthy, with no co-existing medical condition or other predisposing 
factors [6]. Whilst the viral genetic determinants of influenza severity have been 
intensively studied, host determinants are much less well studied. 
 
A better understanding of the biological predispositions and pathways leading to 
severe influenza may lead to improved therapeutic options, and in 2009 the World 
Health Organization identified studies of the role of host genetic factors on 
susceptibility to severe influenza as a priority [7,8]. This systematic review was 
conducted with the objective of summarizing the current state of evidence that host 
genetic factors play a role in human susceptibility to influenza virus infection or 
disease. 
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METHODS 
The systematic review was conducted and reported in accordance with the PRISMA 
guidelines and the protocol was registered on the international prospective register of 
systematic reviews (PROSPERO registration number: CRD42011001380. Available 
at: http://www.crd.york.ac.uk/prospero/). Briefly, we conducted a systematic review 
to summarize relevant published and unpublished evidence of host genetic factors 
influencing the risk of influenza infection or disease (illness following infection). This 
comprised a search of PubMed, Web of Science, the Cochrane Library, and 
OpenSIGLE (grey literature bibliographic database) using a pre-defined search 
strategy (supplemental material). Two reviewers independently screened all the titles 
and abstracts to identify publications that may be relevant. A third reviewer assessed 
the two independent lists of selected and rejected sources and made the final selection 
where there were discrepancies. The full text of all the sources in the final list was 
obtained and reviewed independently by two reviewers to decide if they met the 
inclusion/exclusion criteria. The reference list of all selected sources was reviewed to 
identify relevant articles that may have been missed by the search strategy. Individual 
researchers were contacted directly to obtain additional information where the source 
material could not be obtained or to enquire about on-going or unpublished research.  
 
Certain categories of research were excluded from this review. A very large number 
of genes are up or down regulated during influenza infection and disease, and it was 
deemed outside the scope of this piece of work to review the extensive literature on 
the biological responses to natural or experimental influenza infection. These studies 
have recently been reviewed elsewhere [9]. Therefore we excluded studies of the 
molecular biology and pathogenesis of influenza except where the study directly 
compared the response to infection in genetically distinct animal strains with the 
objective of identifying host genetic determinants of response. We also excluded 
studies that solely examined the affects of gene knockouts, since a knockout mouse 
phenotype, although very useful for understanding pathogenesis, does not provide 
information on heritability of susceptibility under normal conditions, representing null 
alleles which rarely occur as such in the human population.  
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RESULTS 
The search strategy was run on 26th June 2011 and identified 1371 unique articles 
published in English for which the title and abstract was reviewed. 58 met the criteria 
for full text review, of which 29 were considered relevant to the study and could be 
obtained (Figure 1). A further 43 relevant articles were identified through a review of 
the bibliographies of the 29 selected papers and through contact with lead authors. A 
total of 72 articles were therefore included in the review. The identified published 
evidence fell into the following categories: studies in animals of host genetics; studies 
or reports of familial aggregation or heritability; studies in humans of blood group; 
studies in humans of HLA type; and studies in humans of host genetics. 
 
Animal studies 
It has long been known that susceptibility to influenza varies between inbred mouse 
strains because most laboratory strains carry a mutation in the Mx1 gene, which is a 
strong resistance locus for mouse-adapted influenza strains [10]. But more recently, it 
has been shown that genetic background also plays an important role for resistance or 
susceptibility, independent of the Mx1 allele. 
 
Myxovirus resistance gene 
The resistance of certain inbred mouse strains to influenza A infection was first 
reported in 1962 [10] and was subsequently localised to the Mx1 gene on 
chromosome 16 [11]. The Mx1 and Mx2 genes encode interferon inducible proteins, 
and Mx1 is able to inhibit influenza virus replication [12-21]. The role of Mx proteins 
in protection against influenza has recently been reviewed [22]. Susceptible mice have 
either deletions or a nonsense point mutation in the Mx1 gene that results in non-
functional Mx1 protein [18]. Mice expressing Mx1 are also better protected from the 
high mortality caused by the lethal H5N1 (A/Vietnam/1203/04) and H1N1/1918 
viruses and from the lung pathology mediated by these viruses [23,24]. Influenza 
viruses differ in their susceptibility to the action of Mx, with adaptive mutations 
permitting evasion of the Mx response or rapid viral replication outpacing the Mx 
response [22,24-28]. The H1N1/1918 and H5N1 (A/Vietnam/1203/04) viruses both 
demonstrate high replication efficiency and are highly pathogenic, and although both 
are sensitive to the antiviral activity of Mx, H5N1 (A/Vietnam/1203/04) is more 
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sensitive than H1N1/1918 [23,24,26]. Influenza virus strains of avian origin appear to 
have greater sensitivity to Mx than human influenza strains, indicating that adaptive 
mutations to escape Mx control may be required for successful cross-species 
transmission [26,28].  
 
Mx gene homologues are found in many species and the homologue in humans is the 
MxA protein encoded by the MxA gene on chromosome 21 [29,30]. In humans MxA 
demonstrates antiviral activity [13,16,17,19-21] and whilst polymorphisms of the 
human MxA gene exist, their relevance to influenza susceptibility has not been 
examined. 
 
Other susceptibility loci 
Although Mx genes are the best studied, there are many other candidates genes for 
influenza susceptibility. Several groups have directly studied the influence of genetic 
background on the susceptibility of different mouse strains to influenza.  All groups 
confirm that host genetic background plays a critical role in susceptibility to influenza 
and that highly susceptible mouse strains develop high viral loads, an elevated 
inflammatory response, and severe lung pathology following infection with a range of 
influenza viruses [27,31-33]. These studies were performed on inbred mouse strains 
that carried an Mx1 mutant allele. 
 
Toth et al have examined the genetic basis of differences between mouse strains 
(BALB/cByJ and C57BL/6J) in sleep patterns during influenza H3N2 A/Hong 
Kong/X31/68 (HK-X31) infection, identifying a quantitative trait loci (QTL) on 
chromosome 6 associated with influenza-induced slow-wave sleep patterns [34]. The 
group also showed large differences between mouse strains (BALB/cByJ and 
C57BL/6J) in the expression of genes in the lung following influenza HK-X31 
infection [35]. In 2011 the same group showed significant strain differences in disease 
severity (as measured by survival and body temperature), viral titres and cytokine and 
chemokine concentrations in the lungs of four inbred strains of mice (BALB/cByJ, 
C57BL/6J, A/J, and DBA/2J) but did not demonstrate any statistically significant 
genetic loci associated with influenza HK-X31 severity using a QTL approach, 
although suggestive statistical associations were reported for regions on three 
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chromosomes (G-CSF chromosomes 5; CXCL10 chromosome 9, and IL-6 and 
CXCL1 on chromosome 18) [33]. 
 
Srivastava et al examined the susceptibility of seven inbred strains to influenza H1N1 
A/Puerto Rico/8/34 (PR8) and identified one resistant (C57BL/6J) and one highly 
susceptible strain (DBA/2J) [31]. The response of these two strains to H7N7 
A/Seal/Massachussetts/1/80 (SC35M) was also examined and DBA/2J mice were 
highly susceptible to SC35M virus infection compared to C57BL/6J mice.  A cross 
between these two strains showed the resistant phenotype, although with a slightly 
higher weight loss than the parental resistant strain, suggesting that susceptibility in 
mice may be a polygenic trait. Further studies by this group examined differential 
gene expression following PR8 infection of susceptible versus resistant mouse strains 
[36]. Innate immune response genes were up regulated in both strains but to a greater 
extent in the susceptible strain, and overall a large number of genes were up or down 
regulated only in the susceptible strain (75, 538, and 993 on days 1, 2, and 3 after 
infection respectively). Blazejewska et al then looked at the effect of three mouse 
adapted H1N1 PR8 viruses (“low pathogenic” PR8M and PR8F, and “highly virulent” 
hvPR8) in two mouse strains that had previously been shown to be resistant 
(C57BL/6) and susceptible (DBA/2J) to PR8M [27,31].  They found that whilst 
PR8M showed differential pathogenicity in the two strains as previously observed, 
PR8F and hvPR8 replicated equally well in both strains and caused similar weight 
loss and mortality, demonstrating that pathogenicity is co-determined by both host 
and pathogen genetics. Additional studies of the relative sensitivity of the DBA/2J 
mouse strain compared to C57BL/6 have shown that the DBA/2J strain is susceptible 
to a wide range of human, avian and swine derived influenza viruses [37,38].  
  
Boon et al explored the genetic determinants of susceptibility to an H5N1 virus 
containing 7 gene segments of A/Hong Kong/213/2003 H5N1 virus and the PB1 gene 
segment from A/Chicken/Hong Kong/Y0562/2002 H5N1 (termed HK213) infection 
using gene mapping of 66 strains of inbred mice (inbred between C57BL/6J and 
DBA/2J parent strains) and identified five genetic loci (quantitative trait loci 2, 7, 11, 
15 and 17) associated with resistance to H5N1 HK213 disease [32]. This suggests that 
multiple genes determine H5N1 susceptibility in mice. A total of 121 genes located 
within these five loci were identified as candidates based on RNA expression 
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analysis, which was narrowed to 30 candidates based on differential expression 
between susceptible and resistant strains. In particular, there were 3, 14, 5, 2 and 6 
candidate genes in QTL’s 2, 7, 11, 15 and 17, respectively.  The authors compared the 
outcome of HK213 infection in one mouse strain that expressed hemolytic 
complement and one that did not, finding that strains expressing hemolytic 
complement (Hc) gene, which is located on QTL 2, experienced increased survival 
rates at a 10-fold higher initial inoculum. However no association between Hc 
expression and susceptibility to influenza was observed in subsequent work by 
Trammel or Boon [33,39]. 
 
Boon et al further studied the susceptibility of 21 inbred mouse strains to H5N1 
HK213 infection, demonstrating that although viral loads were much higher in 
susceptible strains, the relationship between viral load and cytokine concentrations 
was the same in resistant and susceptible strains [39]. The authors concluded that this 
indicates that mouse strain differences in susceptibility to H5N1 lies in a failure to 
control viral replication rather than the induction of an aberrant inflammatory 
response. Gene expression and pathway analysis in six strains showed that differential 
gene expression mostly consisted of up-regulation in susceptible strains of genes in 
proinflammatory pathways, indicating the immune response is quantitatively but not 
qualitatively different between strains. Resistant mouse strains (SMR, C57BL/6R, and 
BALB/cR) did not express a distinctive set of genes controlling replication or disease. 
85 individual genes, again mostly associated with proinflammatory pathways, were 
identified whose expression was associated with susceptibility to severe disease. 
Three candidate genes identified in the 2009 study were also significant in the 2011 
publication and are being further explored (Grn, Ifi53, and Dhx58). In summary the 
2011 work by Boon et al suggest that genetic polymorphisms conferring susceptibility 
to severe H5N1 disease in mice lie in pathways that are involved in the early control 
of virus replication. 
 
Summary of animal models 
Mouse models clearly demonstrate a strong genetic effect on susceptibility to a range 
of influenza viruses. The Mx genes are the best studied but their relevance to 
susceptibility in humans is unknown and although the MxA gene should be considered 
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a candidate gene for further studies, there are many other candidates. Crossbred 
mouse strain studies have identified a large number of potential candidates. 
 
Familial aggregation or heritability 
Independent of genetic effects it is expected that influenza infection will aggregate in 
families since transmission of influenza is common within households. Family 
aggregation of severe influenza disease is however more likely to have a direct 
genetic component but such clustering might also be seen with indirect genetic effects 
(e.g. genetic predisposition to obesity) or non-genetic shared risk factors (e.g. air 
pollution). 
 
From the perspective of genetic epidemiology, familial aggregation is said to occur 
when the frequency of a phenotype is more common amongst close relatives of 
people with the disease than in the general population [40]. Heritability is the 
proportion of the variation in the frequency of the phenotype that can be attributed to 
genetic variation. Familial aggregation can occur without heritability if the increased 
familial risk is due to shared non-genetic factors. On the other hand, genetics can still 
be important without any detectable heritability, since if there is no genetic variation 
in a population then heritability is zero, even though all cases may require a particular 
genetic background. However, significant heritability does suggest the presence of 
genetic factors that may be detectable by genotyping studies. 
 
Genealogical studies 
Two studies utilised large genealogical databases to look for evidence of heritability 
of susceptibility to death from influenza [41,42]. The study by Albright et al used a 
Utah database to look at 4855 deaths from influenza between 1904 and 2004 [41]. 
Gottfredsson et al concentrated on the 1918 influenza pandemic in Iceland and looked 
at 455 deaths over a six-week period [42]. Both studies found evidence of familial 
aggregation of influenza deaths but differed in their conclusions regarding heritability. 
Albright et al concluded that their results supported heritability since there was an 
increased relative risk of influenza death amongst relatives of people who died of 
influenza (relative risk 1.54; 95%CI 1.42–1.67; P-value <.0001), and this was greater 
than observed for relatives of spouses of individuals dying from influenza. Also, 
influenza deaths in relatives were frequently not associated closely in time (they 
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studied deaths over 100 years) and there was greater than expected relatedness 
amongst influenza deaths even after close relatives were excluded. Gottfredsson et al 
concluded that their results did not provide evidence of a heritable predisposition to 
death from 1918 influenza, as they did not identify a statistically significant difference 
in the relative risk of influenza death in relatives of people who died of influenza  
(relative risk in 1st degree relatives = 3.75; 95% CI 2.53-5.24) compared to relatives 
of their spouses (relative risk in 1st degree relatives = 2.95; 95% CI 2.01-4.49. P-
value for comparison of relative risk in the two groups = 0.198). The apparently 
conflicting conclusions of these two studies was discussed by Dowell and Bresee, 
who highlighted the fact that the highest relative risk of influenza death in both 
studies was in the spouse of cases, so shared social and environmental conditions are 
important factors and the family aggregation of severe influenza (for whatever reason) 
offers opportunities to identify and target high risk individuals [43].  
 
The study by Gottfredsson et al had ten-fold fewer subjects than the study by Albright 
et al and as such was considerably less well powered to detect differences in the risk 
of death in relatives of cases compared to relatives of spouses. Also Gottfredsson’s 
study did not assess the relatedness of cases and was not able to examine deaths 
outside the six-week period studied, which would be less confounded by common 
exposures. As such the study by Albright et al provides moderate evidence of a 
heritable component to the risk of influenza death, whereas the Gottfredsson study is 
inconclusive. 
 
Ethnicity 
Racial differences in influenza attack rates have been described historically [44,45]. 
More recently, an increased risk of hospitalization or death with pandemic influenza 
H1N1 in indigenous and minority ethnic groups has been reported, particularly in the 
America’s, Australasia and the Pacific [46-51]. Ethnic disparities are observed for 
many infectious diseases, much of which relates to inequalities in socioeconomic 
status and related differences in living conditions, access to health care, behaviours, 
and the prevalence of chronic diseases. No studies have been conducted to determine 
the genetic component of ethnic differences in rates of influenza hospitalization and 
death.  
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Familial aggregation of influenza H5N1 
Influenza H5N1 is a rare human infection that displays clustering and familial 
aggregation of cases [3,5,52]. Around one third of all H5N1 cases occur in clusters 
and of the 54 H5N1 clusters summarised in January 2010, 50 were comprised only of 
blood relatives [5]. Pitzer et al have examined the familial aggregation of H5N1 cases 
and  argued that although familial aggregation of H5N1 cases is observed, it is more 
consistent with non-genetic variation in household risk of exposure to H5N1 than 
host-genetic factors [53]. Horby et al have disputed the inferences drawn by Pitzer et 
al and argued that the totality of the epidemiological data is suggestive of a host 
genetic effect on susceptibility to H5N1 infection [3]. In addition to the familial 
aggregation of cases the evidence put forward by Horby et al includes: the low 
number of unrelated clusters, the occurrence of related cases that are separated in time 
and space (and therefore not compatible with common source exposure), and the poor 
correlation of exposure with risk [3]. 
 
Influenza associated encephalopathy (IAE)  
Acute encephalitis is a rare but well recognized complication of influenza infection, 
that occurs mostly in children aged under 5 years and is reported more commonly in 
East Asia than elsewhere [54]. There is little data to assess if there is genetic 
susceptibility to IAE other than a report of a mother and daughter with H1N1/09 IAE, 
two siblings with H5N1 IAE, and an analysis of three IAE cases which reported a 
missense mutation in the TLR3 gene in one case [55-57]. Acute Necrotizing 
Encephalopathy (ANE) is a distinct clinical syndrome that is characterised by 
multiple necrotic brain lesions and is associated with influenza infection but also with 
other viral infections [58]. A subset of patients with recurrent or familial ANE 
(ANE1) have a missense mutation in the ran-binding protein 2 (RANBP2) gene on 
chromosome 2 (q12.3) [58-60]. The mechanism by which this mutation confers 
susceptibility to ANE is not yet established. ANE is a very distinct clinical syndrome 
that, whilst having a genetic basis, is unlikely to have any relation to more general 
susceptibility to influenza. 
 
Summary of familial aggregation or heritability 
Although the data are limited and historic, the two genealogy studies clearly 
demonstrate familial aggregation of the risk of influenza-associated death. The Utah 
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study presents moderate evidence of a heritable component to the risk of influenza-
associated death. Whilst familial aggregation of H5N1 cases is generally accepted, 
there has been no formal estimation of the excess risk in relatives of cases compared 
to the general population. Such studies (e.g. familial relative risk studies) are 
theoretically feasible but challenging given the widespread distribution of H5N1 cases 
in time and space [61]. Estimating heritability of H5N1 is likely to be impossible 
since it is probably not feasible to disentangle genetic and non-genetic effects with 
such small numbers of cases.  
 
Blood group 
The 1960’s and 70’s saw a period of interest in the relationship between the ABO 
blood group and susceptibility to influenza infection. Studies involved observations of 
natural influenza infection [62-64], experimental infection [65], and serological 
studies [64,66-73]. The data are inconsistent, with authors reporting an increased risk 
of influenza in subjects with blood group O [62,65,66], groups O and B [63,68], B 
alone [67,74], A [73], A and B [64], AB [64,71], or no difference by blood group 
[69,70,72]. One group examined the ability to excrete soluble ABO blood group 
antigens in body fluids (secretor) and the risk of respiratory viral infections, and found 
a positive association between being a ‘secretor’ and influenza A infection [75]. 
 
Human leucocyte antigen (HLA) 
Work in the 1970’s by McMichael et al and extended by Doherty, Shaw and Biddison 
demonstrated that cell-mediated lysis of influenza infected cells is dependent on HLA 
specificities [76-81]. It is now well recognised that the HLA molecules plays a central 
role in antigen presentation to T-cells and indeed HLA is the classic example of 
genetic susceptibility to infectious diseases and of the influence of infectious diseases 
on human genomes [82]. Subsequent studies in mice and humans demonstrate that the 
HLA phenotype (H-2 in mice) influences the magnitude and specificity of the 
cytotoxic T lymphocyte (CTL) response to influenza infection [83-85]. Considerable 
work has also been undertaken to identify particular epitope-HLA molecule 
combinations that are associated with protective CTL responses in order to inform the 
design of vaccines targeting cell-mediated immunity [86,87].  However no genetic 
studies have been conducted to identify polymorphisms in HLA loci associated with 
susceptibility to influenza infection. Given the inherent diversity of HLA loci, the 
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complex interaction of HLA in determining responses to infection, and the linkage of 
HLA to other genes involved in innate immunity, such studies will be challenging 
[82,85].  
 
Human genetic studies 
Only one published human genetic study of susceptibility to influenza was identified. 
This study was a case control study that included 91 severe H1N1/09 cases and 98 
exposed but asymptomatic, unrelated household controls [88]. The authors took a 
discovery rather than a candidate gene approach, using a commercial chip that 
incorporates around 50,000 SNPs in regions associated with cardiovascular, metabolic 
and inflammatory syndromes (HumanCVD Genotyping Beadchip). 28,368 SNPs were 
analyzed and four SNPs on three different chromosomes had p-value of <0.0001. 
These SNPs remained associated after controlling for the potential confounding 
factors of obesity, diabetes, arterial hypertension, age, gender, and smoking. Three of 
the SNPs were in genes: an immunoglobulin Fc receptor (FCGR2A); a complement 
binding protein (C1QBP); and a protein that mediates the entry of replication protein 
A into the nucleus (RPAIN). Given the small size of the study, there is a reasonable 
probability that these are false positive findings, with the false discovery rate (the 
expected proportion of statistically significant findings that are false positives) for the 
four SNPs ranging from 22% to 56%. 
 
Reviews 
Five review articles were identified. The review by Trammel and Toth summarized 
animal and human data on genetic influences on influenza infection, with a particular 
focus on studies of differential gene expression [89]. This review highlighted the 
earlier work of Toth et al that identified 75 immune related genes (including 13 
interferon related genes and 10 chemokine related genes) that were differentially 
expressed in C57BL/6J compared to BALB/cByJ mice in response to influenza H3N2 
HK-X31 infection [35]. The review also identified increased expression of seven 
common genes in both H1N1/1918 and H3N2 HK-X31 infection of BALB/c mice, 
and 17 genes that showed increased expression in both human bronchial epithelial cell 
lines and mice infected with H3N2 (A/Udon/307/72	  human bronchial epithelial cell, 
HK-X31 mice) [35,90-92]. The review by Zhang et al proposed a list of around 100 
candidate genes that may be related to susceptibility to influenza infection based on 
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existing knowledge of the proteins involved in virus replication and the innate 
immune response [9].  An Editorial Commentary by Mubareka and Palese on the Utah 
genealogical study also discussed some potential candidate genes for host 
susceptibility to influenza, such as mannose-binding lectin, toll-like receptors, retinoic 
inducible gene I, 2’5’-oligoadenylate synthetase 1, and MxA [93]. Horisberger 
reviewed the data on the relationship between the Mx1 gene and influenza as it stood 
in 1995 (see section on Mx1) [94]. Horby et al reviewed the epidemiological evidence 
for genetic susceptibility to H5N1 and concluded that the data are suggestive of a host 
genetic influence on susceptibility to H5N1 disease [3]. 
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 DISCUSSION 
In mouse models the severity of influenza infection is clearly associated with both the 
pathogen and host genome. The observation that similar patterns of susceptibility or 
resistance of specific mouse strains are observed for a wide range of influenza viruses 
suggests that some of the host genetic determinants of susceptibility may be common 
across influenza subtypes. Susceptibility in mice is polygenic, and a number of 
candidate genes, including MxA, have been proposed. To date none of these candidate 
genes have been tested in studies of humans. Animal experiments will continue to be 
important for refining understanding of host-pathogen genetic interactions and for 
testing hypotheses about the pathogenesis of severe influenza. 
 
In humans the best available evidence, relying on a single study of 4855 deaths, 
suggests a heritable component of susceptibility to death from seasonal and pandemic 
influenza. Given the numerous confounding factors, replication of this finding will 
require a similarly large study. Although heritability has not been quantified for 
H5N1, the marked familial aggregation and other epidemiological features suggest a 
stronger heritable predisposition. To date only one study of human host genetics and 
susceptibility to severe influenza has been published and no human genetic 
polymorphisms associated with susceptibility to seasonal, pandemic or avian 
influenza have been convincingly demonstrated.  
 
Susceptibility to severe seasonal or pandemic influenza in humans is likely to be 
polygenic and is also likely to be co-determined by pathogen characteristics, prior 
infection history, co-morbidities, and environmental factors. In addition, the lack of 
evidence implicating any specific genes in humans suggests a hypothesis-free 
genome-wide approach should be taken. As such, very large studies will be required 
to identify genetic effects on susceptibility to severe influenza.  
 
Pandemic H1N1 offers a rare opportunity to study genetic susceptibility to severe 
influenza in a context that, compared to seasonal influenza, is less confounded by 
infection history and pathogen diversity. However, large sample sizes will still be 
required to detect polygenic traits and case selection will need to consider 
confounding by cross-protective immunity and co-morbidity. Several groups have 
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compiled series of severe H1N1/09 cases but it seems very unlikely that any single 
group will have sufficient cases to conduct an adequately powered genome-wide 
association study [95]. To have a realistic prospect of identifying susceptibility loci 
for H1N1/09, groups will need to form a consortium, as has been successful for other 
diseases [96]. The chances of identifying susceptibility loci in H1N1/09 can be 
enhanced by adopting an ‘extreme-trait’ study design e.g. where cases are previously 
healthy young adults who develop very severe disease with high viral loads and no 
evidence of bacterial co-infection. Influenza encephalitis is another ‘extreme-trait’ 
where case cohorts should be assembled for comparison with other influenza disease 
cohorts. There may still be possibilities to study susceptibility to 1918 pandemic 
influenza through linkage studies within large genealogical cohorts, where pedigree 
and cause of death data stretch back to the early 1900’s [41].  
 
Susceptibility to H5N1 may be less complex than ‘human influenza’, since the 
phenotype appears to be more dichotomous than continuous, immunity probably plays 
a lesser role, co-morbidity seems less important, and familial aggregation is more 
marked. The importance of understanding the pathogenesis of highly pathogenic 
influenza and the possibility that a rare genetic variant with a moderate to large effect 
underlies H5N1 susceptibility makes efforts to assemble DNA from H5N1 cases 
worthwhile. Given the small number of H5N1 cases and the possibility of a rare 
variant with a moderate to large effect, genome-wide association studies may not be 
the optimal design and alternative approaches to identifying causal loci may be 
needed, such as sequencing candidate genes, the whole exome, or the even whole 
genome [97,98]. Purely epidemiological studies may contribute to understanding the 
genetic component of familial aggregation of H5N1 by quantifying heritability. 
 
High viral replication efficiency, or from a host perspective a failure to control virus 
replication, is emerging as a key factor in severe influenza disease and is determined 
by both host and virus factors [27,39]. Thus studies of the determinants of influenza 
severity may benefit from a combined host-pathogen genetics approach, where the 
analysis of host genetic associations is conditioned upon the pathogen genotype in 
order to identify genotype-genotype interactions.  
 
Conclusion 
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The fundamental question ‘Is susceptibility to severe influenza in humans heritable?’  
remains unanswered. It is unanswered not because of a lack of genotyping or analytic 
tools, nor because of insufficient severe influenza cases, but because of the absence of 
a coordinated effort to define and assemble cohorts of cases. The recent pandemic and 
the ongoing epizootic of H5N1 both represent rapidly closing windows of opportunity 
to increase understanding of the pathogenesis of severe influenza through multi-
national host genetic studies. 
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Table 1. Key studies of familial aggregation, heritability, or genetic susceptibility in humans 
 
Author (Year) Study / Investigation Main Findings 
Albright FS (2008) [41] Study of 4855 deaths from influenza between 
1904 and 2004 in a Utah genealogical 
database. 
Evidence of heritability included: risk of influenza death greater in 
relatives of people who died of influenza than in relatives of the 
spouse of the person dying of influenza. Deaths in related people 
frequently did not occur close in time. Greater 'relatedness' 
amongst influenza deaths compared to age, gender and location 
matched controls. 
Gottfredsson M (2008) 
[42] 
Study of 455 deaths from 1918 influenza over 
a six-week period in Iceland.  
Familial aggregation of deaths was observed but there was no 
detectable heritable component as the difference in the risk of 
death between relatives of people who died of influenza and 
relatives of their spouse was not statistically significant. 
Mubareka S (2008) [93] Commentary on the two genealogy studies Heritability is unproven but the high risk in spouses identified in 
both studies indicates that people who share households with 
severe influenza cases are themselves at increased risk of severe 
influenza. 
Pitzer VE (2007) [53] Analysis of family clustering of H5N1 cases A high proportion of household clusters would be expected to be 
limited to ‘blood relatives’ by chance alone.  
Horby P (2010) [3] Review of epidemiology of H5N1 cases Epidemiological patterns that suggest host genetic susceptibility 
include familial aggregation of cases, related cases occurring 
separated by time and place, and low apparent risk in people who 
are highly exposed.   
Olsen S (2005) [52] Summary of family clustering of H5N1 cases 15 H5N1 clusters occurring between December 2003 and July 
2005 were summarised. 
WHO (2011) [5] Summary of H5N1 clusters reported to WHO, 
January 2003-March 2009 
Amongst a total of 480 Human H5N1 cases reported to WHO 
there were 54 clusters involving 138 cases (29% of cases). The 
remaining 342 cases were sporadic. In 50 clusters everyone was a 
blood relative. In the 4 remaining clusters, 2 clusters that included 
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>3 people, 9/11 people were blood relatives; and in 2 clusters, 
each contained 2 unrelated people. 
Zhang L (2009) [9] Review of candidate genes for influenza 
disease and immunity. 
Proposed a list of around 100 candidate genes based on published 
literature of their potential role in the pathogenesis of influenza. 
Zuniga J (2011) [88] Case-control genetic association study. 91 
cases of A/H1N1/2009 associated pneumonia 
and 98 exposed but asymptomatic household 
contacts. Genotyped using a cardiovascular 
disease chip with around 50,000 SNPs.  
Four SNPs were associated with severe pneumonia with a 
p<0.0001 after adjustment for gender and comorbidities (obesity, 
hypertension, and diabetes). 
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Table 2. Key studies of heritability or genetic susceptibility in mice 
 
Author (Year) Study / Investigation Main Findings 
Mx   
Lindenmann J (1962) [10] Experimental inoculation of A2G mice with 
H1N1/NWS/1933 virus 
A2G mice exhibit considerable resistance to 
intracerebral and intranasal to 
H1N1/NWS/1933 inoculation. 
Staeheli P (1988) [18] Molecular analysis of Mx1 alleles using 
restriction fragment length polymorphism 
(RFLP) and southern blot analysis of classical 
inbred mouse strains. 
 
The establishment of Mx1+ and Mx1- mouse 
lines was due to a single nonsense mutation in 
the Mx gene, which was represented in 
present-day mice by the prototype strains A2G 
and CBA/J. 
Horisberger MA (1995) [94] Review article of Mx genes and influenza    
Salomon R (2007) [23] Comparison of the effect in mice with and 
without a functional Mx1 gene of inoculation 
with H5N1 A/Vietnam/1203/04 and 
reassortants with the non-lethal virus 
A/chicken/Vietnam/C58/04.  
Compared to Mx1-/- mice, Mx1+/+ mice were 
protected from A/Vietnam/1203/04, showing 
lower viral tires, less pathology, and no 
deaths.  
 
Tumpey TM (2007) [24] Comparison of the effect in mice with and 
without a functional Mx1 gene of inoculation 
with H1N1/1918 and H5N1 
A/Vietnam/1203/04. 
Compared to Mx1-/- mice, Mx1+/+ mice were 
protected from 1918 H1N1 and 
A/Vietnam/1203/04, showing lower viral tires, 
less weight loss, and fewer deaths.  
Grimm D (2007) [25] Characterization of influenza A H1N1 (PR8) 
that is unusually virulent in Mx1+/+ mice.  
Virulence of PR8 is due to high replication 
ability, not inherent resistance to Mx1.  
Dittmann J (2008) [26] In-vitro study of the inhibitory effect of mouse 
Mx1 protein and human MxA protein on 
different influenza strains in cell culture or 
minireplicon assay.  
Influenza A viruses varied in their sensitivity 
to Mx proteins, with avian virus showing 
greater sensitivity than human viruses.  
Haller O (2009) [22] Review article of Mx genes and influenza    
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Zimmermann P (2011) [28] Study of the inhibitory effect of mouse Mx1 
protein and human MxA protein on H1N1/09 
(A/Hamburg/4/09) and highly pathogenic 
avian H5N1 (A/Thailand/1(KAN-1)/04) 
H5N1 (A/Thailand/1(KAN-1)/04) was more 
sensitive to Mx proteins than H1N1/09 
(A/Hamburg/4/09). This sensitivity was 
associated with the NP gene. 
Other susceptibility loci   
Toth LA (1999) [34] Study of strain associated variation in slow-
wave-sleep patterns in response to influenza 
H3N2 (HK-X31) infection. Sleep measurement 
of 13 recombinant inbred strains, which were 
from a cross between C57BL/6ByJ and 
BALB/cByJ mice. Quantitative Trait Loci 
(QTL) linked to phenotype were identified 
using a genome wide linkage scan against 223 
loci. 
 
A 10- to 12-cM interval on chromosome 6 
between D6Mit74 and D6Mit188 contains a 
quantitative trait loci (QTL) affecting the SWS 
response to influenza infection during the light 
phase.  
Ding M (2008) [35] Complementary DNA microarray analysis of 
lung and basal forebrain of influenza H3N2 
(HK-X31) infected and uninfected BALB/cByJ 
and C57BL/6J mice 
Gene expression in the lung in response to 
influenza infection was greater in 
BALB/cByJ. In lung, 361 different genes 
changed expression after influenza infection 
of BALB/cByJ mice as compared with 16 in 
C57BL/6J mice. Of 75 genes related to the 
immune response, 3 showed increased 
expression in the lungs of infected C57BL/6J 
mice, compared with 70 in infected 
BALB/cByJ mice. 
Trammell RA (2008) [89] Review article of human and animal data on 
host genetic susceptibility to influenza. 
 
Srivastava B (2009) [31] Comparison of response to H1N1 (PR8) 
infection in seven inbred laboratory mouse 
Different strains exhibited large differences in 
their response to PR8 infection. DBA/2J mice 
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strains. Additional comparison of response to 
H7N7 (SC35M) infection in one of the 
susceptible strains (DBA/2J) and one of the 
more resistant strains (C57BL/6J).  
were highly susceptible to both H1N1 (PR8) 
and H7N7 (SC35M) infection compared to 
C57BL/6J mice. DBA/2J mice showed higher 
viral loads, higher cytokine and chemokine 
expression, and greater lung pathology 
compared to C57BL/6J mice.  
Boon AC (2009) [32] Comparison of response of susceptible 
(DBA/2J) and resistant (C57BL/6J) mice, and 
66 recombinant inbred mouse strains to H5N1 
(HK213) infection using genome-wide linkage 
analysis and RNA expression analysis. HK213 
was selected for its reduced lethality in 
C57BL/6J mice while retaining lethality in 
DBA/2J mice. 
 
 
Following HK213 infection susceptible strains 
showed greater viral loads and pro-
inflammatory cytokines than resistant strains.  
Gene mapping with recombinant inbred 
strains revealed five Quantitative Trait Loci 
located on Chromosomes 2, 7, 11, 15, and 17 
associated with resistance to HK213 virus. 
121 unique candidate genes were identified 
whose genetic polymorphisms or different 
expression levels may have affect H5N1 
pathogenesis.  
 
Alberts R (2010) [36] Comparison of response to H1N1 (PR8) 
infection in susceptible (DBA/2J) versus 
resistant (C57BL/6J) mouse strains, analyzed 
by microarray gene expression analysis. 
 
DBA/2J mice had a sstronger 
chemokine/cytokine response. Innate immune 
response genes were up regulated in both 
strains but to a greater extent in the susceptible 
strain, and overall a large number of genes 
were up or down regulated only in the 
susceptible strain.  
Boon AC (2011) [39] Comparison of viral loads and host responses 
in 21 inbred mouse strains infected with H5N1 
(HK213). RNA expression and 
chemokine/cytokine analysis was undertaken 
Susceptible strains exhibited higher viral loads 
and concentrations of proinflammatory 
mediators. There was increased expression of 
proinflammatory genes in susceptible strains 
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in three susceptible strains (DBA/2S, 
129/SvImS, and A/JS) and three resistant 
strains (SMR, C57BL/6R, and BALB/cR). 
compared to resistant strains. Relationship 
between viral load and cytokine 
concentrations was the same in resistant and 
susceptible strains. 
 
Trammell RA (2011) [33] Evaluation of survival, viral load, and 
cytokine/chemokine responses induced in lung 
of four inbred mouse strains (BALB/cByJ, 
C57BL/6J, A/J, and DBA/2J) and QTL 
mapping 21 recombinant inbred strains 
following exposure to H3N2 (HK-X31).  
DBA/2J mice demonstrated greater 
susceptibility to severe disease. There were 
variable response patterns of mouse strains 
after in vivo and in vitro exposure to HK-X31. 
No significant QTL were detected. 
 
Blazejewska P (2011) [27] Comparison between DBA/2J and C57BL/6J 
mice of infection with three mouse-adapted 
variants of the H1N1 PR8 strain: PR8M, PR8F 
and hvPR8. 
The PR8F and the hvPR8 variants were lethal 
for both DBA/2J and C57BL/6J mouse strains; 
however, the PR8M variant is only lethal for 
DBA/2J mice. Infection of C57BL/6J mice 
with a re-assorted PR8 virus demonstrated that 
the HA gene is the primary determinant of 
virulence of the PR8F variant. 
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Figure 1. Identification and screening of articles for inclusion in systematic re-
view.
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Abstract 
Background 
Marked family clustering of highly pathogenic avian influenza A/H5N1 cases suggest that host 
factors may determine susceptibility to severe H5N1 disease.  
 
Method and Findings 
To identify single nucleotide polymorphisms associated with susceptibility to H5N1 we undertook a 
genome-wide, case-control discovery study in 51 H5N1 cases from Vietnam and Thailand. Five 
SNPs in two distinct genetic loci on Chromosome 2 were identified with odds ratios of 3-4 and P ≤ 
5 x 10-5 (three SNPs at Interleukin-1 gene cluster and two SNPs at TRPM8). One SNP at TRPM8 
(rs7560562) reached genome-wide significance at P ≤ 5 x 10-8. When genetic variation at both loci 
was considered simultaneously we found strong evidence of an association with susceptibility to 
H5N1 (P-trend = 7.80 x 10-12), with an odds ratio of 31 (95% ci = 9.84 – 98.18) for individuals 
carrying three copies of the risk alleles compared to wild-type individuals.  
 
Conclusions 
We have identified two potential candidates for genetic susceptibility to H5N1 that warrant further 
exploration and should encourage efforts to gather replication data sets from other countries with 
human H5N1 cases. 
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Introduction 
Highly pathogenic avian influenza A/H5N1 continues to circulate widely in poultry in many 
countries and cause human cases with high mortality (~60%). Over 50 cases have been reported so 
far in 2011 and Cambodia has experienced its highest-ever annual number of cases (eight), with 
100% mortality. Meanwhile the rapid evolution and genetic divergence of H5N1 viruses present a 
continuing risk of the emergence of strains with enhanced ability to infect humans [1]. A full 
understanding of the determinants of the high virulence of H5N1 is critical for developing 
predictive, preventive, and therapeutic tools against the public health threat of highly pathogenic 
influenza viruses.  
 
Around one third of all H5N1 cases have occurred in clusters, and 50 of the 54 H5N1 clusters 
reported as of March 2009 were comprised entirely of blood relatives [2]. The deaths this year of a 
mother and son in Cambodia, and of two siblings and their mother in Indonesia demonstrate the 
continued family clustering of H5N1 cases. Several authors have commented that this familial 
clustering suggests an important host genetic effect [3-6]. In addition to the familial aggregation of 
cases, additional evidence that suggests a heritable component to susceptibility to H5N1 includes 
the small number of clusters of unrelated cases, the occurrence of related cases that are separated in 
time and space (and therefore not compatible with common source exposure), and the very low risk 
of infection in some highly exposed groups such as poultry cullers [5].  
 
In mice, genetic background plays a substantial role in susceptibility to severe disease following 
infection with H5N1 and other influenza viruses, with susceptible mouse strains developing high 
viral loads, an elevated inflammatory response, and severe lung pathology [7-11]. Studies in cross-
bred mouse strains, gene expression studies, and analysis of know biological pathways have 
resulted in a large number of candidate genes being proposed for susceptibility to severe influenza 
disease [9,12-14]. However, to date none of these candidate genes have been studied in humans.  
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As with non-infectious diseases, there is usually a complex interaction between the pathogen, 
environmental influences, and a range of innate and adaptive host factors [15,16]. Occasionally 
however, highly penetrant, single locus genotypes have been identified which clearly confer either 
enhanced susceptibility or protection against infection [17,18]. H5N1 may be a particularly fruitful 
‘outlier’ in which to study host genetic determinants of influenza pathogenicity in humans since 
H5N1 displays marked familial clustering, an extremely virulent phenotype that does not seem to be 
associated with old age or pre-existing chronic illnesses, and is not complicated by pre-existing 
immunity [19]. Therefore the host determinants of H5N1 severity are likely to be less complex than 
for other types of influenza.  
 
Although extremely challenging due to the small number of cases and the limited availability of 
DNA from many of these cases, the importance of H5N1 as an exemplar of severe human influenza 
warrants substantial efforts to determine host genetic factors associated with this infection. We 
report the first attempt to identify single nucleotide polymorphisms (SNPs) associated with H5N1 
disease. A genome-wide, case-control, discovery approach was chosen since there are no prior 
genetic association studies in humans. 
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Methods 
Ethical approval 
The study was reviewed and approved by the ethical review boards of the University of Oxford 
Centre for Tropical Medicine; the National Institute for Hygiene and Epidemiology, Vietnam; and 
the Department of Medical Sciences of the Ministry of Public Health, Thailand. ClinicalTrials.gov 
Identifier: NCT01074736. All living subjects provided written informed consent. Written consent to 
attempt DNA extraction and genotyping from archived samples of people who had died from H5N1 
was obtained from relatives of the deceased person. 
 
Setting 
The recruitment of cases and controls was conducted in Vietnam and Thailand between June 2008 
and April 2010. Eligible H5N1 cases were identified from the national case lists maintained by the 
relevant national public health authority in each participating country. These were respectively, the 
National Institute for Hygiene and Epidemiology in Vietnam and the Ministry of Public Health in 
Thailand.  
 
Participants 
An individual was eligible for inclusion as a case of H5N1 infection if the individual had a 
clinically compatible illness (defined as respiratory symptoms and, an abnormal chest x-ray or 
encephalitis), and; influenza A/H5 RNA was identified in a clinical sample by reverse transcription-
polymerase chain reaction, or influenza A/H5 was cultured from a clinical sample, or convalescent 
serum samples had high titres (1:80 or higher) of anti-H5 antibodies by microneutralization assay. 
The H5N1 case patients were all initially diagnosed between December 2003 and February 2009.  
 
In Thailand ethnically matched unrelated controls were prospectively recruited from the same 
community as each H5N1 case patient. In Vietnam four different sources of controls were used. 1.) 
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Ethnically matched unrelated controls prospectively recruited from the same community as H5N1 
case patients; 2.) Unrelated participants in a community cohort study of influenza transmission in an 
area where human H5N1 cases had previously occurred; 3.) Population-based, unmatched cord 
blood samples; 4.) Relatives of H5N1 case patients.  
 
Community controls were used in order to reduce the chances of significant population stratification 
and to minimize other unmeasured biases. The cord blood samples represented a large, already 
genotyped data set that could be readily used as a reference panel to confirm Vietnamese control 
allele frequencies. The use of population-based, unmatched controls is valid when the studied 
disease is rare [20]. Relatives of H5N1 cases were recruited in an attempt to provide samples for a 
family-trio linkage analysis. Since insufficient family-trios were recruited for a family linkage 
study, non first-degree relatives were included in the analysis as controls. 
 
Laboratory methods 
DNA was extracted from samples (whole blood, mouthwash, and archived respiratory tract samples 
and serum/plasma samples) using standard protocols. Genotyping of the Vietnam and Thailand 
samples was performed using the Illumina Omni-Express chip according to manufacturer’s 
instructions. Genotypes were assigned in batches for each country separately. 
 
Statistical analysis 
Statistical analysis was conducted using PLINK version 1.06. Both SNP-based and sample-based 
quality control checks were performed. For SNPs, the quality control criteria for inclusion in the 
analysis were a) Call rate > 95 percent and, b) Minor allele frequency > 5 percent and, c) No 
significant deviation from HWE as assessed by P > 10-7 and, d) only autosomal SNPs. For samples, 
the quality control criteria for inclusion in the analysis were a) per-sample call rate > 95 percent, b) 
no first-degree relatives present within sample pairs, c) no significant outlying population ancestry.  
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Samples were then subjected to biological relationship verification using the principle of variability 
in allele sharing according to the degree of relationship, in order to identify and exclude 1st degree 
relatives. Those individuals who showed evidence of cryptic relatedness (possibly either due to 
duplicated or biologically related samples) were removed before principal component (PC) analysis 
was performed. PC analysis was undertaken to account for spurious associations resulting from 
ancestral differences of individual SNPs. Principal component analysis was conducted using multi-
dimensional scaling.  
 
Statistical tests of association were performed using the model-free allelic test to maximize 
statistical power. Meta-analysis was performed using the Cochran-Mantel-Haenszel stratified 
analysis, as previously described [21]. We also conducted an unguided 2 degrees of freedom 
genotype test (model free) to verify non-departure from the additive model for each SNP. 
 
To assess the additive effect of the genotype of the two highest scoring SNPs, a two-locus 
association analysis was performed using a simple 1 d.f. score test (trend test per-copy of the risk 
allele at either genotype), with the odds ratios for individuals carrying ≥ 1 copy of the risk allele at 
either locus compared against individuals who are wild-type at both loci (reference odds ratio = 
1.0). Only individuals with non-missing genotypes for both SNPs were included in this analysis.  
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Results 
Forty-five Vietnamese H5N1 cases and 178 controls (11 unrelated, ethnically matched community 
controls for K’hor ethnic minority; 70 unrelated controls from a community cohort; 97 non first-
degree relatives), plus an additional 2,018 Vietnamese cord blood controls passed the quality 
control filters. Six Thailand H5N1 cases and 33 unrelated community controls passed the quality 
control filters.  
 
A starting number of 733,055 autosomal SNPs were present on the Illumina Omni-Express. In 
Vietnam, a total of 5,206 SNPs had call rates < 95 percent, and 84,795 SNPs had minor allele 
frequencies of less than 5 percent and were excluded from analysis. Another 7,882 SNPs showed 
significant deviation from Hardy-Weinberg equilibrium (P < 10-7) and were also excluded from 
analysis. For Thailand, 6,435 SNPs had call rates < 95 percent, and 74,009 SNPs had minor allele 
frequencies of less than 5 percent. Another 36 SNPs showed significant deviation from Hardy-
Weinberg equilibrium (P < 10-7) and were also excluded from analysis. This left a total of 635,172 
SNPs common in both Vietnam and Thailand sample collections for downstream statistical 
analysis. All samples genotyped showed per-sample call rates of > 95%. No duplicates or first-
degree relatives were detected from the cases and controls used for analysis. Principal component 
analysis showed that cases and controls were well matched for both the Vietnam and Thailand 
sample collections (Figure S1). 
 
Single-locus analysis modeled with allele-based tests of association showed no inflation of test 
statistics compared to the null distribution (Figure 1). Joint analysis of the Vietnam and Thailand 
data showed five SNPs in two distinct genetic loci on Chromosome 2 with P ≤ 5 x 10-5 (three SNPs 
at the Interleukin-1 gene cluster, and two SNPs at transient receptor potential channel melastatin 8 
[TRPM8]), with P ≤ 5 x 10-8 at TRPM8 rs7560562 (Table 1, Figure 2). An additional four SNPs in 
the Interleukin-1 alpha gene had P ≤ 6 x 10-5 (Table 1). Review of the genotyping cluster plots in 
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both Vietnamese and Thailand collections showed distinct genotype clouds for SNPs, confirming 
their good quality (Figure S2). The allele frequencies of the Vietnamese controls were found to be 
consistent with the frequencies in a larger set of Vietnamese cord blood controls (Table S1). 
 
The risk of H5N1 jointly conferred by the two lead SNPs at TRPM8 (rs7560562) and IL1A / IL1B 
(rs4849124) was assessed. We observed evidence of association (P-trend = 7.80 x 10-12) over and 
above that seen with single SNP analysis (Table S2). The risk of H5N1 infection was around 30-
fold higher (OR 31.08; 95% ci = 9.84 – 98.18) in individuals carrying the maximal three risk alleles 
compared to individuals with no risk alleles (we did not observe any individuals carrying all four 
risk alleles at the two loci).  
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Discussion 
Summary and interpretation  
This study has identified five SNP’s in two loci on chromosome 2 that are associated with influenza 
A/H5N1 disease with an odds ratio of 3-4 and a P value of ≤ 10-5. Three of these SNPs are in the 
region encoding for the cytokines Interleukin-1 alpha (IL-1a) and Interleukin-1 beta (IL-1b), whilst 
two are in the region encoding for an ion channel, TRPM8. One SNP in the TRPM8 region reached 
genome wide significance [22]. The unavoidably small sample size requires that these findings are 
interpreted with caution since they may represent false positive rather than true positive associations 
[23], and even if real, the effect size (odds ratio) is likely to be overestimated [24,25].  
Nevertheless, the epidemiology of human H5N1 cases is suggestive of a strong genetic effect and 
both the identified loci are plausible candidates and potential therapeutic targets.  The greatly 
increased risk associated with a combination of risk alleles from both loci strengthens the 
confidence in their individual associations and suggests susceptibility is dependent on both genes. 
 
Clinical relevance 
Interleukin-1 cytokine gene cluster on chromosome 2 
The cytokines IL-1a and IL-1b are key to the innate recognition of invading microorganisms and 
the early initiation of an inflammatory reaction [26]. High levels of pro-inflammatory cytokines, 
including IL-1, are found in natural and experimental H5N1 infection, and correlate with disease 
severity, suggesting that cytokine dysregulation plays a role in the pathogenesis of H5N1 disease 
[27-32]. Functional-genomics approaches have shown up-regulation of IL-1a/b genes in response to 
H5N1 infection [14,33], and studies in IL-1 receptor deficient mice show that IL-1 may be critical 
to the control of extra-pulmonary spread of H5N1 [34,35]. IL1-b has previously been proposed as a 
candidate gene for study of the host genetic control of response to influenza infection [13].  
 
TRPM8 
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The TRPM8 gene codes for a nonselective transmembrane ion channel that is involved in the 
detection by sensory nerve cells of cold temperatures and of chemicals, such as menthol, which 
produce a cooling sensation [36,37]. TRPM8 is also found in other tissues including human 
bronchial epithelial cells, and has recently been linked to respiratory diseases, with ongoing work 
suggesting that TRPM8 expressed in bronchial epithelial cells also responds to respiratory viruses 
[38-40]. Activation of the TRPM8 channel in human bronchial epithelial cells results in the 
expression of inflammatory cytokines, including both IL-1a and IL-1b [41]. TRP channel 
modulators are under development for a range of clinical conditions [38]. 
 
Conclusion 
These data represent the first empirical evidence from humans of an association between genetic 
loci and susceptibility to H5N1. Although the identified SNPs may be false positive signals, the 
unusual threat posed by H5N1 warrants further exploration of these findings and should encourage 
efforts to gather replication datasets from other countries that have experienced H5N1 cases. 
Increases in sample size within the limits possible for a rare disease such as H5N1 may not however 
substantially increase the confidence in the results of any genome-wide analysis, and fine mapping 
or functional studies should therefore be pursued.                   
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Table 1. Results of Single Nucleotide Polymorphism analysis 
    Vietnam       Thailand        Meta-analysis   
SNP Alleles* Function 
Freq 
affected 
Freq 
unaffected 
OR P value 
Freq 
affected 
Freq 
unaffected 
OR P value OR 95% CI P value Phet+ 
Interleukin 
1, alpha 
              
rs4848300 G/A Intergenic (3’) 0.144 0.0435 3.71 6.22 x 10-4 0.167 0.0152 13 0.012 4.15 (1.96 - 8.79) 6.53 x 10-5 0.33 
rs17561 A/C Exonic 
(missense) 
0.144 0.0435 3.71 6.22 x 10-4 0.167 0.0152 13 0.012 4.15 (1.96 - 8.79) 6.53 x 10-5 0.33 
rs2856837 A/G Intronic 0.148 0.0435 3.81 4.75 x 10-4 0.167 0.0152 13 0.012 4.25 (2.01 - 9.02) 4.81 x 10-5 0.34 
rs1800587 A/G Exonic  
(UTR-5) 
0.144 0.0435 3.71 6.22 x 10-4 0.167 0.0152 13 0.012 4.15 (1.96 - 8.79) 6.53 x 10-5 0.33 
rs4848304 G/A Intergenic (5’) 0.144 0.0435 3.71 6.22 x 10-4 0.167 0.0152 13 0.012 4.15 (1.96 - 8.79) 6.53 x 10-5 0.33 
Interleukin 
1, beta 
              
rs4849124 A/G Intergenic (3’) 0.156 0.0466 3.77 3.53 x 10-4 0.167 0.0152 13 0.012 4.18 (2.01 - 8.67) 3.71 x 10-5 0.33 
rs2853550 A/G Intergenic 
(nearGene-3’) 
0.156 0.0466 3.77 3.53 x 10-4 0.167 0.0152 13 0.012 4.18 (2.01 - 8.67) 3.71 x 10-5 0.33 
TRPM8               
rs7560562 G/A Intronic 0.422 0.202 2.89 1.97 x 10-5 0.667 0.121 14.5 1.67 x 10-5 3.44 (2.17 - 5.47) 4.75 x 10-8 † 0.03 
rs6721761 A/C Intronic 0.456 0.233 2.76 3.30 x 10-5 0.667 0.152 11.2 9.77 x 10-5 3.22 (2.04 - 5.07) 1.81 x 10-7 0.053 
* Reverse strand notation 
+ P-value for heterogeneity of effect 
† P = 1.03 x 10-7 after continuity correction for significant test of heterogeneity of effect.
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Table S1. Minor allele frequencies for SNPs rs7560562 and rs4849124 in Vietnamese H5N1 cases (N = 45), Vietnamese unrelated adult 
controls (N = 178), and Vietnamese cord blood controls (N = 2,018).  
 
CHR SNP  Gene Base position MAF H5N1 cases  MAF controls MAF Vietnam cords 
2 rs7560562   TRPM8   234576953 0.422 0.205 0.22 
2 rs4849124     IL-1  113293372 0.156 0.045 0.0599 
MAF: Minor allele frequency 
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Table S2. Two-locus association test for TRPM8 rs7560562 and IL1A/IL1B rs4849124. 
Number of 
risk alleles 
Number of cord 
blood controls 
Number of 
controls 
Number of 
cases 
Frequency of cord 
blood controls 
Frequency 
of controls 
Frequency 
of cases 
Odds 
ratio 
95% confidence 
interval of OR 
Association 
test: Trend P 
Thailand          
0 - 25 0 - 75.8 0 1.00 NA  
1 - 7 3 - 21.2 50 NA NA  
2 - 1 2 - 3 33.3 NA NA  
3 - 0 1 - 0 16.7 NA NA  
Total  33 6  100 100   0.000033 
          
Vietnam          
0 1092 95 13 54.1 59 28.9 1.00   
1 738 52 16 36.6 32.3 35.6 2.25 (1.08 - 4.70)  
2 174 14 12 8.62 8.7 26.7 6.26 (2.81 - 13.93)  
3 15 0 4 0.74 0 8.9 24.35 (7.11 - 83.39)  
Total 2019 161 45 100 100 100   7.88 x 10-9 * 
          
Joint analysis          
0 1092 120 13 54.1 61.86 25.49 1   
1 738 59 19 36.6 30.41 37.25 2.22 (1.09 - 4.52)  
2 174 15 14 8.62 7.73 27.45 6.91 (3.20 - 14.93)  
3 15 0 5 0.74 0 9.80 31.08 (9.84 - 98.18)  
Total 2019 194 51  100 100   7.80 x 10-12 * 
 
NA = Unable to accurately estimate the odds ratios (OR) due to cells with zero counts. 
* Trend P for all controls including cord blood population controls 
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Figure 1. Quantile-quantile plot of the joint analysis of Vietnam and Thailand
data.
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Figure S1. Analysis of genetic ancestry for H5N1 cases and controls against HapMap
reference collections.
The top two principal components (PC) of genetic ancestry are plotted. Panel A: Vietnam. Panel
B: Thailand.
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Figure S2. Illumina genotype cluster plots for SNPs rs4849124 and rs7560562 in
Vietnam and Thailand H5N1 sample collections.
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Chapter 13
Discussion(genetics study)
13.1 Contribution to knowledge on host genetic
susceptibility to H5N1
Although the epidemiology of H5N1 is highly suggestive of a strong familial risk of
H5N1 (Aditama et al., 2011; Horby et al., 2010; WHO, 2010) a genome-wide association
study for such a rare disease was always going to be a high-risk, high-return exercise. It is
therefore both surprising and satisfying that the study has identified two possible candidate
loci for susceptibility to H5N1 infection. Nevertheless, the small sample size, the large
number of tests of association, and the low prior probability that any individual marker is
associated with the outcome, means that the probability of false-positive results is high.
However, a recent analysis of discovery and replication GWA studies has found that a
threshold for genome-wide statistical significance of P≤5×10−8 may be too stringent, with
73% of borderline associations (P>5×10−8 and P ≤5×10−7) being successfully replicated
(Panagiotou and Ioannidis, 2011). Given that the maximum number of H5N1 cases is
unlikely to be sufficient to reach stringent criteria for replication (genome-wide significance
of P ≤5×10−8 excluding the discovery data set) and the potential importance of any true-
positive association, the findings from the H5N1 GWAS deserve serious exploration.
The Interleukin-1 family is a group of 11 proteins produced by a variety of cell types, of
which the two cytokines IL-1α (IL-1F1) and IL-1β (IL-1F2) were the first to be discovered
(Barksby et al., 2007). The action of IL-1α and β is mediated through binding to type I
IL-1 receptors (IL-1RI) and results in the expression of a wide range of proteins involved in
the innate immune response and inflammation (Weber et al., 2010). As discussed in paper
6, IL-1α and IL-1β are highly plausible candidates for involvement in the pathogenesis
of severe H5N1 disease since a hyper inflammatory response is characteristic of natural
(de Jong et al., 2006; Deng et al., 2008; Peiris et al., 2004; To et al., 2001) and experimental
HPAI H5N1 infection (Baskin et al., 2009; Cameron et al., 2008; Cheung et al., 2002;
Cilloniz et al., 2010, 2009; Perrone et al., 2008; Sandbulte et al., 2008; Szretter et al.,
2007). These loci are especially interesting since blocking IL-1 activity through the use
of a recombinant IL1-receptor antagonist (anakinra) has already entered clinical practice
for the treatment of chronic inflammatory disorders. However, Boon et al. (2011) have
reported that H5N1 pathogenesis in genetically diverse mice is mediated by viral load
rather than an aberrant immune response and Salomon et al. (2007) have reported that
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mice deficient in key cytokine responses still succumb to H5N1 infection. Therefore the
host responses that limit the severity of H5N1 infection may act through control of virus
replication rather than immune responses.
The association with the TRPM8 gene is a novel and unexpected finding, and vali-
dates the use of an hypothesis-free genome-wide approach rather than a candidate-gene
approach. As discussed in paper 6, there are tantalising hints of biological plausibility,
with TRPM8 proteins possessing sialic acid residues (Morenilla-Palao et al., 2009), be-
ing expressed on bronchial epithelial cells (Sabnis et al., 2008), responding to respiratory
viruses (Abdullah et al., 2011), and activating inflammatory pathways (Sabnis et al., 2008).
Forms of TRPM8 that are rich in sialic acid residues are also preferentially localised in
lipid rafts within the cell membrane (Morenilla-Palao et al., 2009), and lipid rafts may
act as a platform for influenza virus cell entry and budding (Chazal and Gerlier, 2003;
Matrosovich et al., 2006; Scheiffele et al., 1997). TRPM8 molecules have received interest
from the pharmaceutical sector as therapeutic targets for asthma and chronic obstructive
pulmonary disease, and as such several TRP channel modulators are in development (Ban-
ner et al., 2011). Avenues for the development of therapeutic products therefore already
exist if the association is substantiated.
However, many preliminary gene-disease associations cannot be replicated, the so called
“winner’s curse” (Kraft, 2008), so prudence is needed when stating the importance of
these findings. Ideally the GWA study would have been better powered by including
China, Indonesia, and Egypt from the outset, but it proved impossible to engage the
serious interest of these countries until the results of the Vietnam and Thailand analysis
became available. The rarity of H5N1 cases means that traditional GWA methods and
statistical thresholds run a high risk of failing to detect susceptibility loci if they exist.
This dilemma is the same for any rare disease and alternative approaches, such as whole-
genome or whole-exome sequencing in highly selected patients, will be needed for the
discovery of rare gene variants (Cirulli and Goldstein, 2010).
13.2 Further research directions
Substantial further work on host-genetic susceptibility to H5N1 is ongoing. In order
to replicate the findings of the initial study, the case-control study has been extended to
China, Cambodia, Indonesia, and Egypt. Sixteen case samples and 62 controls have been
collected in China and are being genotyped in collaboration with the China Center for
Disease Control, whilst DNA samples have been acquired from a mother and child cluster
plus controls from Cambodia and are in storage at the Genome Institute of Singapore
(GIS). The Indonesian Minister of Health has agreed to conduct the study in Indonesia,
with the protocol currently being prepared for ethical review by the National Institute
for Health Research and Development. The Ministry of Health of Egypt have also agreed
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to participate and are currently preparing the protocol for ethical review. Sequencing of
the full IL-1α, IL-1β, and TRPM8 genes in the H5 cases already genotyped is ongoing at
GIS. We are collaborating with Richard Webby at St. Jude Children’s Research Hospital
to conduct titration studies with H5N1/HK/213/03 in B6 mice with depletion using anti-
IL-1α and anti-IL-1β antibodies and a TRMP8 antagonist compound. IL-1α, IL-1β, and
TRPM8 knock-out mice are also being bred for knock-out studies.
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Chapter 14
Concluding remarks
In this thesis I have presented work that aims to provide insights into the epidemiol-
ogy of influenza. The cohort study has added to the body of knowledge on the burden
and epidemiology of inter-pandemic and pandemic influenza in the tropics by providing
community level data that were previously absent, whilst the genome-wide association
study offers a potential explanation for the observed clustering of H5N1 cases. The cohort
data have value for planning influenza control programs in Southeast Asia but also for
formulating and examining hypotheses about the distribution and nature of the forces
driving the evolution of influenza. The GWA study has provided the first direct evidence
of genetic loci associated with susceptibility to H5N1 and opens new avenues of research
to test these findings and their relevance to the pathogenesis of H5N1 and other types
of influenza. It is therefore hoped that this work constitutes research of both ‘light’ and
‘fruit’ (Bacon, 1620): research that illuminates fundamental processes but which is also
useful for the practical task of controlling influenza.
The research has also stimulated ideas for a future research agenda. The publication of
the results of the H5N1 GWA study along with results in press of an association between
interferon-inducible transmembrane protein and severe influenza (personal communication
Paul Kellam) will build momentum for further studies of host genetics and influenza.
Whilst gene sequencing and functional studies are critical, there is also a necessity to
present robust statistical evidence of an association between putative loci and disease risk,
and to provide reliable estimates of the proportion of risk attributable to those loci. This
will require the pooling of data since no individual research group has sufficient severe
influenza cases to conduct an adequately powered GWA study. The pooling of data across
influenza subtypes/types is also important since host and pathogen genomes co-evolve
and interact to determine pathogenesis, and studies of host genetic factors influencing
the risk of severe influenza disease should therefore be conditioned on pathogen genetics
(Lambrechts, 2010). The challenge ahead is to unite centres working in isolation on small
numbers of patients to crystallise a consortium with sufficient patients and expertise to
conduct authoritative studies on the host determinants of severe influenza.
Whilst knowledge and understanding of influenza evolution and epidemiology has in-
creased in recent years, it is probably fair to say that over the period that this research
was conducted the control of influenza has not improved substantially. Public health inter-
ventions such as school-closures and hand-hygiene are short-term holding measures that
are unlikely to have a significant or sustainable impact on the burden of influenza, whilst
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influenza vaccination remains available to only a small minority of the global population
at risk. A good starting point may be the rehabilitation or rebranding of influenza as an
‘everyday’ cause of disease and death. Pneumonia remains the biggest killer of children
worldwide and it is likely that influenza causes 5-10% of these deaths and may contribute
to a much larger proportion(Nair et al., 2011). A potential role in pneumonia-prevention
programs of the immunisation of pregnant women and children against influenza deserves
much greater attention. Whilst a broadly protective vaccine that does not require an-
nual reformulation and delivery is an admirable aspiration, the epidemiology of influenza
suggests that this is a formidable challenge. Currently available influenza vaccines, par-
ticularly live-attenuated vaccines, may however be practical tools for influenza control
in developing countries. In addition, vaccine probe studies1, as have been conducted for
Haemophilus influenzae type b and pneumococcus, may be a particularly fruitful approach
for gaining insights into the preventable fraction of influenza-associated disease in children
in developing countries (Gessner et al., 2005).
A better understanding is also required of the critical components of influenza epi-
demiology that should be targeted for surveillance and control. Significant gaps remain
in our understanding of the role of East and Southeast Asia in the global epidemiology
of influenza, and although the number of HA gene sequences available from this region
has increased greatly in recent years, sampling remains patchy. This leaves substantial
room for phylogenetic and phylogeographic patterns to be biased by missing data and the
selective choice of virus subsets for genotyping. The increasing awareness of the need to
look beyond HA when considering viral evolutionary dynamics (Bhatt et al., 2011) means
that full-genome sequencing of systematically collected and chronicled isolates is required.
Population-based sero-surveillance is an under-developed area that also warrants atten-
tion. Sero-surveillance offers the tantalising prospect of being able to look ‘upstream’ to
measure patterns and changes in the driver of virus evolution (population immunity), but
is hampered by the lack of high-throughput and replicable antibody assays. The HI assay
is sensitive to experimental conditions (e.g. red cell type and operator) and because of
this experimental variability and the labour needed to process large numbers of samples
in duplicate, is not well-utilised as a public health surveillance tool (Katz et al., 2011;
Stephenson et al., 2007). What is more, increases in HI titres of only one dilution have
traditionally been ignored as they may represent assay error, but it seems likely that such
increases frequently represent a real response to infection. The application of a threshold
of a four-fold rise to define infection may therefore provide an incomplete picture of the
overall pattern and intensity of influenza infection, and the serological definition of infec-
tion for surveillance purposes should be reassessed. In addition, efforts are also needed to
identify whether the antibody status of individuals can be aggregated to provide a mean-
ingful measure of population immunity that has a quantifiable relationship to selection
1A vaccine trial designed also to ‘probe’ the vaccine-preventable burden of disease
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pressures. These issues represent a long but potentially navigable pathway towards devel-
oping sero-surveillance as a valuable tool for monitoring and predicting global influenza
epidemiology.
To conclude, the work presented in this thesis advances our knowledge of influenza
epidemiology and also helps to define elements of a future research agenda, but it is
undeniable that ample scope remains for deepening our understanding of influenza and
translating this into practical tools for control that benefit everyone.
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Identification of H5N1-Specific T-Cell Responses
in a High-risk Cohort in Vietnam Indicates the
Existence of Potential Asymptomatic Infections
Timothy J. Powell,1 Annette Fox,2 Yanchun Peng,1 Le Thi Quynh Mai,3 Vu T. K. Lien,3 Nguyen L. K. Hang,3 LiLi Wang,1
Laurel Y.-H. Lee,1 Cameron P. Simmons,4 Andrew J. McMichael,1 Jeremy J. Farrar,4 Brigitte A. Askonas,1 Tran Nhu Duong,3
Pham Quang Thai,3 Nguyen Thi Thu Yen,3 Sarah L. Rowland-Jones,1 Nguyen Tran Hien,3 Peter Horby,2 and Tao Dong1
1MRC Human Immunology Unit, University of Oxford, John Radcliffe Hospital, United Kingdom; 2Oxford University Clinical Research Unit and
3National Institute of Hygiene and Epidemiology, Hanoi, and 4Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam
(See the editorial commentary by Epstein, on pages 4–6.)
Background. Most reported human H5N1 viral infections have been severe and were detected after hospital
admission. A case ascertainment bias may therefore exist, with mild cases or asymptomatic infections going
undetected. We sought evidence of mild or asymptomatic H5N1 infection by examining H5N1-specific T-cell and
antibody responses in a high-risk cohort in Vietnam.
Methods. Peripheral blood mononuclear cells were tested using interferon-c enzyme-linked immunospot T assays
measuring the response to peptides of influenza H5, H3, and H1 hemagglutinin (HA), N1 and N2 neuraminidase, and
the internal proteins of H3N2. Horse erythrocyte hemagglutination inhibition assay was performed to detect antibodies
against H5N1.
Results. Twenty-four of 747 individuals demonstrated H5-specific T-cell responses but little or no cross-
reactivity with H3 or H1 HA peptides. H5N1 peptide-specific T-cell lines that did not cross-react with H1 or H3
influenza virus HA peptides were generated. Four individuals also had antibodies against H5N1.
Conclusions. This is the first report of ex vivo H5 HA-specific T-cell responses in a healthy but H5N1-exposed
population. Our results indicate that the presence of H5N1-specific T cells could be an additional diagnostic tool for
asymptomatic H5N1 infection.
Influenza H5N1 remains endemic in domestic poultry in
large parts of Asia, and although the total number of
human infections is relatively small, sporadic human ca-
ses with a high risk of death are still being reported [1, 2].
Since 2003, .500 human cases of highly pathogenic
influenza A H5N1 have been reported, with 119 cases
occurring in Vietnam [3]. At present, H5N1 influenza
cannot be transmitted readily between humans, but the
possibility remains of a recombination between H5N1
and other influenza viruses, resulting in a virulent and
easily transmissible virus [4].
The reported frequency and severity of H5N1 infection
in humans is almost certainly biased by the under-
detection of mild or asymptomatic cases: leading to an
underestimate of the number of cases and an overestimate
of the case fatality rate. The extent of this bias is indicated
by seroprevalence surveys that have reported anti-H5
antibody prevalence in exposed groups of between 0%
and 12% [5–9]. The presence of virus-neutralizing anti-
body is important for protection against influenza, and
antibodies that recognize specific hemagglutinin (HA)
subtypes can give an indication of recent infection history
[10, 11]. However, measurement of H5N1-specific neu-
tralizing antibodies has been problematic because the
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traditional hemagglutination inhibition (HAI) assay has low
sensitivity for the detection of H5N1 antibodies [12]. Alternative
assays that have been used for the detection of H5N1 infection
include horse erythrocyte HAI, microneutralization, and pseu-
doparticle assays [13]. These assays are all subject to false-positive
reactions due to the presence of cross-subtype neutralizing anti-
bodies [14]. Measuring interferon (IFN) c secretion by peripheral
blood mononuclear cells (PBMCs) after stimulation with pools of
HA peptides from different influenza strains demonstrates the
specificity and reactivity of T cells generated by strain-specific
vaccination [15–17] or memory cells generated after natural in-
fection [18–21].
In this study, we set out to investigate the rate of infection
with H5N1 virus in a community in rural Vietnam that had
previously experienced H5N1 cases in both poultry and humans
by measuring the prevalence of specific T-cell responses against
the HA and neuraminidase (NA) of H5N1 influenza virus. We
also compared T-cell responses against the proteome of seasonal
H3N2 and the HA and N1 of H5N1 and H1N1 influenza in the
community cohort with those in a group of persons who had
recovered from H5N1 infection and in healthy controls with no
exposure to H5N1.
MATERIALS AND METHODS
Patient Cohorts
For the community cohort, a household-based cohort was es-
tablished in a community in northern Vietnam that had pre-
viously experienced outbreaks of H5N1 in poultry and human
H5N1 cases. Human H5N1 infections had occurred in the
community in 2004, and additional human cases were identified
in 2007 and 2008 in nearby villages. Poultry outbreaks of H5N1
had been detected in the province intermittently since 2004,
including an outbreak 1 month before the beginning of the
study. Households were randomly selected from a complete
household register using a random number table. If a selected
household declined to participate, the nearest neighbor was
approached for participation. Members of the cohort provided
blood for collection of PBMCs and plasma in December 2007.
For the recovered case patients, persons who were convalescent
after H5N1 infection (n 5 19) were recruited between July 2008
andMarch 2009, at intervals of 84–1449 days (median, 1300) after
H5N1 onset (HHT Trang, A. Fox, T. Dong, LQMai, VTK Lien,
T. Powell, TN Duong, NTT Yen, PQ Thai, NT Hien, P Horby,
authors’ unpublished data). For the healthy control group, PBMCs
from volunteers (n 5 271) from the United Kingdom and Viet-
nam were tested by enzyme-linked immunospot spot (ELISPOT)
assays [19]. All participants provided written informed consent.
The study was approved by the ethical review boards of the Na-
tional Institute of Hygiene and Epidemiology (Hanoi, Vietnam),
the University of Oxford (United Kingdom), and the London
School of Hygiene & Tropical Medicine (United Kingdom).
Media, Peptides, and ELISPOT Screening
Dulbecco’s phosphate-buffered saline (Sigma–Aldrich) and R10
(Roswell Park Memorial Institute 1640 medium plus 10% vol/vol
fetal calf serum, glutamine, and penicillin streptomycin) medium
were used as described elsewhere [19]. The sequences of the full
influenza proteome from H3N2, A/New York/388/2005 (HA and
NA) and A/New York/232/2004 (H3N2) (internal proteins), HA
from H1N1 (A/Hong Kong/1134/98 and A/NewYork/228/2003),
and H5 and N1 from H5N1 (A/Vietnam/CL26/2004) were
split into overlapping peptides of 18–21 residues overlapping
by 10, using Peptgen (http://www.hiv.lanl.gov/content/sequence/
PEPTGEN/peptgen.html) synthesized by Sigma-Aldrich. Peptides
were divided into pools (Table 1). Overlapping peptides spanning
the entire length of each HA protein were split up into 2 pools
(eg, H5 into H5-1 and H5-2), and the amino acid range is shown
for each pool. The exact sequences of the peptides are available on
request.
Blood samples were taken from volunteers at local sites and
transported to the National Institute of Hygiene and Epidemiol-
ogy on the same day, where PBMCs were isolated and 2.5 3 105
were incubated with peptides at 2 lg/mL overnight, as described
elsewhere [19]. Plates were read on an ELISPOT plate reader
(CTL). Positive pools were defined using established criteria of
3 times average background and/or.10 spots per well [19]. Spot-
forming units were the actual number of spots generated from
a known number of cells.
Table 1. Peptide Pool Identities
Pool
Peptide Identity
(No. of Peptides in Pool)a
HA1-1 H1 HA1 1–294 (37)
HA1-2 H1 HA1 285–565 (37)
HA3-1 H3 HA3 1–298 (37)
HA3-2 H3 HA3 289–556 (37)
HA5-1 H5 HA5 1–281 (38)
HA5-2 H5 HA5 272–565 (39)
NA1-1 N1 NA1 1–227 (30)
NA1-2 N1 NA1 218–442 (31)
NA2-1 N2 NA2 1–303 (40)
NA2-2 N2 NA2 294–467 (24)
PB1-1 H3N2 PB1 1–380 (50)
PB1-2 H3N2 PB1 370–757 (50)
PB2-1 H3N2 PB2 1–384 (52)
PB2-2 H3N3 PB2 375–759 (52)
M1/2 H3N2 M1 1–252 (34); M2 1–97 (13)
NP-1 H3N2 NP 1–261 (34)
NP-2 H3N2 NP 252–498 (34)
NS1/2 H3N2 NS1 1–230(29); NS2 1–121(17)
PA-1 H3N2 PA 1–370 (49)
PA-2 H3N2 PA 361–716 (46)
a Numbers are the range of the AMINO ACIDS contained within the pool.
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Generation of B-Cell Lines and Antigen-Specific T-Cell Lines
Epstein Barr virus (EBV)–transformed B-cell lines (BCLs) were
generated by adding EBV supernatant, from a B958 cell line, to
1–2 3 106 PBMCs in a 96-well plate for 3–4 hours, followed by
2 lg/mL cyclosporine (Sandoz Pharmaceuticals) in R15 (RPMI
medium with 15% vol/vol fetal calf serum). Antigen-specific
short-term T-cell lines (STLs) were generated by pulsing PBMCs
with peptide for 90minutes, washing once, and then culturing in
96-well plates in H10 (10% vol/vol human AB serum; National
Blood Service). Three days later, interleukin-2 (PeproTech EC)
was added at a final concentration of 200 U/mL. STLs were
maintained by restimulating with peptide-pulsed autologous
BCLs every 10–15 days. For cultured ELISPOT assays, STLs were
rested in H10 for 26–36 hours and then used in an ELISPOT assay.
T cells (n5 40 000) were mixed with 10 or 2 lg/mL peptide pools
and cultured for 18–20 hours, and then spots were developed
using above protocol [22, 23]. T-cell lines that did not expand or
were negative at ELISPOT assay were excluded from analysis.
Cloning of Cell Lines
Cell lines were stimulated with peptide-pulsed autologous
BCLs for 3–4 hours followed by labeling with human IFN-c
capture kit (Miltenyi Biotec). High IFN-c producers were
sorted on a MoFlow cytometer (DakoCytomation). Clones were
restimulated every 14–21 days using phytohemagglutin-treated
irradiated allogeneic PBMCs, as described elsewhere [24].
Intracellular Cytokine Staining
Cells were stimulated with 10 lg/mL peptide for 1 hour fol-
lowed by addition of BFA/Monesin (BD Biosciences). After an
additional 12–16 hours, cells were washed, labeled with anti-
CD4 Pacific blue (eBiosciences) anti-CD8 fluorescein iso-
thiocyanate (BD Biosciences), permeabilized with FixPerm (BD)
labeled with anti–tumor necrosis factor a Allophycocyanin
(APC) (eBiosciences) and anti–IFN-c Phycoerythrin PE (eBio-
sciences), then washed with Perm/Wash (BD) and fixed. Cells were
analyzed on a CyAn flow cytometer (DakoCytomation).
HAI Assay and Antibody ELISPOT Assay
Plasma was tested in a standard HAI assay with antigens
representing clade 1 and clade 2.3.4 H5N1 strains circulating
in Vietnam and horse red blood cells, as described elsewhere
[7, 12]. Donors were considered positive if they had an antibody
titer of 1:40 or more [25].
RESULTS
Sufficient blood for ELISPOT assays was obtained from 747
participants in December 2007. Thirty-six participants had re-
sponses to H5 HA by ELISPOT assays. Twenty-four participants
(3.2%) demonstrated specific responses to the H5 HA peptide
pools but far lower ($2-fold, but the majority of H5-specific
responses were 5-fold) or no response to either H1 HA or H3
Figure 1. Enzyme-linked immunospot spot (ELISPOT) assay results in cohort
volunteers with H5 peptide-specific responses. Peripheral blood mononuclear
cells were stimulated with overlapping peptides from H1, H3, and H5 proteins
to the first half (A) and second half (B ) of the protein. Asterisks denote donors
who were also positive for H5 antibody. C, Percentage of each cohort who
had H5-specific T-cell responses by interferon-c ELISPOT assays. Number
of donors in each cohort is shown underneath each bar. Abbreviations:
HA, hemagglutinin; SFU, spot-forming units.
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HA peptide pools. This included 6 donors who only made re-
sponses to H5 peptide pools and were negative for H3 and H1
pools (Figure 1A, B). There were 111 participants who had
ELISPOT responses to H5 that are less than or equal to the H1
and/or H3 responses (Supplementary Table 1). However, none
of 271 healthy controls at low risk of H5N1 exposure showed
H5N1-specific responses, and 16% of person who had recovered
from H5N1 infection made specific responses to H5 HA pools
(Figure 1C). Of these recovered patients, tested during acute
infection for H5 HAI, 5 of 14 were positive (HHT Trang,
A. Fox, T. Dong, LQ Mai, VTK Lien, T. Powell, TN Duong,
NTT Yen, PQ Thai, NT Hien, P Horby, authors’ unpublished
data). Thirty-seven (5%) of the community cohort
participants had positive H5 antibody titers, and 4 also
showed H5-specific T-cell responses (Figure 1A, B, denoted by
asterisks). Within this group of individuals, 12 had T-cell
responses (4 with H5-specific responses, a subset of these) and
25 had no T-cell responses.
For further analysis of the H5-specific responders, STLs and
cultured ELISPOT experiments were performed. Tables 2 and 3
show the results of direct ex vivo and cultured ELISPOT from
a number of different donors who were positive for H5 re-
sponses at initial screening, and PBMCs were then expanded as
STL. Figure 2A shows 3 examples of HA STLs that show higher
responses to H5N1 HA pools than to H1N1 or H3N2 HA pools.
When similar experiments were done with other lines, 4 donors
had H5-specific STL after expansion in vitro (Table 2). Ten
donors had responses to internal pools that were either H3N2
peptide pool specific or cross-reactive with both H5N1 and
H3N2 peptide pools (Table 3).
To determine the T-cell recognition of the single peptides
containing potential epitopes from H5 HA pools in individuals
with H5N1-specific T-cell responses, STLs were generated and
tested by cultured ELISPOT assays using single peptides. The STL
grown from donor 0081 for the HA5-1 pool was able to recognize
only the peptide with the amino acid sequence 160–177 of
HA5160–77 FRNVVWLIKKNSTYPTIK and not the equivalent
peptides from H1 or H3 (Figure 2B). Another line grown from
this donor using the HA5-2 pool was able to respond only to the
peptide HA5439–56; TYNAELLVLMENERTLDF from the H5
strain of virus but not to the equivalent H1 and H3 peptides
(Figure 2C). A similar response to HA5439–56 was also found with
a second donor (data not shown). A second line generated from
donor 0081 using pool HA5-2 was specific to peptide HA5344–64
KKRGLFGAIAGFIEGGWQGMV (Table 2). Notably, HA5344–64
was CD4-restricted and HA5439–56 was CD8-restricted, so the H5
HA specificity was not limited to only CD8 T cells.
To investigatewhether this cohort had cross-reactive responses
against peptides from the internal proteins of influenza, STLs
were generated to internal peptide pools that had been found to
be positive in initial ELISPOT screening. These lines were tested
for reactivity against seasonal (H3) peptides and also H5 pep-
tides. STLs from 5 donors were able to recognize internal peptide
pools from both H3N2 and H5N1 (Figure 3 and Table 3). We
found 1 CD4 clone that was able to respond to peptide NS1163–85
GHTIEDVKNAIGVLIGGL, a peptide derived from an internal
H3N2 NS1 protein that has not been documented elsewhere. We
also identified several previously unknown individual peptides
containing potential T-cell epitopes in H3N2 internal proteins
that were cross-reactive with equivalent H5N1 peptides: PA163–80
Table 2. H5 Hemagglutinin (HA) Responders and Generation of HA5-Specific Short-Term T-Cell Lines (STLs)
Donora and Stimulation Poolb
Ex Vivo Responses STL
H5N1c H3N2 H1N1 Single Peptide Identityd CD4/CD8 Cell Typee
Donor 0081
HA5-1 1 2 2 HA5160–77 ND
HA5-2 1 2 2 HA5439–56, HA5344–64 CD8, CD4
Donor 0092
HA5-1 11 2 2 CD8
HA5-2 11 2 2 CD8
Donor 0148
HA5-2 11 2 2 HA5344–64 CD4
Donor 0275
HA5-2 1 2 2 CD4
Abbreviation: ND, no data.
a Donor number assigned during collection.
b Peptide pool used to stimulate the STL or peripheral blood mononuclear cells (PBMCs), as shown in Table 1.
c Ex vivo enzyme-linked immunospot response on fresh PBMCs;11 indicates strong response (.100 spot-forming units [SFU]/106 PBMCs);1, medium response
(40–99 SFU/106 PBMCs); 2, no response (,40 SFU/106 cells).
d Single peptide defined by incubation of STLs with single peptides.
e Lymphocyte subset CD4/CD8 defined by tumor necrosis factor a or interferon-c secretion in intracellular cytokine staining (ICS) after restimulation.
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RIKTRLFTIRQEMASRGL, PB2427–44 RLNTMHQLLRHFQK-
DAKV, PB2637–55 TVNVRGSGMRILVRGNSPV, NP199–216
RGINDRNFWRGENGRRTR, and PA406–21 KACELTDSIWIEL-
DEI, noted in Table 3.
DISCUSSION
We used ELISPOT assays to analyze T-cell responses to in-
fluenza in members of a community exposed to H5N1 and
found that 24 of 747 (3.2%) had specific responses to H5 HA
peptides but little or no response to equivalent H3 or H1 HA
peptides. H5-specific responses were further confirmed by
cultured ELISPOT assays and by growing STLs and clones.
AlthoughH5HA-specific CD4 T-cell responses can be generated
in unexposed healthy individuals by in vitro expansion from
PBMCs [26], this is the first study to detect H5 HA-specific
T-cell responses directly ex vivo in a cohort at high risk of H5N1
exposure. In contrast, we did not detect any ex vivo H5
HA-specific T-cell responses in 271 unexposed healthy controls.
Almost 5% of participants (37 of 747; 4.9%) had horse
erythrocyte HAI antibody titers$1:40, and 4 of them had both an
H5N1-positive antibody titer and H5-specific T-cell responses.
The poor correlation between the antibody and T-cell measure-
ments may be a result of different kinetics of persistence after
Table 3. Internal Peptide-Specific Short-Term T-Cell Lines (STLs)
Donor andPoola
Ex Vivob,c Expanded STL Specificity
Single Peptide Identifiedd CD4/CD8eH3N2 H5N1 H3N2
Donor 0018
NP-1 11 111 111 NP199–216 CD8
Donor 0053
NP-1 11 ND 111 CD4
Donor 0080
NP-1 11 11 11 CD8/CD4
NS1/2 11 11 11 CD4
Donor 0081
PB2-2 11 ND 111 PB2427–44, PB2637–55 ND
NS1/2 11 ND 11 NS1163–85 CD4
Donor 0092
PB1-1 11 ND 1 CD4
NP-1 11 1 11 ND
PA-1 11 ND 1 CD4
Donor 0109
NP-1 1 ND 1 ND
Donor 0130
NP-2 1 ND 11 ND
Donor 0141
NP-1 11 1 11 ND
NP-2 11 1 11 CD4
Donor 0142
M1/2 11 1 11 CD4
NP-1 11 1 11 CD8
Donor 0275
M1/2 11 1 11 CD4
NP-2 11 1 11 CD4
Donor 0492
NP-2 11 ND 11 CD8/CD4
Abbreviation: ND, no data.
a Peptide pool as defined in Table 1.
b Ex vivo enzyme-linked immunospot (ELISPOT) response on fresh peripheral blood mononuclear cells (PBMCs); 11 indicates strong response (.100 spot-
forming units [SFU]/106 PBMCs); 1, medium response (40–99 SFU/106 PBMCs); 2, no response (,40 SFU/106 cells).
c Derived STL. Rested ELISPOT response: 2. no response, 1, #50 SFU/105 cells; 11, 50–100 SFU/105 cells; 111 . 100 SFU/105 cells.
d Single peptide identified by stimulation in ELISPOT.
e CD4/CD8 defined by tumor necrosis factor a or interferon-c intracellular cytokine staining (ICS) after restimulation.
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virus exposure. H5N1 antibodies have been shown to persist after
severe infection [27] but decline after mild or asymptomatic in-
fection [5]. H5-specific T-cell responses are seen only in a small
proportion of confirmed cases, possibly because T-cell responses
are short-lived, as seen with seasonal influenza [28], and it is not
known how long specific H5 T-cell responses may persist. Both
HAI and T-cell assays may not identify all infections, because
there have been studies in which only 2 of 5 virologically con-
firmed H5N1 cases have antibodies detectable by HAI [12], and
H5N1-specific T cells are not detected in all persons convalescing
after confirmed H5N1 infection (HHT Trang, A. Fox, T. Dong,
LQ Mai, VTK Lien, T. Powell, TN Duong, NTT Yen, PQ Thai,
NT Hien, P Horby, authors’ unpublished data). Therefore, mea-
sured rates of prevalence could be underestimated whichever assay
(antibody or T cell) is used. Multiple time points and samples
would answer questions of persistence [5, 27], and further studies
are needed to explore this issue. Not many donors make both
T-cell and antibody responses, and this may be due to underlying
issues of immune repertoire between different donors or for the
H5N1 cohort differences in clinical interventions [29]. Because the
measured proportion of H5 HAI–positive results was greater in
patients who had recovered from H5N1 infection than in the
community cohort, HAI correlates to some extent with rate of
infection or exposure. T-cell or antibody responses have been
shown to persist for up to 6 months in vaccine studies [30, 31] but
to decline after early time points. Most studies use only early time
points [less than one month] after infection [15, 16]. Therefore,
this study was undertaken during the influenza season to obtain
samples during or shortly after influenza exposure [25].
The detection of subclinical H5N1 infection has several im-
portant implications. First, it can provide a more accurate as-
sessment of the probability of animal-to-human transmission
and of the severity of human H5N1 infection. Second, persons
with subclinical or asymptomatic H5N1 infection will not be
hospitalized and may be at risk of coinfection with another
seasonal virus, which could reassort with H5N1 [32]. Third,
identifying groups with different severities of H5N1 infection
can contribute to our understanding of the pathogenesis of se-
vere H5N1 influenza and factors that may influence suscepti-
bility to severe disease [6].
Most donors have cross-reactive H5N1 T-cell responses to
peptides from internal influenza genes that have been shown
elsewhere to respond to infected target cells [19, 20]. There
could be an important role for cross-reactive T-cell responses in
protection against H5N1. Further characterization of these
Figure 2. Hemagglutinin (HA)–specific short-term T-cell lines show
specificity for H5 pools, but not H3 or H1 pools, and are specific to
single H5 HA peptides. A, Peripheral blood mononuclear cells (PBMCs)
were expanded in vitro using HA5-1 or HA5-2 peptide pools and
interleukin (IL) 2. Ten days later, cells were rested overnight in IL-2–free
media and then tested in an enzyme-linked immunospot spot (ELISPOT)
assay using H5 pools, HA5-1 or HA5-2, depending on the specificity of
the line, or a mixture of H3/H1 pools from the same corresponding
region of the HA protein. B, C, STLs were restimulated with antigen
pulsed autologous B cells. After 10-day stimulation and 30-hour rest,
cells were tested in their response to specific peptides and the release
of interferon-c was measured by ELISPOT assay. A, B, C, Results shown
are spot-forming units (SFU) per 105 cells of duplicate or triplicate wells
(6 standard deviations).
H5N1-Specific T-cell Responses d JID 2012:205 (1 January) d 25
 at Oxford University on December 28, 2011
http://jid.oxfordjournals.org/
Downloaded from 
201
recognized peptides will help in the design of universal influenza
vaccines that target the less variable internal genes of the virus.
H5 HA-specific T cells are most likely to have been generated
as a result of prior infection with, or exposure to, a low level of
H5N1 virus. CD8 T cells are stimulated more readily by virus
infection rather than inactivated vaccines [31, 33]. A low level of
infection may have occurred because upper human respiratory
tract lacks the a2,3-galactose sialic acid receptors that H5N1
viruses preferentially bind [34] so that the H5N1 virus is unable
to replicate to a high titer.
In conclusion, we report evidence of possible subclinical
H5N1 infection demonstrated with T-cell ELISPOT assays.
These responses were not detectable by horse erythrocyte HAI.
We consider that detection of H5N1-specific T-cell responses
may be a useful adjunct to serology to identify the prevalence of
infection with H5N1. Further research is needed with different
cohorts in different geographical areas to determine whether this
is universally applicable. Characterization and comparison of
T-cell responses between asymptomatic responders and patients
who have recovered from H5N1 infection may provide insights
into the immune responses associated with severity of infection.
Identification of cross-reactive epitopes in asymptomatic in-
dividuals may provide useful information for universal influenza
vaccine design.
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Appendix B
R code
# R−s c r i p t f o r c r e a t i n g f i g u r e 2 in re sear ch paper 4 .
# Proport ion o f cases occurr ing in househo ld c l u s t e r s by p r o b a b i l i t y o f
i n f e c t i o n f o r d i f f e r e n t househo ld s i z e s .
# Clear workspace
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
rm( l i s t = l s ( ) )
l ibrary ( Hmisc )
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
# Set to output two graphs s i d e by s i d e
par ( mfrow = c (2 , 2) )
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
# SECTION 1 − DEFINE PARAMETERS
# tau i s p r o b a b i l i t y o f i n f e c t i o n ( assumed e q u a l f o r everyone )
tau . vector . length<−100
tau . vector<−seq (0 , 1 , length=tau . vector . length )
# Maximum nine persons per house in Ha Nam
n . vector<−( 1 : 9 )
# Total number o f houses in Ha Nam study
no . house . category<−c (231 ,342 ,533 ,541 ,334 ,111 ,16 ,8 ,8 )
# Proport ion o f househo lds o f s i z e n d e f i n e d by qn
qn<−c ( no . house . category/sum( no . house . category ) )
qn
# [ 1 ] 0.108757062 0.161016949 0.250941620 0.254708098 0.157250471
# [ 6 ] 0.052259887 0.007532957 0.003766478 0.003766478
# average house s i z e
sum( qn∗ ( 1 : length ( qn ) ) )
# [ 1 ] 3.419021
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
# SECTION 2 − DERIVE DATA FOR EACH HOUSEHOLD SIZE
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# Loop through ’n . vec tor ’ in the same way .
proport ion . in . c l u s t e r s<−matrix (NA, nrow=length ( tau . vector ) , ncol=length
(n . vector ) )
for ( i in 1 : length (n . vector ) ) {
n <−n . vector [ i ]
for ( j in 1 : length ( tau . vector ) ) {
# d i s t r i b u t i o n o f number o f cases per house
d i s t . c a s e s . per . house<−dbinom ( 0 : n , n , tau . vector [ j ] )
# average number o f cases per house
ca s e s . per . house<−n∗tau . vector [ j ]
# ( t o t a l number o f cases i s cases per house t imes m)
# t o t a l number o f cases in c l u s t e r houses i s m times sum of (
d i s t r i b u t i o n t imes 2 : n)
# ( c l u s t e r s are houses wi th 2 or more cases )
c l u s t e r . c a s e s . per . house<−sum( d i s t . c a s e s . per . house [ 3 : I (n+1) ] ∗I ( 2 : n
) )
# p ropo r t i on o f cases in c l u s t e r s
proport ion . in . c l u s t e r s [ j , i ]<−c l u s t e r . c a s e s . per . house/ ca s e s . per .
house
}
}
# Set NA to e q u a l zero − so pro por t ion in c l u s t e r s i s zero when
househo ld s i z e i s 1
proport ion . in . c l u s t e r s [ i s . na( propor t ion . in . c l u s t e r s ) ] <− 0
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
# SECTION 3 − SIMULATION TO DERIVE MEDIAN AND PREDICTION LIMITS
# s i z e ( number o f houses ) o f v i l l a g e to s i m u l a t e denoted by N
N<−2000
# Number o f househo lds o f s i z e n ( unrounded )
Nqn<−c (N∗qn )
# Number o f s i m u l a t i o n s
n . s imu la t i on s<−10000
# Prepare matrix to accep t data
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proport ion . in . c l u s t e r s . s imu la t i on<−matrix (NA, nrow=length ( tau . vector ) ,
ncol=3, dimnames=l i s t (NULL, c (’2.5 percentile’ , ’median’ , ’97.5 
percentile’ ) ) )
# Number o f househo lds o f s i z e n rounded
Nqn . round<−round(N∗qn )
# the rounding in the above may r e s u l t in a t o t a l number o f houses not
e q u a l to the s p e c i f i e d number
# most common house s i z e i s 4 ; ensure the t o t a l i s maintained by
modi fy ing t h i s e lement
Nqn . round [ 4 ]<−N−sum(Nqn . round [ c ( 1 : 3 , 5 : length (Nqn . round) ) ] )
# Check
sum(Nqn . round)
[ 1 ] 2000
# Prepare v e c t o r to accep t data f o r s i m u l a t i o n r e s u l t s
proport ion . in . c l u s t e r s . vector<−rep (NA, n . s imu la t i on s )
for ( i in 1 : length (n . vector ) ) {
n <−n . vector [ i ]
for ( j in 1 : length ( tau . vector ) ) {
# d i s t r i b u t i o n o f number o f cases per house
d i s t . c a s e s . per . house<−dbinom ( 0 : n , n , tau . vector [ j ] )
# s i m u l a t e v i l l a g e
# don ’ t need to do t h i s f o r every f i x e d house s i z e
# j u s t do i t f o r the f i r s t one
i f ( i ==1){
i f ( tau . vector [ j ]==0){
proport ion . in . c l u s t e r s . s imu la t i on [ j , ]<−c (0 , 0 , 0)
} else {
proport ion . in . c l u s t e r s . vector<−rep (NA, n . s imu la t i on s )
for ( k in 1 : n . s imu la t i on s ) {
house . s i z e s . long . s imu la t i on<−rep ( 1 : 9 , Nqn . round)
ca s e s .by . house . s imu la t i on <−rbinom(
n =length ( house . s i z e s . long . s imu la t i on ) ,
s i z e= house . s i z e s . long . s imulat ion ,
prob=tau . vector [ j ] )
# p r i n t ( t a b l e ( cases . by . house . s i m u l a t i o n ) )
# Expected t o t a l number o f cases in househo lds o f s i z e n
denoted by x
t o t a l . c a s e s . s imu la t i on<−sum( ca s e s .by . house . s imu la t i on )
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c l u s t e r . case . s imu la t i on<−sum( ca s e s .by . house . s imu la t i on [
ca s e s .by . house . s imulat ion >=2])
# p ropo r t i on o f cases in c l u s t e r s
proport ion . in . c l u s t e r s . vector [ k ]<−c l u s t e r . case .
s imu la t i on/ t o t a l . c a s e s . s imu la t i on
}
# p r i n t (summary( pr opo r t io n . in . c l u s t e r s . v e c t o r ) )
proport ion . in . c l u s t e r s . s imu la t i on [ j , ]<−
quantile ( propor t ion . in . c l u s t e r s . vector , probs=c ( 0 . 0 2 5 ,
0 . 5 , 0 . 975 ) )
}
}
}
}
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
# SECTION 4 − PLOT HOUSEHOLDS DATA AND SIMULATION
plot ( tau . vector , p roport ion . in . c l u s t e r s [ , 1 ] , yl im=c ( 0 , 1 ) , xl im=range (
tau . vector ) , l t y =2, type=’l’ , x lab="Probability of infection if 
exposed" ,
y lab="Proportion of cases occuring in household clusters" )
for ( i in 2 : length (n . vector ) ) {
l ines ( tau . vector , p roport ion . in . c l u s t e r s [ , i ] , l t y =2)
}
l ines ( tau . vector , p roport ion . in . c l u s t e r s . s imu la t i on [ , "2.5 percentile" ] ,
col =26, lwd=1, l t y =3)
l ines ( tau . vector , p roport ion . in . c l u s t e r s . s imu la t i on [ , "median" ] , col =26,
lwd=2, l t y =1)
l ines ( tau . vector , p roport ion . in . c l u s t e r s . s imu la t i on [ , "97.5 percentile"
] , col =26, lwd=1, l t y =3)
# Add minor t i c k marks
l ibrary ( Hmisc )
minor . t i c k ( nx=5, ny=0, t i c k . r a t i o =0.5)
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
# SECTION 5 − MARK PROB INFECTION CORRESPONDING TO 22% CLUSTERING
lower . bound . tau . median<−min( tau . vector [ p roport ion . in . c l u s t e r s .
s imu la t i on [ , "median" ]<=0.22])
upper . bound . tau . median<−min( tau . vector [ p roport ion . in . c l u s t e r s .
s imu la t i on [ , "median" ]>=0.22])
lower . bound . propor t ion . median<−max( propor t ion . in . c l u s t e r s . s imu la t i on [ , "
median" ] [ p ropor t ion . in . c l u s t e r s . s imu la t i on [ , "median" ]<=0.22])
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upper . bound . propor t ion . median<−min( propor t ion . in . c l u s t e r s . s imu la t i on [ , "
median" ] [ p ropor t ion . in . c l u s t e r s . s imu la t i on [ , "median" ]>=0.22])
s l ope <−(upper . bound . tau . median−lower . bound . tau . median)/ (upper .
bound . propor t ion . median−lower . bound . propor t ion . median)
i n t e r p . tau<−lower . bound . tau . median + ( s l ope∗(0.22− lower . bound .
proport ion . median) )
segments ( x0=0, x1=i n t e r p . tau , y0 =0.22 , y1 =0.22 , col =555 , lwd
=2)
segments ( x0=i n t e r p . tau , x1=i n t e r p . tau , y0=0, y1 =0.22 , col =555 , lwd
=2)
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
# Re−p l o t to f o c u s on low end o f p r o b a b i l i t y o f i n f e c t i o n
plot ( tau . vector , p roport ion . in . c l u s t e r s [ , 1 ] , yl im=c ( 0 , 0 . 5 ) , xl im=range
( 0 , 0 . 2 ) , l t y =2, type=’l’ , x lab="Probability of infection if exposed"
,
y lab="Proportion of cases occuring in household clusters" )
for ( i in 2 : length (n . vector ) ) {
l ines ( tau . vector , p roport ion . in . c l u s t e r s [ , i ] , l t y =2)
}
l ines ( tau . vector , p roport ion . in . c l u s t e r s . s imu la t i on [ , "2.5 percentile" ] ,
col =26, lwd=2, l t y =3)
l ines ( tau . vector , p roport ion . in . c l u s t e r s . s imu la t i on [ , "median" ] ,
col =26, lwd=3, l t y =1)
l ines ( tau . vector , p roport ion . in . c l u s t e r s . s imu la t i on [ , "97.5 percentile"
] , col =26, lwd=2, l t y =3)
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
# SECTION 5 − MARK PROB INFECTION CORRESPONDING TO 22% CLUSTERING
lower . bound . tau . 2 . 5<−max( tau . vector [ p roport ion . in . c l u s t e r s . s imu la t i on [ ,
"2.5 percentile" ]<=0.22])
upper . bound . tau . 2 . 5<−min( tau . vector [ p roport ion . in . c l u s t e r s . s imu la t i on [ ,
"2.5 percentile" ]>=0.22])
lower . bound . propor t ion . 2 . 5<−max( propor t ion . in . c l u s t e r s . s imu la t i on [ , "2.5
 percentile" ] [ p ropor t ion . in . c l u s t e r s . s imu la t i on [ , "2.5 percentile"
]<=0.22])
upper . bound . propor t ion . 2 . 5<−min( propor t ion . in . c l u s t e r s . s imu la t i on [ , "2.5
 percentile" ] [ p ropor t ion . in . c l u s t e r s . s imu la t i on [ , "2.5 percentile"
]>=0.22])
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s l ope <−(upper . bound . tau .2.5− lower . bound . tau . 2 . 5 ) / (upper . bound .
proport ion .2.5− lower . bound . propor t ion . 2 . 5 )
i n t e r p . tau<−lower . bound . tau . 2 . 5 + ( s l ope∗(0.22− lower . bound . propor t ion
. 2 . 5 ) )
segments ( x0=0, x1=i n t e r p . tau , y0 =0.22 , y1 =0.22 , col =555 , lwd
=2)
segments ( x0=i n t e r p . tau , x1=i n t e r p . tau , y0=0, y1 =0.22 , col =555 , lwd
=2)
lower . bound . tau . median<−max( tau . vector [ p roport ion . in . c l u s t e r s .
s imu la t i on [ , "median" ]<=0.22])
upper . bound . tau . median<−min( tau . vector [ p roport ion . in . c l u s t e r s .
s imu la t i on [ , "median" ]>=0.22])
lower . bound . propor t ion . median<−max( propor t ion . in . c l u s t e r s . s imu la t i on [ , "
median" ] [ p ropor t ion . in . c l u s t e r s . s imu la t i on [ , "median" ]<=0.22])
upper . bound . propor t ion . median<−min( propor t ion . in . c l u s t e r s . s imu la t i on [ , "
median" ] [ p ropor t ion . in . c l u s t e r s . s imu la t i on [ , "median" ]>=0.22])
s l ope <−(upper . bound . tau . median−lower . bound . tau . median)/ (upper .
bound . propor t ion . median−lower . bound . propor t ion . median)
i n t e r p . tau<−lower . bound . tau . median + ( s l ope∗(0.22− lower . bound .
proport ion . median) )
segments ( x0=0, x1=i n t e r p . tau , y0 =0.22 , y1 =0.22 , col =555 , lwd
=2)
segments ( x0=i n t e r p . tau , x1=i n t e r p . tau , y0=0, y1 =0.22 , col =555 , lwd
=2)
lower . bound . tau . 9 7 . 5<−max( tau . vector [ p roport ion . in . c l u s t e r s . s imu la t i on
[ , "97.5 percentile" ]<=0.22])
upper . bound . tau . 9 7 . 5<−min( tau . vector [ p roport ion . in . c l u s t e r s . s imu la t i on
[ , "97.5 percentile" ]>=0.22])
lower . bound . propor t ion . 9 7 . 5<−max( propor t ion . in . c l u s t e r s . s imu la t i on [ , "
97.5 percentile" ] [ p ropor t ion . in . c l u s t e r s . s imu la t i on [ , "97.5 
percentile" ]<=0.22])
upper . bound . propor t ion . 9 7 . 5<−min( propor t ion . in . c l u s t e r s . s imu la t i on [ , "
97.5 percentile" ] [ p ropor t ion . in . c l u s t e r s . s imu la t i on [ , "97.5 
percentile" ]>=0.22])
s l ope . 2 <−(upper . bound . tau .97.5− lower . bound . tau . 9 7 . 5 ) / (upper . bound .
proport ion .97.5− lower . bound . propor t ion . 9 7 . 5 )
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i n t e r p . tau . 2<−lower . bound . tau . 9 7 . 5 + ( s l ope . 2∗(0.22− lower . bound .
proport ion . 9 7 . 5 ) )
segments ( x0=i n t e r p . tau . 2 , x1=i n t e r p . tau . 2 , y0=0, y1 =0.22 , col =555 ,
lwd=2)
# Add minor t i c k marks
l ibrary ( Hmisc )
minor . t i c k ( nx=5, ny=5, t i c k . r a t i o =0.5)
#−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
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